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Abstract 
Matrix-assisted laser desorption/ionisation (MALDI) is a soft ionisation technique suitable for 
ionising biological molecules for analysis by mass spectrometry (MS). MALDI MS is typically 
performed on vacuum-compatible solid samples and on instruments with intermediate to high 
vacuum (10-2-10-7 mBar) ion sources.  
Less commonly, MALDI can be performed at atmospheric pressure (AP). However, AP-MALDI 
presents useful advantages. For example, compatibility is expanded to include samples with 
components usually volatile under vacuum conditions. Liquid samples may be analysed with ease. 
Recent developments in the fieldusing liquid support matrices (LSMs), which incorporate a viscous 
liquid into a solution of a MALDI matrix compound, have demonstrated the ability to reliably 
generate stable ion signal over long periods of time.  
Interestingly, the combination of AP-MALDI, LSMs and a heated ion inlet on the mass 
spectrometer enables the predominant generation of multiply charged ions. MALDI MS spectra 
are usually dominated by signals for singly charged ions, with high charge states generally the 
domain of electrospray ionisation (ESI). The m/z of highly charged proteins enables AP-MALDI 
analysis on narrow m/z range mass spectrometers. Additionally, tandem mass spectrometry 
(MS/MS) experiments also benefit: collision induced dissociation (CID) results in more fragment 
ion signals from multiply charged precursor ions and electron transfer dissociation (ETD) is 
possible, since it requires a minimum 2+ charge state to be performed at all.  
Liquid AP-MALDI has potential for mass profiling and sample screening, due to the reliability of 
the signal. In this thesis, the ability to rapidly analyse liquid samples using a prototype AP-MALDI 
ion source was demonstrated. Applications included the identification of doubly charged 
phospholipid ions by MS/MS; profiling of lipids, peptides and proteins for sample classification; 
and the assessment of milk samples for -lactamase activity. Barium adduct ions of 
phosphatidylcholines were successfully analysed by liquid AP-MALDI CID and ETD MS/MS to 
reveal detailed structural information. Profile analysis of milk extracts was used to classify milk 
samples. A major section focuses on the rapid and confident detection of bovine mastitis, a 
disease with a considerable economic impact.  
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1 Introduction 
 
1.1 Mass Spectrometry – a brief historical overview 
Mass spectrometry (MS) is a chemical analysis technique with roots that span back over a century 
into the investigation of “canal rays” by Wilhelm Wien.1 In 1908 he discovered that these rays 
(originally discovered in 1886 by Eugen Goldstein), which we now know to be positive ions, were 
deflected by magnetic and electric fields.2 The English scientists Sir Joseph John Thomson (1906 
Nobel Prize in Physics winner and the discoverer of the electron) and Francis William Aston (the 
1922 Nobel Prize in Chemistry winner) built upon this understanding in 1913 to detect beams of 
cations, which had passed through electric and magnetic fields, on a photographic plate.3 Two 
distinct traces were visible and attributable to Neon isotopes, 20Ne and 22Ne. This was the first 
discovery of isotopes of a stable element and is the first example of mass spectrometry. In 
addition to Arthur Jeffrey Dempster’s introduction of a mass spectrometer in 1918, Aston was 
responsible for the further development of his “mass spectrograph” into a true scientific 
instrument in 1919, with revisions to the design continuing for years after.4, 5 
In 1940, in what retrospectively is a significant moment in world history, a mass spectrometer was 
used to demonstrate the separation and collection of uranium isotopes.6 This led to the 
development of a 'calutron' for large-scale uranium enrichment during the Manhattan Project, 
alongside the gaseous diffusion method.7 This ultimately resulted in the development of 235U-
based nuclear fission bombs. The very first nuclear weapon used in warfare was 235U-based and 
was detonated above Hiroshima, Japan, in August 1945 by the USA.8  
An important advancement of the mass spectrometer was the proposal of the time-of-flight (TOF) 
mass analyser, a design which forwent the magnetic fields of its contemporaries. The concept was 
introduced by Stephens in 1946.9 A working instrument was demonstrated by Cameron and 
Eggers in 1948 (“Velocitron”) and later by Wolff and Stephens in 1953.10, 11 The TOF has become a 
staple mass analyser in contemporary mass spectrometry, incorporated into most of the major 
manufacturers’ product lines.  It is found in hybrid quadrupole-time of flight (QTOF) systems, first 
developed by Micromass (now Waters) in 1996, which are pervasive in biological MS.12-16 
 
Advances in the latter half of the 20th century saw recognition, in the form of the 1989 Nobel Prize 
in Physics, for Hans G. Dehmelt and Wolfgang Paul’s development of ion trapping techniques.17 
Most ion traps used for mass spectrometry are Paul traps, making use of radio frequency electric 
fields from three-dimensional quadrupoles, in linear, cylindrical or planar geometries. Linear ion 
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traps are commonly used as detectors for gas chromatography and incorporated into triple-
quadrupole mass spectrometers. Penning traps have found use in Fourier transform-ion cyclotron 
resonance (FT-ICR) MS, which enabled high m/z resolving power using technology derived from 
nuclear magnetic resonance (NMR) spectroscopy.18 The basis for a specific ion trap mass analyser 
that has become ubiquitous in modern biological MS, was described as early as 1923, and 
modified again in 1981.19, 20 Eventually, this concept of ion trapping was also applied by Alexander 
Makarov in form of the ‘Orbitrap’ mass analyser and was demonstrated with a laser desorption 
ion source before the conclusion of the 20th Century.21 Since 2005, mass spectrometers 
incorporating this type of ion trap have been exclusively manufactured and sold by Thermo Fisher 
Scientific. 
A plethora of ionisation techniques suitable for coupling to mass spectrometers were developed 
in parallel with mass analyser advancements. Most of these were only able to ionize atoms or 
small molecules, for example electron ionisation (EI) and chemical ionisation (CI), now typically 
found on gas chromatography-mass spectrometry (GC-MS) systems. Perhaps the most important 
ion sources for biological applications, electrospray ionisation (ESI) and matrix-assisted laser 
desorption/ionisation (MALDI), came into widespread use in the 1990s after development 
through the 1980s. Both are forms of 'soft' ionisation, resulting in little fragmentation of fragile 
molecules, and their application to biological macromolecules was partly awarded the 2002 Nobel 
Prize in Chemistry.22-25 
 
1.2 Quadrupole-time of flight (QTOF) mass spectrometry 
All mass spectrometers used throughout this project were of the QTOF design, thus particular 
focus will be paid to explaining their functionality. QTOF mass spectrometers are hybrid 
instruments, at the minimum combining a linear scanning quadrupole mass analyser (Q) followed 
by an orthogonal-acceleration TOF mass analyser (oaTOF). Figure 1 shows a schematic for an early 
Waters QTOF instrument. Additional abbreviations may be encountered, for example QqTOF (‘q’ 
indicating the second, transmission-only quadrupole for fragmentation experiments) and Q-IM-
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TOF (the IM indicating an ion mobility analyser situated between the resolving quadrupole and 
TOF analyser). For brevity, ‘q’ and ‘oa’ are often omitted now that the technology has matured.  
 
Figure 1: Simplified schematic of a QTOF MS; the blue line represents the ion beam from source to detector. 
 
The quadrupole mass analyser 
A QTOF’s quadrupole is rarely used as a mass analyser beyond instrument installation 
qualification and tuning, as its performance, in terms of mass accuracy, resolving power and m/z 
range, compared to the TOF analyser is poor. Modern systems do not include a detector post-
quadrupole. The scanning required for detection of all m/z within the desired acquisition range 
introduces inefficiencies in ion transmission, giving a low duty cycle. The reduced Mathieu 
equations describe the AC field component, often referred to as the radiofrequency (r.f.) 
component, and DC field component when operating as a mass analyser26: 
 
𝑞𝑀 =
4𝑒𝑉
(𝑚/𝑧)𝜔2𝑟0
2   Equation 1: Mathieu equation (r.f. component) 
 
𝑎𝑀 =
8𝑒𝑈
(𝑚/𝑧)𝜔2𝑟0
2   Equation 2: Mathieu equation (DC component) 
 
Where e is elementary charge, V is the r.f. voltage amplitude,  is the r.f. angular frequency, U is 
the DC voltage and r0 is the inscribed radius of the quadrupole. In analyser mode, the m/z 
transmission range is narrow. The duty cycle is significantly reduced since ions outside of the scan 
window are lost. However, the ability to ‘park’ a Q mass analyser on a specified m/z window does 
make it a useful device for MS/MS experiments (discussed in 1.2.1). Operating in transmission 
mode (without a DC component, i.e. ‘r.f.-only’), the quadrupole can act as a high mass filter, with 
stepping of the r.f. voltage required to transmit wider mass ranges. Duty cycle is reduced to a 
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lesser degree than in scanning mode but stepping still results in losses. The depth of the effective 
potential well is inversely proportional to m/z, so transmission is reduced at higher m/z in both 
modes. Many hybrid quadrupole MS instruments use an ‘MS profile’ to enhance ion transmission 
over a greater m/z range. 
Q mass analysers also have a much poorer mass resolving power relative to a TOF. Higher 
resolution for a Q mass analyser comes at the expense of scanning speed, meaning further duty 
cycle reduction. 
Other ion guides, operating under the same principles as a quadrupole, include other multipoles 
(hexa-, octa-, etc) and ring ion guides. Each features a characteristic pseudopotential well profile. 
Quadrupoles generate a V-shaped pseudopotential well, which enables narrow m/z window 
selection and ion focusing at the expense of transmission efficiency. Multipoles of higher number 
produce a more U-shaped pseudopotential well suited for higher transmission efficiency. Ring ion 
guides have the most U-shaped pseudopotential well of all the above, with a flat bottom and 
steep sides.27 Ion transmission is achieved by alternating the electrostatic potential polarity of two 
alternately-connected sets of stacked rings. Stacked ring optics are found in Waters QTOFs as 
collision cell and ion mobility optics, where a mass-resolving capability is not necessary, but 
trapping and transmission performance is required. 
 
Figure 2: Description of potential wells for different ion guides (where r0 is the distance to the outermost electrode 
surface from the ion guide central axis), and diagrammatic representation of each ion guide. Adapted from Figures 1 
and 3 as presented by Guan and Marshall.27 
 
The time-of-flight mass analyser 
Fundamentally, the TOF analyser relies on the conservation of energy; specifically, the conversion 
of potential energy (ep) to kinetic energy (ek).  
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𝑒𝑝 = 𝑄. 𝑈           Equation 3: Electric potential energy 
And 
𝑒𝑘 =
1
2
𝑚𝑣2    Equation 4: Kinetic energy 
 
Where Q is the elementary charge, U is voltage, m is mass and v is velocity. These are the 
parameters on which a TOF MS operates. A diagram of a combined linear/reflectron MALDI-TOF 
MS is shown in Figure 3. TOF MS typically uses constant energy acceleration (CEA); an accelerating 
potential, U, is applied to ions before the field free region, thus providing the same ek to all. The 
alternative, constant momentum acceleration has not found widespread use.28 The flight time of 
ions through the field free region is recorded upon contact with a detector, with ions of greater 
m/z ratio taking longer than those with a smaller m/z ratio. 
 
Figure 3: Diagram of a linear/reflectron TOF MS. Low mass (small circle) ions arrive at the detectors faster than high 
mass ions (big circles) of the same charge. The reflectron reduces the flight time spread between high (black) and low 
(white) energy ions of the same m/z ratio, providing higher mass resolution than linear TOF mode. 
Since velocity is simply = distance/time, the m/z ratio is calculable from the following relationship: 
 𝑡 = 𝑘√
𝑚
𝑧
    Equation 5: Ion flight time 
 
Where t is the flight time and k is a constant derived from the flight distance d and the electric 
potential difference U, applied to accelerate ions: 
 
𝑘 =
𝑑
√2𝑈
  Equation 6: Instrument parameter-derived constant 
 
The TOF of a QTOF is positioned orthogonally to the ion beam exiting the quadrupole and transfer 
optics (see Figure 1). As a result, the beam must be redirected inside the TOF to enter the field-
free drift region, whereas the ion beam from a linear/reflectron TOF is produced axially to the 
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analyser. An assembly of electrostatic grids, culminating as the ‘pusher/puller’ or ‘ion modulator’, 
sample the incident ion beam and trigger the beginning of flight time measurement. The pusher 
pulse frequency is varied to accommodate the acquisition m/z range, since ions of greater m/z 
drift more slowly than low m/z ions in the field-free region between modulator and detector, as 
described by Equation 5. 
For instance, the flight time of two ions, [A+H]+ and [B+H]+, of mass 1000 Da and 10,000 Da 
respectively and unit charge of 1+, for an example flight distance of 1.5 m and accelerating 
potential of 10 kV: 
𝑡([𝐴 + 𝐻]+) =
1.5 𝑚
√2 × 10000 𝑉
√
(1000 𝐷𝑎 × 1.66 × 10−27 𝑘𝑔)
1.602 × 10−19 𝐶
= 3.42 × 10−5𝑠 
𝑡([𝐵 + 𝐻]+) =
1.5 𝑚
√2 × 10000 𝑉
√
(10000 𝐷𝑎 × 1.66 × 10−27 𝑘𝑔)
1.602 × 10−19 𝐶
= 1.08 × 10−4𝑠 
 
Thus, a wider m/z range reduces the number of times the pusher can trigger per second without 
causing ions to overlap, thus reducing TOF duty cycle. For example, the Synapt G2-Si QTOF mass 
spectrometer employed for most analyses of this project, with an acceleration potential of 10 kV, 
was used with a pusher interval of 69 µs for m/z 100-2000, and 110 µs for m/z 100-5000.  
Additionally, the benefit of multiply charged ions for increasing the duty cycle when analysing 
large molecules can be demonstrated with the example of [B+10H]10+: 
 
𝑡([𝐵 + 10𝐻]10+) =
1.5 𝑚
√2 × 10000 𝑉
√
(10009 𝐷𝑎 × 1.66 × 10−27𝑘𝑔)
(10 × 1.602 × 10−19 𝐶)
= 3.42 × 10−5𝑠 
 
Multiply charged ions also possess greater kinetic energy because of the relationships described 
in Equations 3 and 4. The flight time is shorter for higher charged ions of an analyte of mass m, 
because the velocity is higher, resulting in a greater amount of kinetic energy imparted upon 
hitting the detector. TOF analysers in a QTOF have multichannel plate detectors (MCPs) 
connected to a time-to-digital converter (TDC) or analogue-to-digital converter (ADC). A fast ADC 
is beneficial for applications requiring high dynamic range. Each channel on the MCP acts as 
electron multiplier, in the presence of a strong electric field. An impacting ion produces a cascade 
of electrons, which are amplified and recorded. An ion of charge 2+ ejects approximately double 
the number of electrons from the MCP as a 1+ ion of the same m/z.29 Ultimately this manifests as 
greater sensitivity to multiply charged ions, in addition to the duty cycle improvement from the 
narrower acquisition m/z range. For these reasons, a doubly charged ion signal tends to 
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overrepresent the number of ions detected when compared to the singly charged ion of the same 
analyte. This is also true for MALDI-axialTOF mass spectrometers, but without the pusher duty 
cycle factor, since the m/z measurement is initiated by the firing of the laser, rather than a pusher 
pulse.  
 
The mass resolving power of a CEA TOF analyser is described by: 
 
𝑚
∆𝑚
=
𝑡
2∆𝑡
  Equation 7: CEA TOF mass resolving power 
 
Where m is mass and, Δm is the peak width at half its maximum intensity, t is time-of-flight and Δt 
is the time difference in arrival times for the two ion packets. Slight energy differences in 
otherwise identical ions entering the field free region are a limiting factor for TOF resolving power 
since this produces the peak width.30 The 
𝑡
2∆𝑡
 dependency leads to a decrease in resolving power 
with increasing m/z since the kinetic energy distribution for heavier ions is higher than for lighter 
ions.28 Orthogonal acceleration in a QTOF instrument alleviates some of the kinetic energy 
differences, so the resolving power for heavier ions tends to be better than for axial TOF. Modern 
commercial reflectron oaTOFs typically have a resolving power of 10,000 – 60,000, at 
approximately m/z 1000, depending on their mode of operation (which sacrifice sensitivity for 
improved peak resolution). Mass resolving power is typically quoted for an analytical standard at 
a defined m/z. 
The variance in flight times for ions of identical m/z is reduced by incorporating an ion mirror, 
which effectively doubles the ion beam path length, reduces energy spread and results in more 
highly resolved peaks in the mass spectrum. 
 
𝑡 =
𝑑
√2𝑈
√
𝑚
𝑧
+
2𝐿𝑚√2𝑈
𝑈𝑚
√
𝑚
𝑧
 Equation 8: Time of flight with a single-stage reflectron 
 
Where t is ion flight time, Lm is the length of the ion mirror, U is pusher potential difference, Um is 
the ion mirror potential difference and other parameters are as described in Equations 5 and 6. 
Dual-stage reflectrons may be used to improve resolving power performance. These feature two 
electric fields of differing field strengths; the first, strong to rapidly decelerate ions and the 
second weaker.31 Dual-stage reflectrons can correct kinetic energy distributions to the second 
order, limited to just the first for the single-stage variety, hence the improved resolving power 
and are typical of the reflectrons found in oaTOFs today.32 
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An oaTOF usually incorporates a reflectron, producing a V-shaped ion path, for improved 
resolution compared to a linear TOF. Some commercial instruments incorporate multiple 
reflectrons or reflectron passes to boost resolution further, for instance, with W and N-shaped 
paths (examples in Figure 4). Additional novel TOF geometries are also reported in the 
literature.33-35 
 
 
Figure 4: Schematics of (a) W-optics on a Waters Synapt G2-Si and (b) N-optics of a Sciex X500R QTOF. 
 
1.2.1 Tandem mass spectrometry 
QTOF mass spectrometers are capable of tandem mass spectrometry (MS/MS) experiments. 
MS/MS involves an ion fragmentation step experiment performed between two MS stages. With 
knowledge of an analyte’s precursor and MS/MS product ions, detailed structural information can 
be determined, and confident analyte identity assigned. MS/MS is also described as MSn, where  
n >1. For example, fragmentation of MS2 products is an MS3 experiment. Multiple stages (>3) of 
MSn are achievable on high performance ion traps such as FT-ICR, Paul traps and Orbitrap 
instruments featuring a linear ion trap.36, 37 
With respect to QTOF MS, the most routine MS/MS experiment is collision induced dissociation 
(CID) MS/MS, which involves the fragmentation of quadrupole-selected precursor ions through 
collisions with an inert gas (argon, nitrogen, etc.) at elevated kinetic energy.38 Energy transferred 
to the precursor ions in these collisions is distributed throughout the ion and causes bonds to 
break and rearrange. The product ions of these collisions are transmitted to the TOF for analysis. 
Since the precursor ions are selected by a narrow m/z window, typically only transmitting the 
precursor ions’ isotopologues, fragments are indicative of the precursor ions’ structure. 
Reconstruction of these fragments can enable identification of the precursor ions. This is routinely 
used for small molecules in selected or multiple reaction monitoring (SRM, MRM) experiments; 
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the ‘transition’ from precursor ion to one or more product ions is monitored to confirm the 
identity of the analyte. 
The study of the proteins of a biological system, “proteomics”, has been a significant application 
of MS for the last two decades. In proteomics, CID MS/MS is commonly used for identification of 
peptides/proteins in a ‘bottom-up’ workflow; first, proteins are digested by a highly specific 
enzyme (usually trypsin); then the resulting peptides are analysed by LC-MS/MS. Since peptide 
ions that undergo CID generally fragment to produce a predictable series of ‘b’ (N-terminal) and 
‘y’ (C-terminal) ions through cleavage of peptide bonds (see Figure 5), confident identification of 
thousands of ions per experiment is possible with a fast mass spectrometer and the appropriate 
software. The nomenclature for peptide fragment ions was developed in the mid-1980s.39, 40 ‘Top-
down’ analysis with intact proteins is also possible, although not all MS/MS techniques are 
effective for protein ion fragmentation.41 Top-down proteomics analyses are often performed by 
MALDI-TOF MS after offline sample fractionation.  
  
Figure 5: Schematic of peptide fragmentation and nomenclature. a, b and y ions are usually observed from low energy 
CID and ISD/PSD; c, z+1 and z+2 ions are typical of electron-mediated techniques. 
 
The Waters Synapt instruments are capable of CID pre- and post- ion mobility since they feature  
‘trap’ and ‘transfer’ collision cells. Thus, drift time measurements on either precursor or product 
ions is possible. An additional MSn fragmentation scheme called time-aligned parallel (TAP) 
maintains the drift time of fragment ions so that they match the precursors’ (example in Figure 6). 
This method can be used as a pseudo-MS3 technique for identifying fragments of fragments by 
their alignment on a mobiligram (m/z versus drift time). In addition to TAP MS3, pseudo-MS3 can 
be achieved using in-source fragmentation (ISD). On a QTOF instrument with an API inlet, this 
simply involves increasing the inlet cone voltage. Product ions are like those produced in CID. 
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When a known analyte is being analysed, this allows a second stage of MS/MS to be performed 
on its fragments. It is not a suitable MS/MS technique for complex mixtures of similar 
components, since ISD does not offer precursor ion selectivity. 
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Figure 6: 2-dimensional m/z vs DT plots for CID-MS/MS of a sphingomyelin (m/z 647.5) compound in the trap (a) and 
transfer (b) cells of a Synapt G2-Si. Fragmentation in the transfer cell keeps product ions ‘time-aligned’ with the 
precursor ion as indicated by the green arrow. 
Another fragmentation technique which has become advantageous in biological mass 
spectrometry is electron transfer dissociation (ETD). It is one of many electron-mediated MS/MS 
methods and has been successfully implemented on QTOF, Orbitrap and quadrupole ion trap 
17Y_05M _11D_003_SM_C12_CID_DHB.raw : 1
17Y_05M _11D_004_SM_C12_TAP_DHB.raw : 1
(a) CID in trap cell 
(b) CID in transfer cell 
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(QIT) mass spectrometers. A caveat is that it requires positive ions possessing at least 2 units of 
charge to function, since the core mechanic is an ion-ion reaction involving the transfer of an 
electron from a radical reagent anion to the analyte cation, resulting in a reduction of the analyte 
charge by 1. A negative analogue of ETD ‘nETD’ also exists, but typically has a lower fragmentation 
efficiency due in part to competition from proton transfer reactions.42 Electron transfer with no 
dissociation (ETnoD) is another related technique, used for investigation of protein structural 
rearrangement by the addition of a single electron.43 Similarly, electron capture dissociation (ECD) 
and electron induced dissociation (EID) use electrons of low (1-5 eV) and high (>10 eV) energy to 
promote fragmentation and are most often found on FT-ICR MS.44 ECD is similar to ETD, but does 
not involve the interaction of a cation and anion, but rather a free electron with the cation, 
proposed to be a non-ergodic process.45 EID produces complementary fragments to CID through 
collisions with electrons. ETD is a valuable technique for fragmenting precursors where CID is 
ineffective, finding implementation for proteomics in particular.46, 47 The product ions from 
peptides and proteins are even electron c-ions and odd electron z•-ions which can be 
reconstructed to divulge structural information in much the same way as for CID. ETD is 
favourable for post-translational modification (PTM) analysis, since the fragmentation mechanism 
leaves modifications intact.41  ETD’s application to smaller molecule analysis is less frequent, 
although there are reports of ETD of multiply charged lipid complexes.48, 49 The implementation of 
ETD on the Synapt mass spectrometers involves ionising the reagent by negative mode glow 
discharge, simultaneously with the generation of cations from the sample. The ion optics up to 
and including the TriWave trap (see Synapt G2-Si diagram Figure 16) are rapidly switched in 
polarity to transfer and trap positive and negative ions together, with precursor selection by the 
quadrupole if desired. A DC potential in the trap keeps reagent and analyte ions separated from 
one another until reaction is desired, at which point the potential barrier is lowered. The ETD 
reaction occurs, and fragments are transferred to the TOF through the remaining TriWave cells.50 
 
Fragmentation by photon-induced techniques is a third alternative. Two prominent examples 
include ultraviolet photodissociation (UVPD) and infrared multiphoton dissociation (IRMPD). A 
commercial UVPD implementation exists for the Orbitrap platform but reports for QTOF 
instruments featuring UVPD also populate the literature, but it is in relative infancy.51-53 UVPD and 
IRMPD have featured on Fourier transform-ion cyclotron resonance and modified linear 
quadrupole mass spectrometers.54-56. IRMPD is a common, analogous fragmentation method to 
CID, but can be performed within the FT-ICR cell without affecting the ultra-high vacuum since a 
gas is not introduced. UVPD has the potential to increase specificity and fragment yield beyond 
13 
 
other fragmentation methods.57 The wavelength of the laser can be chosen to enhance specificity, 
for example the production of d-ions from carbon-sulfur bonds with 213 nm photons.58 UVPD also 
offers a route for characterising lipid structures in detail, where other methods fail.59, 60 UVPD was 
not available on the mass spectrometers in this project, but it is an upcoming disruptive 
technology and has relevance to lipid analysis discussed later in this thesis. 
 
1.2.2 Ion mobility-mass spectrometry (IM-MS) 
Ion mobility (IM) devices have been incorporated into commercial mass spectrometers for around 
a decade. These include technologies such as travelling wave ion mobility spectrometry (TWIMS, 
on Waters Q-IM-TOFs), trapped IMS (TIMS, on Bruker timsTOF instruments), drift tubes (DT), field 
asymmetric waveform IMS (FAIMS, able to be retrofitted to the mass spectrometer API inlet) and 
differential mobility analysers (DMA). Amongst the commercially available implementations, TIMS 
has the highest mobility-resolving power, with /=100-250 achievable at room 
temperature.61 Current commercially available TWIMS has /=40-50, although performance 
has been demonstrated to be better than the resolution value would suggest.62, 63 Since only 
TWIMS was used in this project, details of the other techniques are omitted. 
TWIMS has featured in every iteration of Waters’ Synapt product line as the middle cell of the 
TriWave device (see Figure 16 later in the thesis), and as a separate cell prior to the resolving 
quadrupole on the Vion QTOF. The TWIMS cell is operated at elevated pressure with a drift gas, 
typically nitrogen. Helium is used to cool ions entering the high-pressure region. The stacked ring 
assembly is pulsed with an r.f. voltage, the phase on each ring being opposite that of the one 
before. This produces an r.f. wave that carries ions through the drift gas (Figure 7). 
  
Figure 7: The travelling wave IMS concept, as presented on the Waters website.64 
With regards to TWIMS use for mass spectrometry, the separation of ions is not based on their 
m/z ratio but on their physical interaction with the drift gas and gives an additional, orthogonal 
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dimension of information. The travelling time confusingly also called ‘drift time’ (cf. TOF drift 
time), can allow ions of differing unit charge, but identical m/z to be identified. Ions of different 
molecular species (for example, species of phospholipids) are distinguishable by their drift time.65 
If calibrated, the TWIMS cell can also provide information on the collision cross section (CCS) of 
the ions. This physical property can reveal information about the ion structure and is essential for 
characterising ions across multiple TWIMS instruments, since small variations in instrument 
conditions and manufacturing tolerances result in variations in the raw drift time measurement. 
 
1.3 Matrix-Assisted Laser Desorption/Ionisation (MALDI) and other ionisation 
techniques 
1.3.1 MALDI Development and Applications 
Laser Desorption/Ionisation (LDI) MS was first reported during the late 1970s and early 1980s, 
with multiple publications making use of the Laser Microprobe Mass Analyser (LAMMA) 
instrument.66-70 This instrument was developed for biomedical purposes, a field which drives MS 
developments to this day.71 Studies of cations in body tissues were reported67, 68 but also small 
organic compounds;70 the analysis of amino acids and dipeptides was reported in 1985.72 
Application of the technique to organic molecules of up to m/z 100,000 was demonstrated in 
1988, in publications by Tanaka et al., and Karas and Hillenkamp.23, 73 The approach in the former 
used a matrix of fine cobalt powder mixed with glycerol and organic solvents; the latter 
demonstrated MS analysis with a nicotinic acid matrix compound. The matrices enabled 
controlled absorption of laser energy, protecting delicate molecules and enhancing desorption. 
While the use of glycerol-based matrices has continued in some applications and Tanaka was 
awarded part of the 2002 Nobel Prize in Chemistry, organic acid matrices have become the 
standard for routine MALDI MS analysis.22 Particularly, the organic acids 2,5-dihydroxybenzoic 
acid (DHB) and α-cyano-4-hydroxycinnamic acid (CHCA) are staples for peptide mass 
fingerprinting (PMF), intact protein ionisation, polymer analysis and biotyping. Matrices beneficial 
to the analysis of specific molecular families have been reported, for example 2,5-
dihydroxyacetophenone for proteins, dithranol for lipids and small molecules and 2,4,6-
trihydroxyacetophenone for lipids.74-76 The matrix 4-chloro-α-cyanocinnamic acid (Cl-CCA) was 
designed from first principles for MALDI analysis of peptides and has been shown to significantly 
improve analyte signal intensity versus CHCA.77 However, the improvement was only possible 
with 337 nm lasers because of the absorbance properties of the compound. For negative ion 
analysis, matrices with high gas phase basicity may be chosen to provide improvements over 
acidic matrices.78 UV-absorbing organic bases such as 3-aminoquinoline (3-AQ), 9-aminoacridine 
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(9-AA) and 1,8-bis(dimethyl-amino)naphthalene (DMAN) are examples.79-81 The latter has been 
demonstrated for sensitive analysis of small metabolites with low background signal. While 
MALDI analysis of small molecules (<1000 Da) is possible, it is generally hindered by chemical 
noise contributed by matrix-related ions. Matrix suppression modes are available on some 
commercial MALDI mass spectrometers.  
In addition to the matrix compounds themselves, matrix additives can provide additional analysis 
potential. Weak acids like formic and trifluoroacetic acid are commonly added to MALDI samples 
for positive mode analysis to provide additional protons. Metal salts are another additive and 
have been used for lipid and synthetic polymer analysis. Lithium salts are frequently reported in 
the literature, resulting in lithium-cationised analyte ions. Divalent metal salts of alkaline earth or 
transition metals can be used in the same way, and fragmentation of ions cationised like this can 
reveal additional structural information about the analyte.76, 82, 83 
MALDI is most commonly initiated with a pulsed UV laser; either nitrogen gas lasers that emit at 
337 nm, or solid state, frequency-tripled Nd:YAG lasers with =355 nm. Both typically feature a 
pulse width in the 1-10 ns range, application of lasers with pulse widths in the pico and 
femtosecond range is an area of active research. Nitrogen lasers typically have lower pulse 
repetition rates (1-30 Hz) than solid state lasers (commercially available at 10 kHz) and their 
performance degrades over time. However, many MALDI matrices were developed with the 337 
nm wavelength and thus it is still prevalent today. Less commonly used for UV-MALDI are 
frequency-quadrupled Nd:YAG lasers (=266 nm) and frequency-tripled Nd:YLF lasers (=349 nm). 
Visible wavelength MALDI can be conducted with frequency-doubled Nd:YAG lasers (=532 nm).84 
Infrared (IR) MALDI is less common than UV-MALDI, but was demonstrated for analysing 
biological molecules relatively soon after MALDI’s introduction.85 The lasers usually feature a 
longer pulse width in the region of 100 ns. Nd:YAG lasers (=1064 nm) may be used, although 
Er:YAG lasers (=2940 nm) are vastly superior as water and other OH-containing molecules 
strongly absorb this radiation, thus can be exploited as a matrix.86-88 Thus, aqueous samples do 
not require a matrix chromophore to be added, as with MALDI at other wavelengths. Sample 
consumption in IR-MALDI is high, relative to UV-MALDI. Tuneable wavelength pulsed lasers are 
also used in some MALDI studies across a wide range of wavelengths, although they are not 
typical of commercial ion sources.89 
MALDI TOF MS is suitable for clinical analysis, allowing the identification of microbes present in 
fluids and tissue.90-93 To date, two mass spectrometry systems, the Bruker MALDI BioTyper CA 
System (Bruker, Bremen, Germany) and the VITEK MS (BioMerieux, Marcy-l'Étoile, France) have 
received FDA approval for analysis and identification of microorganisms. Rapid data acquisition, 
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the high sensitivity and resolution of TOF instruments and relatively good tolerance to sample 
contaminants have all contributed to MALDI’s establishment as a routine method. Each system 
uses a vacuum source and a UV laser. Both MS biotyping systems feature a linear TOF MS, 
marketed as providing sufficient resolution and sensitivity for microbiology applications. In 
practice this also results in easier to maintain, cheaper, and smaller footprint systems. More 
capable TOF analysers would increase costs and are largely unnecessary for the application. 
 
1.3.2 Ionisation  
MALDI is perhaps most distinct from other soft ionisation methods in that singly charged ions are 
predominantly produced, even for molecules over 100,000 Da.94 A laser pulse is delivered to the 
sample, where it is absorbed and the energy distributed, causing ablation of material (Figure 8). 
 
Figure 8: Illustration of the MALDI process from a liquid droplet  (adapted from Towers and Cramer, 2010 95)  
 It is generally accepted that ionisation occurs by multiple convoluted pathways, as evidenced by 
the variety of models proposed in the literature, which continue to refine understanding of the 
processes.96-101 The ‘lucky survivor’ and ‘cluster’ models suggest that detected ions are the result 
of surviving neutralisation events in the MALDI plume.102 However, aspects of the theory, such as 
ions preformed in the sample, are now less favoured explanations.103 104 An exciton-based 
photochemical model, thermal and droplet-based models have all been proposed.105, 106 
Nevertheless, there is still no complete model that is accepted by the community. 
Explanations of the ionisation processes in ESI are somewhat less convoluted and better 
understood.107 They also potentially have a greater relevance to AP-MALDI of liquid samples than 
traditional MALDI models, since it is expected that droplet desolvation is a critical factor 
(discussed in the following section).108, 109 Increasingly, it is becoming evident that soft ionisation 
methods are closely related. For liquid samples, it has been proposed that there are essentially 
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two processes; neutralisation of the counter ion and separating ions. An ion source may exploit 
either one or both by multiple strategies, for example the application of heat, shockwave or 
voltage. 110 Taking the example of ESI, a high voltage is applied to the sample emitter, which 
neutralises ions of the opposite polarity. Ions of the same polarity are ejected in solvent droplets 
which rapidly evaporate to leave analyte ions or eject ions in a charge equilibration event. ESI 
probes are often fitted with heated desolvation and nebulising gases, and heated MS inlets are 
present on many commercial and modified mass spectrometers. Heated inlets promote additional 
desolvation through the ESI processes described in Figure 9.111 The ion evaporation model (IEM) 
suggests Coulombic repulsion causes ions to leave an evaporating droplet, while the charge 
residue model (CRM) predicts that charges remain on an analyte molecule left behind after 
solvent evaporation. Finally, the chain ejection model (CEM) mostly applies to amphiphilic 
molecules, with the hydrophobic portion aiding ejection of the ion from the droplet.  Recent 
reports of LDI MS of liquid samples suggest an API ion source’s heated inlet is key to achieving 
ionisation since a conventional matrix compound was not used.89, 112. This is largely in agreement 
with reports on solvent- and matrix-assisted inlet ionisation (SAII and MAII respectively), which 
demonstrated ESI-like mass spectra with sample introduction directly into heated API inlets.113, 114 
High charge state ions comparable to ESI have recently been reported in vacuum MALDI 
instruments, through use of high volatility matrices originally used for laserspray ionisation and 
MAI. In addition, it was shown that lower volatility matrices were capable of similar results should 
sufficient desolvation energy be provided by the laser.115  
 
Figure 9: ESI processes resulting in free ions. The CEM is mostly applicable to amphiphilic molecules like proteins. 
1.3.3 MALDI with solid and liquid samples 
Typical sample preparation for MALDI MS experiments results in a crystalline sample. MALDI 
samples prepared as such have found wide adoption in applications including top-down 
proteomics, molecular imaging of body tissues and bacterial speciation.116-118 A variety of 
strategies for applying samples to the MALDI target are employed. For example, sample and 
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matrix may be premixed and then spotted and dried on target, or each may be spotted into the 
same sample well without premixing. Variations on the ubiquitous ‘dried droplet’ method are 
reported throughout the literature.119, 120Thin films and matrix ‘seed-layers’ have been proposed 
to enhance sample homogeneity.121, 122However, there are multiple disadvantages to the solid 
sample state. Sample heterogeneity is a considerable issue, with so-called ‘sweet spot hunting’ a 
necessity to achieve analyte signal.123-125 The samples require time for drying, a problem which 
increases with sample spot volume. In addition, drying conditions like humidity and temperature 
can substantially affect crystal morphology, which in turn affects the analytical performance.126, 127 
There are devices for alleviating these problems, like controlled environment cabinets and matrix 
spraying robots, but each has additional costs, maintenance and performance issues of their own. 
As an alternative, the liquid sample state can be employed. Although it is not as widely 
established as the solid state there are various advantages. There are two categories of liquid 
MALDI matrices; ionic liquid matrices (ILM) and liquid support matrices (LSM). MALDI ILMs 
combine a traditional MALDI organic acid matrix, an organic base, such as 3-aminoquinoline or 
triethylamine, and solvents.128 LSMs integrate an organic acid or base solution and a viscous liquid 
such as glycerol.108, 129-131  
For many liquid MALDI samples, a pseudo-continuous ion beam similar to the spray-type ion 
sources can be achieved since the liquid samples exhibit self-healing properties, eliminating the 
requirement to move the laser as with solid samples. This property allows straightforward tuning 
of the mass spectrometer settings (like in ESI MS) and stable analysis of a sample over time. The 
stable beam also has utility for MS/MS of low abundance analytes, where minutes of data may be 
required to achieve useful spectra.  
Both ILMs and LSMs have some limited compatibility with (high-)vacuum MALDI sources, if the 
volatile components of the droplets fully evaporate under these conditions. Atmospheric pressure 
(AP) or in an external vacuum chamber are alternatives for these cases. However, this means a 
drying stage is not omitted. Without drying outgassing can occur within the mass spectrometer, 
resulting in contamination across the target and internal components and stress on the vacuum 
system. This is a significant problem with a highly populated target plate because even a small 
amount of outgassing per sample adds up to the point where evacuation of the vacuum source 
may fail. In addition, the sample longevity within vacuum sources is low. A sample becomes highly 
viscous after a short period of time and behaves as if it is a solid, i.e. the analysis of a whole target 
will be impractical. 
AP-MALDI is a true alternative to typical vacuum MALDI that can take advantage of liquid samples 
to their fullest. Samples can be loaded immediately after spotting without the risk of 
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contamination or damage to the vacuum system. Low sample consumption allows the analysis of 
a single sample for up to 30 minutes or more at a time.108, 132 Collisions with atmospheric 
molecules enhance desolvation compared to vacuum MALDI. However, AP-MALDI sources are 
uncommon with few commercial ion sources being available. MassTech Inc. have had most 
significant interest in this type of ion source since the turn of the century.133-135 There are also 
home-built sources of varying design used by research groups worldwide.89, 108, 136, 137 
 
1.3.4 Ambient Ionisation. 
At present, there is considerable interest in atmospheric pressure and ambient ionisation 
techniques. Techniques like rapid evaporative ionisation (REI)MS, atmospheric pressure solids 
analysis probe (ASAP), direct analysis in real time (DART) and liquid extraction surface analysis 
(LESA) provide a range of complementary techniques. All have a focus on limited sample 
preparation and rapid analysis.  
REIMS particularly has captured the attention of mainstream media as the ‘iKnife’ device; a 
superficially simple concept introduced by Professor Zoltan Takats that was acquired by Waters 
for further development into a commercial product. Currently, the source features an 
electrosurgical tool which ablates material from tissue samples. The vapours are transferred to 
the mass spectrometer inlet by a Venturi pump where ionisation occurs by impacting on a heated 
surface. The ‘impactor’ is key as it acts to rapidly desolvate the surgical vapours, releasing 
abundant, polar molecules, such as phospholipids, for analysis. Multivariate statistical models are 
built from the mass spectra for online classification of samples. Attention has been paid to its 
application in cancer surgery, where effective removal of as much tumour tissue as possible is 
essential.138 The source design features an inlet for introduction of a lock mass solution. A patent 
claims that solvents sprayed with the lock mass compound improved REIMS ion yield.139 Laser-
based and ultrasound-based REIMS are in development, with the potential for greater sample 
compatibility.140, 141 REIMS has yet to be demonstrated for analysing larger biological molecules; 
the desorption and ionisation conditions may simply be too energetic for peptides and proteins to 
survive (the impactor operates at approximately 900 C.). 
REIMS and other ambient ionisation techniques are also being developed for food applications, 
which are explored in Section 1.5.1.  
 
1.4 Lipid Characterisation  
While characterising molecules by the fragmentation techniques described in Section 1.2.1 is 
routine for many applications, lipids are a challenging class of molecules to fully characterise. The 
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field of lipidomics (the large-scale analysis of lipids from cells and body tissues142) is a rapidly 
developing area of mass spectrometry thanks to technological advancements, such as accurate 
mass MS and IM-MS, and database improvements.117, 143-145 Lipids are important as structural 
molecules in body tissues, but also perform signalling roles in cells. Typical tandem mass 
spectrometry methods do not yield the same depth of information that they are able to reveal for 
peptides. There are many classes of phospholipids, which possess different headgroups (Figure 
10) and other classes such as sphingophospholipids (Figure 11). With CID of lipid ions [L+H]+ or [L-
H]- important structural properties like head group identity and side chain mass can be inferred 
from neutral losses or detection of headgroup ions. However, information such as double bond 
location has required more exotic techniques. For example, phospholipids cationised by alkali 
metals (Alk = Li, Na) in the form of [L+Alk]+ produce different CID spectra compared to [L+H]+.146 
Neutral loss of fatty acid side chains was recorded with [L+Li]+, whereas [L+H]+ predominantly 
produced the headgroup ion. Lithium has been used in many lipid structural studies since, 
although it provides limited double bond information without many successive stages of MSn.82, 
147-151 Phospholipid complexes in the form of [Ln+M]2+ and individual phospholipids in the form of 
[L+M]2+ cationised with alkaline earth metals have been produced by ESI and liquid AP-MALDI, 
respectively.152, 49, 112 The latter was able to identify the double bond location in 
phosphatidylcholines. The stereochemistry of the fatty acids was identified in both cases. ETD of 
[L+2Na]2+ produced by ESI has enabled tentative assignment of double bond locations.48 
21 
 
 
   
   
   
   
   
   
   
   
   
Headgroup Substituent (X) Type Abbreviation 
H Phosphatidic acid PA 
 
 
Phosphatidylcholine PC 
 
 
Phosphatidylethanolamine PE 
 
 
Phosphatidylserine PS 
 
 
Phosphatidylinositol PI 
 
 
Phosphatidylglycerol PG 
Figure 10: Glycerophospholipid general structure and headgroup variations. 
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Figure 11: The general structure of sphingomyelins, a type of sphingophospholipid. 
Other methods involve moving beyond a simple sample additive. The recently developed ozone-
induced dissociation (OzID) is promising for lipidomics since it has been demonstrated to be 
functional on a chromatographic timescale.153, 154 MS plays a similar, critical role as in proteomics; 
in detection and identification of analytes, often by LC-MS/MS.  In OzID, ozonolysis at double 
bonds was performed on ions trapped in a high pressure region in the MS, enabling the 
identification of their location through understanding the resultant product ion spectra.155-157 OzID 
has also been combined with CID to enhance fragmentation.158-160 ESI in an ozone-rich 
environment (OzESI) for double bond ozonolysis has produced similar results to OzID.161 Since 
essentially the only change required to standard instrumentation is to replace the typical trap gas 
with ozone, this method could see wide adoption. Safety with handling ozone and the necessity to 
generate it on-site are matters which must be considered if implementing the technique. 
Taking advantage of the Paternò-Büchi (PB) photochemical reaction, carbonyl compounds can 
react with double bonds by activation in UV light. Subsequent CID of the reaction products 
provides diagnostic product ion spectra for determining the double bond location.162 163 PB-MS 
has been demonstrated online with LC-ESI MS/MS. Little instrument modification would be 
required beyond the UV light source to take advantage of PB reactions in MS. 
Charge transfer dissociation (CTD) currently requires substantial instrument modification since no 
commercial apparatus is available. However, the structural information produced from the 
charge-increased ions [L+H]2+• is considerable.164 Double bond cis/trans isomerism has been 
determined by differential mobility spectrometry-electron impact excitation of ions from organics 
(DMS-EIEIO).165 Cis/trans isomerism was assigned from fragments resulting from electron 
irradiation and separation by DMS.  
Areas of application for lipidomics, whether utilising mass profiling, structural characterisation or 
quantitation, include food analysis and disease detection, both of which were investigated during 
this project. 
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1.5 Food Adulteration 
Modern food production is a global industry. With raw materials sourced from all over the world, 
it is paramount that quality standards are maintained. The health of the consumer is the primary 
consideration; mischaracterised and adulterated products may cause medical issues such as 
allergic reactions, malnutrition or poisoning. Product authenticity is also important from an 
ethical and financial perspective. Economically motivated adulteration (EMA) can put dishonest 
producers at an unfair competitive advantage.  
The importance for ensuring food authenticity and quality was demonstrated in cases which have 
occurred over the last two decades. The ‘Melamine Scandal’ was a high-profile case in 2007-2008. 
Melamine-adulterated milk products entered the supply chain, affecting 300,000 people with six 
juvenile fatalities in China. This led to a ban on the import of milk products from China by the USA 
where the pet food supply chain was compromised.166, 167 Other countries followed suit, with 
consequential economic effect. Melamine was added to boost the apparent protein content of 
products, a property on which quality was assessed, but resulted in severe kidney damage for 
those who consumed it. EU member states were not affected in this case, however, the EU horse 
meat scandal occurred only a few years later (2013). This was another case of fraudsters 
benefiting financially from adulterating products; beef cost €3900 per tonne versus €800 for horse 
meat, so there was a considerable monetary incentive.167  
Throughout this thesis, proof-of-concept AP-MALDI MS liquid sample profiling has been applied to 
milk speciation. Milk (along with olive oil, honey and saffron) is one of the most common targets 
of EMA according to a 2012 report covering the period 1980-2010.168 Cow milk accounts for 85% 
of global milk production.169 Higher value milk, for example that from goats (3.4%) and sheep 
(1.4%), is liable to EMA using cheaper cow milk.170, 171 Animal milk products may also be subject to 
adulteration with cheap, plant-based proteins.172 Many plant proteins are derived from sources 
determined as allergens; soy, wheat and almonds. Conversely, plant-based milk products are 
often consumed by those with lactose intolerance, so their adulteration with animal milk presents 
a similar problem. People following modern diets and lifestyles that omit animal products, such as 
veganism, also suffer in these cases.  
1.5.1 Mass spectrometry profiling in food adulteration testing 
As the technology has matured and become more affordable, food fraud identification has 
become a focus for MS. Methods amenable to routine, high-throughput characterisation of 
samples are possible routes to improve food safety and quality. Classification of food and food 
products has been demonstrated for multiple ion sources on mass spectrometers. A non-
exhaustive list of publications using mass profiling in this area are shown in Table 1. Most of these 
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examples required sample preparation to produce viable mass spectra. For instance, organic 
solvent extraction was necessary for DART of TAGs in milk and milk products.173 The literature also 
includes many studies which took advantage of LC-ESI MS/MS for separation and identification of 
sample components. However, each sample analysis is performed over hours, rather than 
seconds and so these are of less relevance to this project. 
Table 1: MS profiling publications with a focus on food adulteration detection. 
Ion source Sample Analytes Reference 
OPSI with APCI Vegetable oils TG, DG 174 
DART Milk/milk products TG 173 
MALDI Vegetable oils TG 175 
 Cooking oils TG 176 
 Milk powder TG 177 
 Animal milk Phospholipids 178 
 Olive oil Phospholipids 179 
 Animal milk Peptides (tryptic digest) 180 
 Animal milk Proteins 181 
 Cheese Proteins 182 
 Donkey milk Proteins 183 
 Animal milk Peptides, proteins 184 
REIMS Meat Phospholipids 185 
 Pork Phospholipids 186 
 Pork Phospholipids 187 
 Fish Phospholipids 188 
Flow Injection (FI) ESI Milk Proteins 189 
 Milk Oxidised lipids 190 
ASAP Food from jars Plasticisers 191 
Direct Sample 
Analysis (DSA) 
Fruit juices Organic acids, TG 192 
 
Lipids are prominent analytes for determining sample classification as they are highly abundant in 
crude biological samples. However, they are not species-specific unlike peptides and proteins, and 
classification relies on their relative abundance in the mass spectrum. Additionally, the biological 
relevance of lipid classes is only beginning to be understood. This is a limiting property of many 
current techniques such as REIMS and DART, which have yet to demonstrate the analysis of larger 
biological molecules, like peptides or proteins. For REIMS, it has been repeatedly demonstrated 
that with sufficiently intense spectra, rapid and accurate classification models for food analysis 
can be produced with just phospholipid data. The ease and rapidity with which the data can be 
acquired, without sample preparation, is unmatched.185-188 REIMS has yet to be reported for direct 
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analysis of milk for routine food testing despite the dairy industry being an attractive market, 
suggesting milk is a problematic medium for the current sampling probes. 
Although requiring some sample preparation before analysis, MALDI-TOF MS profiling has the 
wide analyte range compared to other profiling techniques. MALDI’s good salt tolerance also 
makes it more suitable than direct injection ESI methods, which suffer from considerable signal 
suppression and background interference in crude samples. Adulteration detection based on 
protein content of the samples has been demonstrated with solid state MALDI samples.181-184 The 
specificity of proteins to the original organism provided powerful distinguishing features in the 
mass spectra. This is not immediately transferable to the MALDI-QTOF platform without some 
compromise. Traditional MALDI over an extended m/z range is not entirely suitable for the QTOF 
platform because of the predominant formation of singly charged ions. The QTOF quadrupole 
must be capable of transmitting ions of greater m/z values than required for ions generated by 
ESI. Typical 4k quadrupoles will transmit up to m/z 4000. MALDI-capable QTOF instruments may 
be equipped with 8k (up to m/z 8000) or even 32k (up to m/z 32000) quadrupoles for high mass 
analysis.193 It is also necessary to consider that a greater m/z range results in a lower duty cycle 
for the TOF analyser, ultimately meaning poorer sensitivity. This may be somewhat negated by 
ion optics that gate ions efficiently into the pusher region. The applicability of a MALDI source 
capable of predominantly producing multiply charged ions for peptides and proteins thus offers 
greater compatibility with the QTOF platform by reducing the analyte ion mass-to-charge ratio. 
The use of highly charged ions generated by AP-MALDI for milk speciation models will be explored 
later in this thesis. Another method for protein-rich samples is enzymatic digestion of the raw 
sample, and analysis of the resulting peptides by MALDI-TOF MS. The challenges for compatibility 
with the QTOF platform are also reduced by producing the lower mass digest products. This 
strategy has been employed for determining levels of adulteration in milk samples from a tryptic 
digest.180 Cow and goat milk peptide markers were detectable to a 5% adulteration level. These 
samples are also amenable to LC-MS/MS; however, this is most useful for confidently identifying 
peptides and proteins rather than rapid sample speciation. A similar approach separating proteins 
by 2D gel electrophoresis (2-DE) followed by MALDI-TOF MS was able to achieve adulteration 
detection at the 0.5% level.194 This technique is relatively labour intensive and is thus less suited 
for high-throughput analysis.  
Some efforts in MS for detection of food product adulteration are focused on the monitoring of 
the relative intensity ratios of pairs of ions.178, 179 However, by focusing on just two ions for 
determining speciation, there is the potential for adulteration of samples on a molecular level to 
circumvent this type of test. It has already been reported that fraudsters are able to manipulate 
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the isotopic abundance in synthetic vanilla to ‘fool’ nuclear magnetic resonance (NMR) analysis 
into classifying it as a natural variety.195  
 
1.6 Analysis of Milk 
1.6.1 Molecular Composition 
Milk is a complex biological fluid containing lipids, peptides, proteins and carbohydrates, amongst 
a variety of other biologically important nutrients and minerals.196 The breadth of molecules 
means milk is a significant source of biological information. For the example of bovine milk, 
around 80% of proteins are caseins; phosphoproteins with poor aqueous solubility. The remaining 
fraction is broadly termed ‘whey protein’, and comprises -lactoglobulin and α-lactalbumin, 
amongst other lower concentration globular proteins. The lipid content includes an abundance of 
free fatty acids, mono-, di- and triacyclglycerols (MG, DG, TG), phospholipids (PL) and 
sphingolipids. Lactose represents the major component of carbohydrates in animal milks (cow, 
goat, sheep, etc.) with an approximate concentration of 5 g/100 g.  
Plant milks are similarly complex but have hugely varied composition depending on the source 
organism. For example, soya milk contains storage and whey proteins totalling 2.9-3.7% of the 
total composition, whereas rice milk has only 0.1-0.2% protein.197 Calcium, vitamin B12, B2, D and E 
are generally less available in plant milks, so they may be fortified when produced as a food 
product. Plant milks are generally lower in saturated fats with respect to animal milk but tend to 
have greater sugar and carbohydrate content (although are lactose-free). 
 
Protein constituents of milk have been extensively investigated by LC-ESI MS198-200 and MALDI-TOF 
MS181-183, 194, 201 to achieve sample characterisation and adulteration detection, but typically 
require significant sample preparation prior to MS analysis. Studies of the lipid content have been 
performed with MALDI-TOF MS177, 202 and DART MS173 and there are numerous reports of milk 
lipid analysis methods for LC-MS(/MS).203-206  
 
1.6.2 Mass Profiling for Disease Detection: Bovine Mastitis 
The molecular composition of milk may differ depending on a cow’s breed, lactation number, age, 
diet and health.196 The latter is of interest as a source of information for disease diagnosis, as an 
alternative to other body fluids like blood, saliva and urine. An advantage is that dairy cows’ milk 
is typically collected twice daily, allowing non-invasive, routine sampling. Modern milking 
machines allow online sampling of multiple animals in tandem, providing an opportunity for high-
throughput monitoring of each animal’s health. One of the most economically impactful diseases 
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for dairy farms is mastitis, an infection response to the invasion of an udder teat by a foreign 
microorganism.207 While infected, milking is uncomfortable for the animal and milk is unsuitable 
for consumption due to the presence of clots and pus. An infected animal is isolated from the milk 
supply chain at the earliest opportunity to avoid reducing the quality of the bulk tank milk. Milk 
from infected animals usually contains higher concentrations of somatic cells, the levels of which 
are a measure of the milk grade. Should bulk tank milk Somatic Cell Count (SCC) rise above the 
regulated value (for example, in the EU, no more than 400,000 cells/mL) the value of the milk is 
decreased.208, 209 Antibiotic treatment is administered per animal to combat the infection; 
however, antibiotics and metabolites must fall below maximum residue limits before milk can be 
sold. For example, no more than 4 µg/kg of benzyl penicillin is allowed by EU regulation, thus 
further financially impacting the dairy.210 Particularly severe or repeat cases can result in the 
animal being deemed economically non-viable and being destroyed. There is considerable 
difficulty in determining subclinical mastitis cases as they tend not to produce visual symptoms 
(reddening of the udder teat, abnormal milk appearance) until they manifest as clinical cases. This 
delay to diagnosis can allow the disease to be spread through the herd. Subclinical cases (loosely 
defined at a SSC of approx. >200,000 cells/mL) also lower milk yield from the cow, but a 
concentration of somatic cells up to approximately 100,000 cells/mL is not deemed to be 
economically impactful.208 The development of tests for earlier diagnosis through biological, 
chemical and physical means is thus an area of research with potential. 
  
Existing detection methods range from “cow-side” to extensive, lab-based, biological tests. 
Bacterial cultures are typically used to determine the underlying cause of a mastitis infection. This 
test is performed over a period of days, introducing extra delay before treatment although some 
farms are equipped with on-site testing facilities.211 Advantageously, bacteria species can be 
identified enabling targeted administration of antibiotics. MALDI MS is already established for 
bacteria identification, and is used in at least one commercial UK laboratory.212, 213 Faster methods 
of mastitis detection include online electrical conductivity (EC) assessment, somatic cell count 
(SCC) and the cow-side California mastitis test (CMT).214 However, these tests have been reported 
with low sensitivity (25%, 39.8% and 60.1% respectively) and specificity (87.1%, 84.4%, 62.7%) 
that shows a significant proportion of false positives.215 False positives are problematic because 
they may introduce greater economic burden, as healthy animals may be removed from milking 
and treated unnecessarily with antibiotics or destroyed. More acceptable rates for both sensitivity 
and specificity have been published in other studies, but there is clearly significant variability in 
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the performance of these tests.216 Visual determination of clots and discolouration may also be 
performed as a crude test to identify the most severe cases. 
 
Since the data produced on a mass spectrometer are computerised, automatic statistical 
assessment can allow unbiased, operator-free classification in addition to providing a record of 
analysis. Classification may be possible from complex LC-MS/MS data or from mass profiles of the 
unfractionated sample. MS offers the potential for mastitis diagnosis by molecular biomarkers. A 
validated biomarker for diagnosing mastitis has yet to be described fully, however some have 
been proposed.217 Milk exhibits proteins over a large concentration range, making sample 
preparation and analysis for detecting low abundance proteins difficult.218 Hogarth et al. reported 
that many of the most abundant bovine milk proteins were absent from 2-DE gels of clinical 
mastitis samples.219 Reasons for this were suggested: the proteins may be subject to degradation 
by proteinases present in the udder from bacteria or as an immunological response, or a 
reduction in the production of the proteins. The former was disregarded as whey proteins are 
resistant to proteolysis, and peptides were not identified in the 2-DE gel. However, it is known 
that endogenous proteases, such as plasmin, will hydrolyse whey proteins.220  
There has yet to be a peer-reviewed publication reporting direct sampling and mass profiling for 
mastitis detection. A limited sample preparation for detection of mastitis-causing bacteria 
without requiring culturing has been reported recently, but with the conclusion that bacterial 
count was highly influential on the ability to perform correct identification.221 Initial results for 
liquid AP-MALDI MS analysis of milk extracts for mastitis detection from this project were 
presented at the British Mass Spectrometry Society Ambient Ionisation special interest group 
(BMSS AI SIG) meeting in January 2016. The following year, presentations by Dr Simon Cameron at 
the same meeting and the American Society for Mass Spectrometry’s Annual Conference on Mass 
Spectrometry and Allied Topics (2017) briefly introduced initial research with a laser ablation(LA)-
REIMS probe. Both AP-MALDI and LA-REIMS require a short sample preparation procedure to 
produce diagnostic spectra; experiments with the former are the basis of much of the Results 
chapter. 
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1.7 Project Aims 
The overarching aim of the project was to develop AP-MALDI for improved analysis of liquid 
samples on a high-throughput scale. This was to take the form of AP-MALDI ion source 
modifications, the use of modern MS instrumentation capabilities, sample preparation 
developments, investigation of method applications and the use of new software techniques. The 
vision was to develop proof-of-concepts, taking advantage of a combination of the above-
mentioned points, to demonstrate the applicability of liquid AP-MALDI MS for solving analytical 
problems. No application was prescribed by the project but rather were to be developed with 
reference to contemporary literature, research group interests and the direction of the industry in 
general. The main area of interest was rapid mass profiling, especially since the FDA approval of 
two MALDI-TOF MS systems (Section 1.3.1) for clinical use showed the potential for 
commercialisation of MALDI as a clinical diagnostic method. In addition, the attention mainstream 
media were paying to the iKnife drove my interest in a similar type of analysis workflow. 
Harnessing the ability to produce multiply charged ions was not stipulated, but when considering 
applications our ability to produce these ions was always considered. 
 
  
30 
 
2 Materials, Instrumentation and Methods 
 
2.1 Materials 
2.1.1 Chemicals 
Water, methanol (MeOH), acetonitrile (MeCN), isopropanol (IPA) and trifluoracetic acid (TFA) (all 
HPLC-grade) were bought from Fisher Scientific (Loughborough, UK). Lipid standards PC 
(16:0/18:0) and SM (d18:1/12:0) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). 
Sodium iodide calibration solution and ETD reagents were bought from Waters (Manchester, UK). 
Peptide Calibration Standard II was purchased from Bruker (Coventry, UK). HPLC-grade n-hexane, 
all other matrix components, reagents, calibrants and analytical standards were acquired from 
Sigma-Aldrich (Gillingham, UK). 
2.1.2 Milk Samples 
Bovine milk (Tesco British skimmed and whole, pasteurised and homogenised), whole caprine 
milk (St Helen’s, Yorkshire, UK, pasteurised and homogenised) and unsweetened soya milk (Alpro, 
Wevelgem, Belgium) were obtained from Tesco.  Raw and pasteurised ovine milk was kindly 
donated by The Sheep Milk Company (Lancashire, UK). Each milk type was aliquoted and stored at 
-80 °C until analysis. Existing research has reported that milk from the same species may exhibit 
variation depending on the source, however no clustering was observed in PCA of samples 
collected over four years from a range of producers.173 Thus, the milk samples here are justified as 
representative of each species. 
For the mastitis investigation, raw bovine milk was sampled from individual dairy cows at the 
Centre for Dairy Research (CEDAR), a facility operated by the University of Reading. Samples were 
taken from a single quarter of the udder, unless collected on the milking carousel. These were 
aliquoted and stored at -80 °C until analysis. Samples were collected intermittently from 
November 2015 (initial samples collected on the carousel) to December 2017. Mastitis diagnosis 
was determined by experienced personnel by cow side evaluation and should be considered 
‘clinical’ cases. Milk was visually assessed by fore milking each teat prior to attachment of milking 
apparatus. If clots were present, the cow was determined to have mastitis. Additional 
microbiological characterisation was undertaken by Quality Milk Management Services Ltd 
(QMMS), a UK laboratory equipped with MALDI MS for identifying microorganisms cultured from 
milk. Figure 12 shows examples of milk from mastitis-diagnosed cows displaying significant visual 
differences. 
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Figure 12: Three examples of milk samples from mastitis-diagnosed cows. 
 
2.2 Liquid support matrix (LSM) composition 
MALDI LSMs used throughout the project are detailed in Table 2. 
Table 2: LSMs used throughout the project. 
ID Chromophore 
Concentration 
(mg/mL) 
Solvents 
(v:v) 
Liquid Support 
(µL added to 100 µL 
chromophore solution) 
Applicable 
Ion Mode 
A DHB 25 MeCN/H2O (7:3) EG (60) +/- 
B DHB 25 MeCN/H2O (7:3) GL (60) +/- 
C CHCA 5 MeCN/Amm. Phos. (7:3) EG (60) + 
D CHCA/TEA 100/100 (L) MeOH/H2O (1:1) GL (20) + 
E 3-AQ 10 MeCN/Amm. Phos. (7:3) EG (60) - 
F 9-AA 10 MeCN/Amm. Phos. (7:3) EG (60) - 
G None N/A MeCN/H2O (7:3) EG (60) +/- 
Abbreviations: DHB; 2,5-dihydroxybenzoic acid, CHCA; -cyano-4-hydroxycinnamic acid, TEA; triethylamine, 3-AQ; 3-
aminoquinoline, 9-AA; 9-aminoacridine; EG; ethylene glycol, GL; glycerol. 
 
Matrix A was used frequently, as it was broadly applicable to a range of applications and provided 
good analyte signal intensity in both positive and negative ion mode. B was also used broadly but 
was superseded by A in most cases. The only difference between A and B was the type of liquid 
support, ethylene glycol (EG) and glycerol (GL), respectively. EG-based LSMs were recently shown 
to provide greater ion signal intensity than the GL-based equivalents.222 C was used for enhanced 
high mass protein analysis.222 D was used on the QTOF Ultima Global (see Section 2.3.1), where 
the ion source did not feature a heated inlet. No other investigated LSMs were found to be 
compatible with this mass spectrometer’s AP-MALDI source. E and F outperformed other matrix 
preparations, in terms of signal intensity and higher charge state production, in the negative ion 
mode, particularly in the analysis of peptides and proteins.223 G did not contain a UV-absorbing 
matrix chromophore and was required to ionise sodium iodide for extended-range (> m/z 2000) 
TOF calibration (see Section 2.3.3). There is potential for this LSM to be applied further, but it is 
somewhat more difficult to use than the other LSMs, as discussed in Section 3.3.3.  
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2.3 Instrumentation 
2.3.1 Mass spectrometers and ion sources. 
Three mass spectrometers were used throughout the project. Due to the prototype nature of the 
AP-MALDI ion sources many instrumental procedures differed from standard operation. 
Preliminary work was carried out on a QTOF Ultima Global (Waters, Wilmslow, UK), retrofitted 
with an API inlet and an in-house developed AP-MALDI source. The internals of this instrument 
are akin to those depicted in Figure 1. On project commencement, the condition of the 
instrument was largely unknown, and initial performance checks with leucine-enkephalin solution 
infused by ESI showed a peak with approx. 50 Da width at the baseline. The TOF pusher power 
supply was replaced, which brought the instrument to a usable state. The first stacked-ring ion 
guide also required substantial cleaning to reduce spontaneous in-source analyte fragmentation 
due to contamination (Figure 13). The 'Global' ion block was also replaced with an 'API' ion block 
because of a broken isolation valve mechanism and degraded seals. 
 
Figure 13: Uncalibrated QTOF Ultima ESI spectra for leucine-enkephalin (a) before and (b) after pusher power supply 
replacement. The first stacked ring ion guide (c) showed significant contamination. 
The source featured a 355 nm laser (FlareUV, Lumanova) with a max pulse rate of 1 kHz and later, 
because of a laser head failure, a VSL-337-ND-S (Spectra-Physics, Mountain View, CA, USA)  
337 nm nitrogen laser that was recovered from a decommissioned instrument. A schematic of the 
laser optical setup is presented in Figure 14. The MS inlet was not modified, i.e. the standard API 
sampling cone was in place and the MALDI sample plate positioned within 5 mm of the cone 
(shown in Figure 15). Since the source was modified without much of the original housing, a 
resistor that modified the ‘Source ID’ voltage to 2.9 V for the source interlock was added to allow 
instrument operation as if a nanoESI source was present. Push switch interlocks were defeated as 
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required. For this and all other instrument modification work, the appropriate health and safety 
(H&S) assessment and documentation were in place. The MALDI sample plate was fitted to a 
thumbscrew-controlled micrometre XYZ-stage by a polytetrafluoroethylene (PTFE) adaptor, and a 
high voltage line (providing up to ±4 kV) was connected. The TOF was operated in ‘V-mode’ for 
optimal sensitivity. Matrix ions were detected from solid state CHCA samples, prepared from a 
saturated solution in acetone, in the first demonstration of the ion source. Only a single LSM (D) 
of those tested was found to be compatible with this source, possibly due to the lack of additional 
desolvation. Unfortunately, one quadrupole RF generator was defective meaning MS/MS was not 
possible with this instrument as the quadrupole could not isolate ions with a specific m/z. Despite 
its problems, the QTOF Ultima Global served as a substantial learning experience and a platform 
for developing the first proof-of-concept method for this project. 
 
 
Figure 14: Optical diagram for the AP-MALDI source mounted to the QTOF Ultima. Components are not to scale. Ghost 
beams are omitted for clarity. 
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Figure 15: Photograph of the QTOF Ultima AP-MALDI source assembly. The DHB-containing sample is shown fluorescing 
upon exposure to the UV laser beam. 
The majority of MS analysis was performed on a Synapt G2-Si HDMS (Waters), a state-of-the-art, 
Q-IM-oaTOF MS that was installed in the laboratory six months prior to this project’s 
commencement. Important features were the StepWave ion guide, for effective removal of 
neutral species from the ion beam; an 8K quadrupole for transmission of an extended m/z range 
(up to approx. m/z 8000); the TriWave device, allowing for ion mobility measurements, ETD, and 
two stages of CID; and a high-resolution TOF analyser (mass resolving power of 10,000 – 40,000 
measured on the [M+2H]2+ ion of [Glu1]-Fibrinopeptide B, mode dependant) for sensitive, 
accurate mass (<1 ppm) measurements. The instrument was typically operated in ion mobility-
TOF mode, with ‘sensitivity’ ion optics in the desired polarity.  
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Figure 16: Schematic of the Synapt G2-Si modified to show the newly developed AP-MALDI source attached.109 The TOF 
ion beam is depicted for sensitivity optics. Original schematic adapted from a presentation by Eleanor Riches224 
The ‘Synapt’ was also modified using a custom-built AP-MALDI ion source, differing from that of 
the QTOF Ultima Global’s in that a custom heated ion transfer tube was fitted to the API inlet as 
described previously.109 The main laser was an MNL100 nitrogen laser (LTB Lasertechnik Berlin, 
Berlin, Germany) and was operated at a repetition rate of 1-30 Hz with approximately 20 µJ/pulse. 
A second laser, a 355 nm Nd:YAG FlareUV 200-100 Waters A1.0 (InnoLight GmbH, Hannover, 
Germany) with a pulse rate of ~0.65-1 kHz was added towards the project’s end. The lasers were 
mounted to an optical breadboard atop the MS, with optics transmitting the beams to the ion 
inlet, as depicted in Figure 15. UV optics, optical breadboard and kinematic components were 
purchased from Thorlabs (Newton, NJ, USA). The laser pulse energy was measured with a J9LP 
pyroelectric Joulemeter (Coherent, Santa Clara, CA, USA).    
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Figure 17: schematic comparison of the inlets of the QTOF Ultima Global and Synapt G2-Si. The heated inlet promoted 
ESI-like desolvation of liquid droplets aiding the formation of multiply charged ions. 
 
 
Figure 18: Optical diagram for the AP-MALDI source mounted to the Synapt G2-Si. Components are not to scale. Ghost 
beams are omitted. 
 
The AP-MALDI ion source was recognised as a nanoESI source by the Synapt, allowing access to 
the standard nanoESI software controls. This was achieved by ensuring the ‘Source ID’ voltage 
was supplied detected as 2.6 V by addition of a 1 k resistor. Other push switch interlocks were 
defeated to allow operation of source gases and high voltages.  
The MALDI sample plate was mounted to an electronically controllable XY-stage assembly (Zaber 
Technologies Inc., Vancouver, Canada) and a thumbscrew-controlled stage for the Z-axis. A PTFE 
MALDI sample plate holder with magnets for fixing the metal MALDI sample plate was attached to 
the XY stage.  The Zaber stages were connected to the Synapt control computer by USB for 
software communication. Three software control schemes were implemented:  
37 
 
1. Zaber Console: The manufacturer’s software, providing a graphical user interface (GUI) 
and scripting environment for stage control. Information such as stage coordinates were 
available here. 
2. Custom-written software with a GUI (developed by former group member Dr Pavel 
Ryumin) suited to selecting locations on a single sample with mouse clicks. This provided a 
more convenient way of selecting wells than the Zaber Console for day-to-day tests. 
3. Scripts run from within Waters Research Enabled Software (WREnS), enabling control of 
the stages by the mass spectrometer. This was the control scheme of choice for large 
sample batches analysed under a fixed set of conditions (see section 2.3.4 and  
Appendix 2).  
 
 
The potential difference between the MALDI sample plate and the ion transfer tube was typically 
set to 3-3.5 kV, the resistance wire around the heated ion transfer was set between 26 and 30 
W,provided by a low voltage DC power supply, and the cone voltage at 30-40 V. The ion transfer 
tube was treated as disposable, since crude samples would slowly contaminate the inlet. Baseline 
expected performance was accepted on achieving 1e4 counts per second measured on the 
[M+2H]2+ ion of [Glu1]-Fibrinopeptide B from a 100 pmol droplet with LSM A. When this was 
unobtainable the tube was replaced. Counter-flow N2 gas was provided through the heated ion 
transfer tube up to a rate of 200 L/h as required (analyte-dependent). The approximate transfer 
tube temperature, at various N2 flow rates, has been published previously.109 A schematic for the 
ion inlet is shown in Figure 19, with a photograph of the setup shown in Figure 20. A variety of 
solid and liquid MALDI samples were compatible with this source, including all of those in Table 2. 
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Figure 19: Schematic of the MALDI sample plate and ion inlet on the Synapt G2-Si AP-MALDI source.109 
 
Figure 20: Photograph of the Synapt AP-MALDI source inlet assembly. 
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Important gases for the ion mobility-TOF MS(/MS) experiments included the drift gas in the 
travelling wave ion mobility spectrometry (TWIMS) cell, which was N2 to give a cell pressure of 
approx. 2.5 mBar, the trap and transfer cell gas for CID, which was argon, to give cell pressures of 
approx. 0.02 mBar, and the helium cell gas, which was set to approx. 3.8 mBar (cf. Figure 5).  
Specific details of each experiment are discussed in the relevant sections. 
For comparative purposes, a QTOF Premier (Waters) was used. It featured the standard 
intermediate vacuum (<0.1 mBar) MALDI source. The laser was a 337 nm nitrogen VSL-337ND-Si 
(Spectra-Physics). The TOF was operated with ‘V-mode’ ion optics. Liquid samples prepared for 
this mass spectrometer first underwent drying in a rough vacuum chamber to limit outgassing 
when loaded.  
In general, open laser beam experiments were only undertaken, and high voltage interlocks 
defeated, after consultation with H&S staff at the University, and in accordance with the site-
specific H&S regulations. All open beam pulsed lasers were secured with physical or digital keys 
and interlocked to the laboratory door to ensure immediate shutdown in the event of 
unauthorised or accidental access. 
 
2.3.2 Lasers and Optics. 
This section refers to the components of the diagrams in Figure 14 and Figure 18. Five pulsed UV 
lasers were used for experiments across the three mass spectrometers. The MNL100 nitrogen 
laser (with a wavelength of 337 nm, max. pulse rate of 30 Hz, and a pulse width of approximately 
3 ns) was used for most of the research reported in this thesis. Nitrogen lasers often have a 
rectangular beam shape with a corner missing due to the output coupler in the laser cavity (Figure 
21). Energy distribution through the beam cross section is relatively even, sometimes described as 
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a ‘top hat’. Generally, the beam quality will decrease with laser age and number of pulses due to 
leakage from the gas cell, although this is a serviceable part.  
 
Figure 21: Pulsed N2 337 nm lasers; (a) schematic from VSL-337-ND-S manual225 (b) photograph of the fluorescence 
produced by irradiation of a white card with this laser, and (c) fluorescence from a white card produced with the 
MNL100 laser. 
The nitrogen laser on the Synapt was fitted so that the beam was 10 cm above and parallel to the 
breadboard surface. This design consideration left space for optical component mounts. The 
beam was attenuated with a neutral density filter attached to a stepper motor, which was 
controlled by an Arduino Uno (Arduino, Somerville, USA) microcontroller and auxiliary 12 V DC-
power supply. The 3.3 V output of the Arduino Uno was used in place of 2x 1.5 V batteries to 
power the red pilot laser. A remote switch was added to the pilot laser to allow for easier 
operation. 
The second pulsed laser attached to the Synapt was the Innolight FLARE PQ UV 1k-30, frequency-
tripled Nd:YAG (355 nm) laser and introduced much later in the project, following research into 
high-repetition rate lasers by group member Jeffrey Brown.132 It was added to the Synapt setup in 
tandem with the 337 nm laser. An additional mirror was included to swap from the 337 nm to the 
355 nm beam. This solid-state laser was vendor-optimised for a maximum pulse rate of 1 kHz, 
although responded to transistor-transistor logic (TTL) triggers down to 650 Hz. It featured a beam 
expander immediately after the laser aperture, and an elliptical beam shape with a cone-like 
energy profile (Figure 22). 
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Figure 22 (a) Fluorescence produced by a white card in the path of the 355 nm FLARE PQ laser beam showing the 
elliptical beam profile. (b) Energy profile for the 1064 nm model of the FLARE PQ laser, reprinted from the 
manufacturer’s documentation.226 An equivalent for the frequency tripled 355 nm wavelength was not available. 
Squares indicate measurements, whilst the line is calculated. 
While this setup left a laser pulse repetition range of 31-649 Hz that could not be investigated 
between the two lasers, the high and low ends of the interesting pulse repetition range were both 
accessible. The Nd:YAG laser head was attached to the breadboard, which functioned as a large 
heatsink and electrical ground. A periscope device was used to raise the beam to 10 cm above the 
breadboard, ensuring compatibility with existing optics used with the 337 nm laser. The energy 
output for the 355 nm wavelength was measured to be approximately 30 µJ per pulse at 1 kHz, 
considerably lower than the laser label’s value of 0.5 mJ per pulse. An attenuator was not fitted as 
the laser beam’s energy was further reduced due to the inherent transmission losses of the 
optical components. For MALDI experiments, the laser energy per pulse reaching the sample plate 
was in the range of 20 – 25 µJ, depending on the laser pulse repetition rate.  
With both UV lasers operating at the same height, optical components were shared by both 
beams and only a single pilot laser was required. The optical diagram in Figure 18 depicts how the 
pilot laser beam was added to the UV lasers’ paths with beam splitters (approx. 10% reflective). 
Irises were used to ensure alignment of the UV and pilot beams was parallel to the breadboard 
surface. The pilot laser was then directed through the lens onto the MALDI sample plate. The 
laser beam was checked to be positioned centrally on the optical components for best fine-tuning 
flexibility. 
The QTOF Ultima Global only featured a single laser at a time and was thus simpler in its laser set-
up. The laser was operated at a maximum pulse frequency of 30 Hz (337 nm or 355 nm). 
The QTOF Premier’s laser apparatus was unmodified from the factory default and typically 
operated with a laser energy set between the arbitrary values of 200 and 500. The maximum 
pulse frequency used was 20 Hz. 
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2.3.3 Instrument Calibration 
The QTOF Ultima Global was calibrated with a mixture of polyethylene glycol (PEGMIX: average 
Mw 200, 600 and 2000 g/mol) ionised from liquid samples with matrix D. The QTOF Premier was 
calibrated with the same calibrant but using a standard MALDI dried droplet preparation with 
CHCA as the chromophore. 
For lipid-only analysis on the Synapt in both ion modes, the ion mobility cell and TOF analyser 
were calibrated with polyalanine. A greater m/z range was acquired for protein and peptide-
containing samples, so the TOF was calibrated with sodium iodide (2 µg/µL in water/IPA 1:1) up to 
m/z 5000. Interestingly, the latter calibration required a sample prepared without a matrix 
chromophore (matrix G) as otherwise no ions relating to NaI were detected (Figure 23). It is 
possible that the NaI ions are formed exclusively by ESI processes and the MALDI matrix 
compound interferes. The NaI solution (0.5 µL) was added to 0.5 µL of a solution of 
water/MeCN/ethylene glycol (3:7:6; v:v:v) on the sample plate. The laser was set to a pulse 
repetition rate of 10 Hz and focused on the droplet edge to achieve desorption and ionisation. 
Typically, data were acquired for three minutes with steady ion generation to produce intense 
spectra suitable for calibration to an accuracy of approx. 1 ppm. 
 
Figure 23: Liquid AP-MALDI-TOF MS spectra for m/z 750-2000 acquired over one minute for samples of sodium iodide 
with (a) DHB LSM A and (b) LSM G. 
2.3.4 Synapt G2-Si setup for automated sample acquisition 
The MALDI sample plate was inserted into the PTFE stage adapter. The XY coordinates of the 
sample well “A2” were recorded from the Zaber Console. Since “A1” was not an accessible well 
due to the stage travel distance, its value was calculated and added to the WREnS script 
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“Arbitrary Wells Acquisition” (see Section 6.1). The script referenced “A1” coordinates to calculate 
values for all other wells of the sample plate. The mass spectrometer was put into “Operate” and 
the ion source parameters were set. The WREnS script was saved, built and run. A new acquisition 
was started through the MS Tune window in MassLynx. On starting the acquisition, a new data file 
was created in the MassLynx project “data” folder, which triggered the WREnS script to initiate 
control of the XY-stage. The laser was started manually once the stage positioned the first sample 
well in front of the mass spectrometer inlet and was run until the acquisition completed.  
 
2.4 Software and data processing 
MassLynx 4.1 was used to acquire data from the Waters mass spectrometers and process mass 
spectra. DriftScope versions 2.4, 2.7 and 2.8 were used for post-acquisition ion mobility filtering 
and CCS calibration. Abstract Model Builder [Beta] (AMX, version 1.0.1563.0), prototype software 
developed by Waters, was used for most multivariate model building and validation from TOF MS 
spectra. The LIPID MAPS database and Waters Metabolic Profiling CCS Library were accessed from 
within Progenesis QI (v2.2, Nonlinear Dynamics, Newcastle Upon Tyne, UK) for lipid 
identification.227 Progenesis Bridge (v.1.0.29, Waters) was required to process profile spectra prior 
to importing into Progenesis QI. The EZInfo plugin (v3.0, Umetrics, Umeå, Sweden) was also 
accessed from Progenesis QI for additional multivariate data analysis tools. Data were plotted 
with MATLAB R2017a and Microsoft Excel as necessary for visualisation or raw outputs (e.g. 3D 
plots). Microsoft Visual Studio 2015 was used for developing attenuator and stage communication 
software. MarathonControl (v.1.60) was used to control the MNL100 laser. UniDec (University of 
Oxford, Oxford, UK) was used to deconvolute multiply charged protein and peptide mass 
spectra.228 Microsoft Excel and Mmass229 were used for Kendrick mass defect (KMD) calculation. 
Where used in this thesis, the KMD was calculated with Equation 9: 
 
𝐾𝑀𝐷 =  (𝐼𝑈𝑃𝐴𝐶 𝑚𝑎𝑠𝑠 × 
14.00000
14.01565
) − 𝑛𝑜𝑚𝑖𝑛𝑎𝑙 𝑚𝑎𝑠𝑠  Equation 9: Kendrick Mass Defect 
 
2.5 Determination of structural information from metal-cationised phospholipids 
Individual methanolic solutions of phosphatidylcholines (PCs) (2 pmol/µL, 200 pmol/µL for TAP 
MS) and an ethanolic solution of sphingomyelin (SM) (d18:1/12:0) (2 pmol/µL) were prepared. 
Multivalent metal salt solutions (MgCl2, CaCl2, SrCl2, BaCl2, MnCl2, CoCl2, ZnCl2, FeCl2, AlCl3, ScCl3, 
CrCl3 and LaCl3; 1 pmol/µL – 1 µmol/µL) were prepared in water. A hexane/isopropanol (3:2 v:v) 
extraction of soya milk was prepared as in Section 2.6. Sample droplets were added to a stainless-
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steel MALDI sample plate by addition of LSM A or G (500 nL), salt solution (500 nL) and analyte 
solution (500 nL) (in that order) to a well. For CID, argon was the collision gas. Nitrogen was the 
drift gas for ion mobility measurements. TAP experiments were performed according to the 
workflow in Figure 24. It was not necessary to adjust the TriWave settings manually for these 
experiments. 
 
Figure 24: Schematic for the TAP MS workflow 
The reagent 1,4-dicyanobenzene was used for ETD experiments with nitrogen as the make-up gas 
(25 mL/min). A specific ETD ion block was fitted to the Synapt's source to allow introduction of the 
reagent through a glow discharge needle. The trap gas flow was manually set to 14 mL/min, and 
the fill time set to 0.1 s. for m/z 128 (negative reagent ions). The trap DC wave was set to 15 V for 
trapping and lowered to between 0.2 V and 1.5 V for ion-ion reactions. Supplementary collisional 
activation was not used. Initial ETD setup was performed with an ESI source and a solution of 
substance P (50 fmol/µL in water/methanol 1:1) to confirm fragmentation efficiency (at least 2%) 
on the [M+3H]3+ ion. All AP-MALDI experiments in this section were conducted with the heated 
inlet counter-flow gas set to 180 L/h and approximately 200 °C.  
 
2.6 Phospholipid sample preparation (“HIP” extraction) 
N-hexane/IPA (HIP, 450 µL, 3:2, v:v) was added to 50 µL milk. The mixture was vortexed for 
approximately 5 seconds then centrifuged at 13,000 rpm for two minutes at room temperature. A 
volume of 750 nL of the clear, colourless supernatant was added to 750 nL of LSM, which was 
previously spotted on a stainless steel MALDI sample plate. This ensured a domed droplet 
morphology, filling the entire well, which was seemingly advantageous for automation as it meant 
the centre of the well would reliably produce strong signal. Homogenous sample morphology also 
reduced variability in the laser incidence angle between samples, a factor which is suspected to 
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influence overall TIC. The samples were each analysed for ten seconds by automated AP-MALDI 
MS to ensure strong signal intensity for best compatibility with software tools used later.  
 
Figure 25: Liquid MALDI droplets of DHB/glycerol LSM (B) and HIP lipid extract. 
 
2.7 Phospholipids, peptides and proteins analyte extraction. 
Aqueous trichloroacetic acid (TCA) solution (250 µL, 5% in H2O, m:v) was added to 50 µL of milk. 
The mixture was vortexed, followed by centrifugation for 2 minutes at 13,000 rpm and room 
temperature. The supernatant was removed by a Pasteur pipette and discarded. The precipitate 
was dissolved in sodium hydroxide solution (200 µL, 0.5 mM, water/isopropanol 1:1). A few 
seconds of sonication was typically required for complete resuspension. The final analyte solution 
was cloudy and white, not dissimilar to milk in appearance. Samples were spotted as in section 
2.3 and analysed for one minute each by automated AP-MALDI. The extra analysis time was 
required to build signal for the protein ion signals specifically, since they were generally much 
weaker than the phospholipid signals. 
 
2.8 Antibiotic extraction and analysis. 
A solution of the antibiotics amoxicillin, ampicillin, cloxacillin, methicillin, penicillin G and cefalexin 
(30 µL) was spiked into water or bovine skimmed milk (50 µL) for a final concentration of 62.5 
pg/µL of each antibiotic. A -lactamase solution (1 µL, 1.5-3.0 units/µL) prepared in Trizma 
solution at pH 7.4 with BSA filler protein (approx. 1 mg/mL) was added to half of the sample batch 
to mimic the presence of β-lactamase-excreting bacteria and hydrolyse the antibiotics. All 
samples were incubated at 30 °C for two hours without further modification to the solution’s pH. 
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Aqueous TCA solution (170 µL, 5% m:v) was added to each sample, which were then vortexed and 
centrifuged at 13,000 rpm for two minutes. The supernatant was the final analyte solution. An AP-
MALDI parallel reaction monitoring (PRM) ion mobility-TOF MS/MS method was developed for 
confidently detecting the antibiotics and their hydrolysis products by their precursor and CID 
product ions. Since most of the antibiotics were supplied as sodium salts and no further 
purification was undertaken, the sodium adduct ions were generally preferential precursors. PRM 
was used to monitor up to three product ions of each antibiotic, to improve specificity and 
sensitivity.230 In contrast to a triple quadrupole MS, all transitions were monitored on the same 
scan. The PRM scan list is shown in Table 3. Data for ions not specified in the list were stripped 
from the MS/MS functions i.e. only signals for monitored precursor and product ions were 
retained. The quadrupole was set to transmit a narrow window of approximately m/z 1 for the 
precursor since the analytes were low mass, and thus mixed with much of the MALDI background 
signal; low mass (LM) resolution was set to 12.0 and high mass (HM) resolution to 15.0 on the 
instrument tune page.  
Table 3: PRM scan list for the antibiotic detection method. 
PRM scan list file Product Ions (m/z) Transfer collision potential ramp (V)  
Set m/z 1 2 3 Start End Ion 
350.1 333.1 305.1 192.2 10 32 [Ampicillin+H]+ 
372.0 196.2 182.2 - 10 32 [Ampicillin+Na]+ 
366.0 349.1 208.1 114.3 10 32 [Amoxicillin+H]+ 
458.0 284.1 299.1 - 10 32 [Cloxacillin+Na]+ 
403.0 244.1 227.2 285.1 10 32 [Methicillin+Na]+ 
335.1 289.1 176.2 - 10 32 [Penicillin G+H]+ 
357.1 313.1 198.2 - 10 32 [Penicillin G+Na]+ 
348.1 303.1 218.1 - 10 32 [Cefalexin+H]+ 
406.0 362.0 284.0 - 10 32 [AmoxH2O+Na]+ 
390.0 268.0 346.0 - 10 32 [AmpH2O+Na]+ 
476.0 432.0 354.0 - 10 32 [CloxH2O+Na]+ 
421.0 377.0 299.0 - 10 32 [MetH2O+Na]+ 
375.0 253.0 331.0 - 10 32 [PenGH2O+Na]+ 
388.0 266.0 344.0 - 10 32 [CefaH2O+Na]+ 
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3  Results and Discussion 
 
3.1 Determination of structural information from metal-cationised phospholipids 
The results of an investigation into the generation and CID of [L+Ba]2+ ions of 
phosphatidylcholines and sphingomyelins were reported in the journal Analytical and 
Bioanalytical Chemistry under the title ‘Collision-induced dissociation of doubly-charged barium-
cationized lipids generated from liquid samples by atmospheric pressure matrix-assisted laser 
desorption/ionization provides structurally diagnostic product ions’.112 This section includes some 
additional results, as well as the results published in the aforementioned article. 
3.1.1 Generation of metal-cationised doubly-charged phospholipids 
Lipids are typically detected as singly charged ions in MS. This may be in the protonated or 
deprotonated forms, or as adducts formed with ions such as Na+, NH4+ or Cl- depending on the 
chosen ion mode and specific lipid species. More unusually, doubly charged lipid-metal adducts in 
the form [L+2M(I)]2+ and [L+M(II)]2+ may be produced.48, 55, 112 For characterising lipid structure, 
multiply charged lipids can be beneficial for detecting structurally informative fragment ions by 
MS/MS. It was discovered that the Synapt’s AP-MALDI ion source can generate phospholipid 
adduct ions with doubly charged metal cations, and further investigation into MS/MS capabilities 
was conducted. Figure 26 shows the signal intensity for analyte ions detected from DHB-based 
(LSM A) liquid AP-MALDI samples of PC (16:0/18:0) (1 pmol) containing alkaline earth metal 
chloride salts (500 pmol). 5 droplets were analysed for one minute per group. The ion species 
[L+M]2+ was notable, since it contained only a single lipid molecule, but was doubly charged. 
Barium chloride-doped samples produced the most intense [L+M]2+ ions, even when considering 
divalent transition metals, so was prioritised for further investigation. This is likely related to the 
ionic radii of the metal ions and how the lipid incorporates the ion into the gas phase structure. 
Shown in Table 4, the radius of the alkali earth metal divalent ions increases down the group.231 
This corresponds to the trend seen in Figure 26 where [L+M]2+ ion intensity increases with 
effective ionic radius. Trivalent metals ions such as La3+ were not found to produce multiply 
charged lipid adduct ions.  
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Table 4: The effective ionic radii of divalent metal cations used for CID MS/MS.231 
Ion Charge Effective ionic radius (pm) 
Mg 2+ 72 
Ca 2+ 100 
Sr 2+ 118 
Ba 2+ 135 
 
 
Figure 26: Signal intensity for ions from samples of PC (16:0/18:0) (1 pmol) doped with alkaline earth metals (500 pmol) 
for 50 s of analysis time. Error bars indicate the 95% confidence interval for 5 individual droplets prepared from the 
same stock solutions. 
Figure 27 depicts the results of optimisation of the amount of MCl2 (M=Ba, Sr) in liquid MALDI 
samples of PC (16:0/18:0) (1 pmol) with respect to obtaining the most intense lipid ion signals. An 
amount between 0.5 – 5 nmol of metal salt per droplet was determined to be optimal after 
assessment with 5 sample droplets per group. Both metal ions investigated produced similar 
trends in the production of the three ions, but absolute signal intensity was lower for Sr.. 
Interestingly, addition of too much MCl2 was detrimental to overall analyte ion intensity. This 
could be due to ion signal suppression caused by the abundance of ions such as Cl-. 
 
[L+Ba]2+ was detected for PCs (16:0/18:0), (16:0/18:1) and (16:0/18:2) and SM (d18:1/12:0) 
(Figure 28 a-c and d) but could not be found for PE (16:0/16:0). It was suggested that although the 
PE amine group would be protonated under the matrix conditions, the proton itself was mobile 
and could leave should a barium ion coordinate to the phosphate group. This could not occur for 
PC and SM since the head group positive charge was fixed at the trimethylamine group. The 
formation of [PE+H]+ appeared to be favoured over [L-H+Ba]+, however. The presence of isobaric 
PC and PE could be determined, in theory, with this observation. At this point, this has not been 
shown since additional PE standards were not purchased. 
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Figure 27: Ion signal intensity of three ion species from an AP-MALDI sample droplet containing 1 pmol PC (16:0/18:0) 
and (a) Ba2+ or (b) Sr2+ ions (500 fmol-500 nmol). Error bars indicate the 95% confidence interval for 5 sample droplets 
from the same stock solutions. 
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Figure 28: Liquid AP-MALDI-TOF MS spectra exhibiting [L+Ba]2+ (underlined labels) and [L+H]+ of phosphatidylcholines (a) 
PC (16:0/18:0), (b) PC (16:0/18:1), (c) PC (16:0/18:2) and sphingomyelin (d) SM (d18:1/12:0). CID of the peak m/z 414.72 
in the spectrum for (e) did not confirm that this peak represents [PE+Ba]2+. 
3.1.2 CID 
In Figure 29, CID product ions of PC and SM were classified into two major groups: intact fatty 
acids with the formula [snx+Ba-H]+ and protonated fragments resulting from the loss of a fatty 
acid [L+H-snx]+ (with x = 1 or 2). The former are highly abundant, a distinction from the CID 
product ions of singly charged lipid-metal adducts where the fatty acids are detected as part of 
[L+H-snx]+ and inferred from neutral loss. Further MS/MS analysis on individual [snx+Ba-H]+ is 
possible. Detection of [snx+Ba-H]+ suggests a putative alternative attachment of the divalent 
metal cation closer to the acyl chains or a relocation of Ba2+ during CID. The ratios of [sn1+Ba-H]+ / 
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[sn2+Ba-H]+ within the same spectra suggest a mechanistic preference for product ion formation 
dependent on the sn1/sn2 position of the fatty acids. The dominant product ions were recorded 
for the fatty acids at the sn2 site, which is in agreement with previous research that indicates the 
sn2 bond as being more labile in CID of [L+H]+ and [L+Li]+.232 CID of SM (d18:1/12:0) revealed a low 
abundance peak for the sn2 chain (m/z 336.1); other peaks were all identified as being 
headgroup-related, although with some additional peaks to those usually detected with CID of 
protonated sphingomyelin ions.  
A comparison of CID MS/MS product ions of [L+M]2+ is shown in the spectra depicted in Figure 30. 
Mn is included as an example of transition metals performing similarly to the Group 2 elements. 
The trend for producing metal-cationised fatty acid CID product ions is evident for all. 
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Figure 29: Liquid AP-MALDI-CID MS/MS spectra of the precursor ions [L+Ba]2+, indicated by *.. (a) PC (16:0/18:0), (b) PC 
(16:0/18:1), (c) PC (18:1/16:0), (d) PC (16:0/18:2), and (e) SM (d18:1/12:0). For the PCs, the dominant product ions are 
[sn1+Ba–H]+ and [sn2+Ba–H]+ (bold label), and [L+H–sn1]+ and [L+H–sn2]+ with other products including [L+H-sn1-
N(CH3)3]+ and [L+H-sn2-N(CH3)3]+ (regular label), and [L+Ba–H-sn1]2+ and [L+Ba–H–sn2]2+ (underlined label). For the SM, 
many head group-related product ion peaks and a minor peak at m/z 336.10, presumably [amide+Ba–H]+ from the sn2 
position, were detected. 
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Figure 30: Liquid AP-MALDI-CID MS/MS spectra of [L+M]2+ where M is (a) Mn (b) Ca (c) Sr and (d) Ba. Peak labels in bold 
describe ions that contain the metal and underlined labels indicate doubly charged product ions. Metal-cationised fatty 
acids are bold only. * indicates the precursor ion. The formation of fragments described with ‘cn’ labels are shown in 
Error! Reference source not found..  
c1 c2 
c3 
c4 c5 
c6 
c7 
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Figure 31: Bonds determined to be fragmented by CID (red) and ETD (blue) of [PC+Ba]2+ from experimental data. The ‘sn’ 
positions, CID and ETD product ions (discussed later) are indicated. 
 
Pseudo-MS3 performed on the [snx+Ba-H]+ fragment ion by in-source decay (ISD) and CID 
produced product ion spectra that indicated the position of double bonds (Figure 32). Selection of 
these ions from a drift plot in a TAP-MS experiment is shown in Figure 33. Charge-remote 
fragmentation of the acyl chain resulted in peaks every m/z 14 (CH2), except where a double bond 
was present. The double bond resulted in a diagnostic peak separation of m/z 40 (H2C-CH=CH). 
Formation of these fragments is proposed to occur by the mechanisms in Figure 34. Abundant ion 
signals of presumably Ba+• (m/z 137.9) and BaOH+ (m/z 154.9) were also detected. In the future, 
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enhancement of the [snx+Ba-H]+ CID product ion signal might be possible by reducing the 
formation of these two ions, i.e. retaining Ba on the acyl chain.  
 
 
Figure 32: Liquid AP-MALDI-CID MS/MS (pseudo-MS3) spectra of ISD product ions of the precursor [L+Ba]2+ (*) for  
(a) [PC (16:0/18:0) +Ba]2+ ➔ [C18:0+Ba–H]+ ➔ products, (b) [PC (16:0/18:1) +Ba]2+ ➔ [C18:1+Ba–H]+ ➔ products, and 
(c) [PC (16:0/18:2)+Ba]2+ ➔ [C18:2+Ba-H]+ ➔ products. 
 
Figure 33: Drift plot from the TAP analysis of [PC (16:0/18:1)+Ba]2+ showing time-aligned MS3 fragments of MS2 ions 
depicted in Figure 30d. 
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Figure 34: Fragmentation mechanisms proposed for the formation of fragments observed from [PC (16:0/18:1)+Ba]2+ 
 
The spectra in Figure 35b and c show the recorded product ion spectra of a lipid found in soya 
milk for the first and second stages of CID, respectively. From these CID spectra and the MS 
precursor ion spectrum (Figure 35a), it was determined that the peak at m/z 459.8 can be 
assigned to PCs, of which the majority contain isomers of the fatty acid C18:2 (m/z 417.1, 
[C18:2+Ba-H]+). This is further supported by the product ion peak at m/z 502.34 which 
corresponds to the loss of [C18:2+Ba-H]+. At both sn positions the acyl chains must be C18:2 since 
m/z 782.6 is the corresponding [L+H]+ ion. The TAP product ion peaks of [C18:2+Ba-H]+ shown in 
Figure 35c reveal that the majority of the C18:2 isomers are C18:2(Δ9, Δ12). There is some 
evidence to suggest C18:2(Δ10, Δ12) is also present (m/z 293.01), another isomer of linoleic acid. 
Linoleic acid is the major fatty acid in soya milk and as such this was not unexpected.233 
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Figure 35: Liquid AP-MALDI TAP pseudo-MS3 analysis of lipids from soya milk extract. The profile spectrum (a) featured 
several doubly-charged peaks (labelled in inset). CID fragments of m/z 459.82+(b) suggest both acyl chains were the 
same length. TAP MS3 of m/z 417.1 suggests the presence of double bonds at the D9 and D12 positions. Precursor ions 
are indicated by *. 
3.1.3 ETD 
The following work is of interest because not only is the literature on ETD of lipid ions limited, but 
ETD performed on MALDI-generated ions is not common either. Barium-cationised PC ions 
[L+Ba]2+ produced by liquid AP-MALDI were successfully fragmented by ETD (Figure 36). The 
product ion spectra were comparable to the spectra obtained from additional experiments 
performed with an ESI source (data not shown). The charge-reduced product ion [L+Ba+e]+• and 
ETD reagent adduct ion [L+Ba+1,3-dicyanobenzene]+• were detected, showing the ion-ion reaction 
was taking place. Structurally important ETD fragments denoted e1 – e3, are indicative of the 
fatty acid side chain identities. For each of the lipids in Figure 36, the e1 and e2 ions, with m/z 
617.2 and m/z 632.2 respectively, correspond to the loss of the C18:n fatty acid. The e3 ions 
correspond to the alternative; loss of the C16:0 side chain. Interestingly, the mechanism for e2 
and e3 results in different bonds being cleaved compared to CID (Error! Reference source not 
found.). Fragments e2 and e3 are the result of ester bond cleavage, as previously reported for 
[L+2Na]2+ ions.48 Unlike CID, fragments corresponding to barium-cationised fatty acids [snx+Ba-
OH]+ were not detected, suggesting the barium ion does not relocate during the ETD process. A 
product ion indicative of the headgroup was not identified. 
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Figure 36: Liquid AP-MALDI-ETD-QTOF MS/MS spectra of barium-cationised (a) PC (16:0/18:0), (b) PC (16:0/18:1) and (c) 
PC (16:0/18:2). 
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3.2  High-throughput milk speciation 
3.2.1 Initial considerations and requirements 
An aim of ambient ionisation techniques is to significantly reduce, or eliminate entirely, the 
requirement for sample preparation. REIMS provides a good example where this is successful for 
direct analysis of biological samples when equipped with an iKnife electrosurgical tool; to the end 
user it is simply a point-and-click sampling device with much of the complexity of mass 
spectrometry obfuscated.138, 234-236 However, the electrosurgical device is optimised for tissue 
analysis. Liquids analysis has proven more difficult and development of laser and sonic probes to 
adapt for these is still ongoing.237 Conversely, our in-house developed AP-MALDI source was 
designed for native compatibility with liquid samples. However, preliminary liquid AP-MALDI MS 
investigations revealed that crude milk would require analyte extraction to produce information-
rich mass spectra. Attempts to analyse crude milk directly, mixed with LSMs, produced sparsely 
populated spectra. Detrimentally, crude milk added to LSM also rapidly became viscous enough to 
behave as if it were solid. This is because the low pH of the LSM, typically around pH 2 for 25 
mg/mL DHB, causes the milk to curdle. Unfolded proteins form clumps and increase the viscosity 
of the droplet. Figure 37 shows a typical spectrum for crude bovine skimmed milk (3-minute 
summed spectrum at 30 Hz laser repetition rate) when analysed with LSM B. Predominantly 
featured were sodium and potassium adduct ions of lactose (m/z 365.12, m/z 381.09), and 
evidence for sodiated and potassiated polysaccharides (m/z 707.23, m/z 723.21). This was 
recently evident in spectra of water/methanol diluted samples analysed by direct infusion ESI in 
the literature.190 Other ions in the range m/z 650-900 were potentially attributable to 
phospholipids but were of low relative intensity considering the acquisition duration. The 
following sections demonstrate how simple sample preparation led to improved spectra obtained 
from milk samples enabling rapid analysis and classification. 
 
 
Figure 37: Positive ion mode AP-MALDI-TOF MS spectrum of crude skimmed milk from direct addition to the DHB-
based LSM B. Sodium and potassium adducts of lactose dominate the spectrum at m/z 365.12 and m/z 381.09. 
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The initial development of lipid profiling by liquid AP-MALDI MS was carried out on the QTOF 
Ultima. Despite attempts to achieve ionisation with a variety of LSMs, only the LSM D was able to 
be used. Nevertheless, lipid profiles were obtained after HIP extraction of cow milk in the first 
analysis. Analysis with LSM D was also trialled on the QTOF Premier to provide a comparison to a 
commercially available, intermediate vacuum MALDI source (Figure 38). 
 
Figure 38: Cow milk lipid extract spectra acquired on the (a) MALDI-QTOF Premier and (b) AP-MALDI-QTOF Ultima MS. 
Once the principle for lipid extraction and MS analysis was demonstrated, the decision was made 
to further develop the method with the Synapt’s AP-MALDI source. The inherent sensitivity of the 
Synapt instrument itself, and the flexibility of the ion source would allow analysis on the order of 
seconds rather than minutes, as was necessary with the QTOF Ultima. The potential for 
automated analysis through the integration of the electronic sample stages and WREnS was also 
attractive. 
Important for high-throughput analysis is limited carryover between samples. The Synapt AP-
MALDI source was assessed with a liquid sample of leucine-enkephalin (1 pmol, LSM A). The 
source was operated with the heated ion transfer tube and counter-flow gas set to the typical 
settings for peptide analysis i.e. 180 L/h counter-flow gas, 200 °C. The TOF analyser was set to a 
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scan time of 100 ms, with an interscan delay of 100 ms. The 337 nm laser was set to a pulse 
repetition rate of 1 Hz. One peak per 5 scans was observed on the extracted ion chromatogram 
(Figure 39). Examination revealed that the analyte signal did not carry over to the next scan on 
this timescale. This was important, as high-throughput could be achieved without overlapping 
sample signals, since the sample stage took at least 0.65 s to move between samples. It was, 
however, beneficial to run analysis with a longer scan time (1 s) to improve per-scan peak 
intensity and compatibility for data analysis. 
 
Figure 39: Chromatogram demonstrating the absence of carryover between scans for the liquid sample analysis by AP-
MALDI. The leu-enk signal (m/z 556.24) is present only for the scan on which the laser was pulsed. The scan time was 
100 ms, with an interscan time of 100 ms. The laser pulse rate was 1 Hz. 
 
3.2.2 Sample classification using phospholipid models 
The supernatant of the HIP extraction was analysed in both the positive and negative ion mobility-
TOF modes with the Synapt’s AP-MALDI ion source. Mobility mode was found to generally 
improve signal intensity for analyte ions. The proposed explanation is that the pulsed ion beam 
from the AP-MALDI source was gated in the ion mobility device and hence better synchronised 
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with the TOF pusher cycles. Ion mobility data was also beneficial to record, enabling charge-state 
filtering, background subtraction and collision cross section calculation. 
Each phospholipid extract sample spot was exposed to approximately 300 laser pulses over a 
period of 10 seconds. Visible consumption, as viewed through the source camera, of the sample 
was not evident after this short analysis period, allowing multiple analyses of the sample if 
required. Advantageously, the DHB LSM A provided sufficiently intense spectra in both ion modes, 
thus a single sub-1.5 µL sample, considering the evaporation of volatile components, provided 
positive and negative mode data. The source parameters were optimised for each polarity; ion 
transfer tube power was kept in the region of 26-30 W to promote desolvation and the MALDI 
sample plate voltage at 3-3.5 kV. The counter-flow gas was set to 180 L/h and 200 L/h for positive 
and negative ion modes, respectively, tuned on the intensity of the peak at m/z 760.6 in an animal 
milk sample.  
 
Figure 40: The distinctive total ion chromatogram produced from automatic sampling using the AP-MALDI source with a 
laser pulse repetition rate of 30 Hz, ten seconds allowed per sample and an inter-sample time of three seconds. The 
dashed line indicates %TIC used for automatic sample detection in software, based on the rise and fall of the signal. 
Distinctive, ‘square wave’ chromatograms were produced by the automated analysis (Figure 40). 
It is interesting to note Figure 41, which shows an example chromatogram and mass spectrum for 
lipid extracts (HIP) of bovine milk analysed for one second each. This is approximately the fastest 
achievable analysis rate with this ion source and the standard Waters MALDI 96-well sample 
plate, limited by the movement speed of the XY-stage, and still produces good quality spectra. 
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Figure 41: (Left) AP-MALDI MS chromatogram of ten lipid extracts using HIP extraction of bovine milk analysed for one 
second each with a 10 Hz TOF scan rate. (Right) The mass profile of the sample indicated on the chromatogram. 
Richly populated positive ion mode mass spectra were produced, particularly in the region from 
m/z 600 to m/z 1000, appearing like those reported in the literature for standard MALDI MS of 
bovine, caprine and ovine milk.178 Ions of two phospholipid classes PC and SM were abundant. 
TAGs were not readily detected presumably because they are typically suppressed by 
phospholipids without additional sample preparation.238 As an aside, preliminary experimental 
data suggested that substituting water for 10 mM ammonium phosphate solution as the matrix 
aqueous component can result in the detection of TAG [M+NH4]+ alongside phospholipids, 
however this was not realised until late into this project. 
45 samples of each of bovine milk (whole and skimmed), whole caprine milk, raw and pasteurised 
ovine milk and unsweetened soya milk were analysed. Individual aliquots were taken from the 
same stock bottle and extracted with the HIP solvent mixture. One liquid MALDI droplet was 
spotted for each of the 45 samples per milk type for a total of 270 spectra. Droplets that escaped 
the sample well during analysis and produced low intensity spectra were ignored for subsequent 
multivariate analysis, resulting in 266 positive ion mode spectra and 268 negative ion mode 
spectra. Likewise, for protein analysis the TCA-based extraction was performed but on half the 
number of aliquots (30 for each of bovine skimmed milk, caprine whole and ovine raw. 15 for 
each of bovine whole, ovine pasteurised and soya), this consideration being made due to the 6-
fold increase in time required to analyse these extracts. 
Example positive ion mode mass spectra for samples from the six milk classes, each analysed for 
ten seconds, are shown in Figure 42. The soya spectrum was distinctly different from the rest: 
some ions with m/z greater than 800 have greater relative abundance than those ions in the 
animal milk. The ions at m/z 782.57 and 820.51 are examples that are essentially absent in the 
animal milks. These signals are attributable to PC(36:4) and PS(39:7) by their m/z. The animal 
milks feature ions such as m/z 815.69, attributable to SM(32:1), which the soya milk lacks. 
Relative intensity variation in ions common to the animal milk spectra can be seen, for example, 
the ratio of ions at m/z 703.57 [SM(34:1)+H]+ and m/z 706.53 [PC(30:0)+H]+ as described 
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previously in the literature.178 This was evident for all technical replicates from the same milk 
stock. Bovine milk featured higher intensity of the PC ion than either caprine or ovine milk. Ovine 
milk featured the highest relative abundance for the SM ion. This trend matches with that 
described in the literature, suggesting it is a characteristic of each type generally. 
 
Negative ion mode mass spectra (see Figure 43) featured peaks for different classes of 
phospholipids than the positive ion mode. PS, PI and PG ions were identified by m/z and collision 
cross section. Collision cross sections were only able to be used as available in databases or 
published research articles. As with the positive ion mode, visual distinction between soya and 
animal milk is possible and the animal milks were more visually similar. Overall, TIC was 
approximately 1 order of magnitude lower in negative mode, with a similar decrease in base peak 
ion intensity.  
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Figure 42: Example positive ion mode AP-MALDI TOF mass spectra for the six milk classes investigated (a) bovine whole 
milk, (b) bovine skimmed milk, (c) caprine whole milk, (d) ovine pasteurised milk, (e) ovine raw milk and (f) soya milk. The 
reported TIC is for a one second scan. 
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Figure 43: Examples of negative ion mode mass spectra for the six milk classes investigated (a) bovine whole milk, (b) 
bovine skimmed milk, (c) caprine whole milk, (d) ovine pasteurised milk, (e) ovine raw milk and (f) soya milk. The 
reported TIC is for a one second scan. The greater m/z range compared to the positive ion mode was used because of 
fewer abundant matrix-related ions and thus the potential for using lower mass metabolites for classification, e.g. m/z 
321.00, 409.01. 
For automatic classification of samples according to their mass spectra, multivariate statistical 
techniques were used within commercial software packages ‘AMX’ and ‘Progenesis QI’ with the 
‘EZInfo’ plugin. Both programs feature mass spectrum normalisation, background subtraction and 
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lockmassing functions for enhancing mass spectra prior to multivariate analysis. The combination 
of these functions can improve the comparability of spectra with varying absolute ion signal 
intensities. Each uses the normalised signal intensities to then compare the variance between 
spectra. AMX sums signal intensity using a binning method (Figure 44) to reduce computational 
load for best compatibility with online classification. The bin size can be specified but it is not 
practical to use a bin size smaller than the peak width, and smaller bins increase model 
computation time significantly. Progenesis QI detects normalised peak intensity for each 
individually resolved peak.  
 
Figure 44: The spectral binning method for a bin size of m/z 1 as used in AMX to reduce computation load. The 
normalised signal intensity is calculated for each bin. 
 
Multivariate statistical techniques such as principal component analysis (PCA), invented in 1901 
by Karl Pearson, have found utility in high throughput MS analysis as they allow the variance 
between many mass spectra to be assessed.239, 240A computer model can be trained to 
characterise samples from mass spectrum features. PCA is an unsupervised method, i.e. the 
correct sample classification is unknown to the model. Thus, it is a way to determine if variable 
features between sample spectra actually exist.241 Linear discriminant analysis (LDA) and partial 
least squares discriminant analysis (PLS-DA) are related techniques suited for automatic 
classification but differ from PCA in that they actively build the model with the sample classes 
predefined.242 It is important that PCA is performed prior to discriminant analyses, as this helps 
prevent overfitting of the data, a problem that can cause a model to fail validation tests. A variety 
of multivariate analysis methods can be found in the research articles in (Table 1) and are 
commonplace in modern research. To consider the subtle, but significant, differences between 
lipid profiles, PCA models were constructed. The parameters for these models are shown in Table 
5. Following separation of samples by class in a 10-dimensional PCA calculation, LDA was 
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performed with three dimensions to build a model suitable for classifying unknown samples. The 
positive and negative ion mode LDA projections are shown in Figure 46. Classification by each 
species is most visually distinct for the positive ion mode.  
Table 5: PCA/LDA model parameters for lipid analysis by liquid AP-MALDI MS profiling 
Model Property Value 
PCA dimensions 10 
LDA dimensions 3 
Intensity limit (arb. unit) 0 
m/z range (Ion mode) 600 – 1000 (+) 300-1000 (-) 
Binning (m/z) 1 
Binning mode Advanced 
Lockmass (m/z) 706.5381, 758.5699 (Soya only) 
Spectrum Interpretation One per burn 
Lockmass Yes 
Background subtraction Yes 
Normalisation Yes 
 
Results of cross validation of all LDA models discussed in this section by a “leave 20% out” 
method, described graphically in Figure 45, are summarised in Table 8. While the positive ion 
mode achieved 100% classification accuracy accounting for the four organisms, the model 
suffered when samples from two groups in a single species were included. Visual overlap of the 
caprine and bovine milk types in Figure 46 suggests little difference in the negative ion mode lipid 
profiles of these samples. The negative ion mode model returned a classification accuracy of 
92.16% for both 4- and 6-class models. The 6-class models split the bovine and ovine milks into 
their two subtypes. While the clustering in the negative ion mode model is less tight, perhaps 
because of lower and more varied analyte ion intensity, there is less overlap between closely 
related samples. The clustering could likely be improved through longer acquisitions improving 
signal to noise ratio and overall signal intensity. It should be noted that the visual projection of 
the data for these models is not precisely an indicator of the model’s accuracy.  
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Figure 45: Graphical representation of the 'leave 20% out' cross-validation. 20% of the data is used as the test set and 
the remaining 80% is used to build the model. The 20% is then tested against this. The process is repeated until all data 
has been in a test set. 
 
Figure 46: 3-dimensional LDA plots of six milk classes constructed from (a) positive and (b) negative ion mode MS 
profiles of lipid extracts; bovine whole (blue), bovine skimmed (red), caprine whole (orange), ovine raw (purple), ovine 
pasteurised (black) and soya (green). 
 
3.2.3 ‘AMX Recognition’ with lipid profiles. 
The ‘AMX Recognition’ software was developed by Waters for real-time sample classification with 
ion sources like REIMS/iKnife, and AMX models. However, it is essentially compatible with any ion 
source, providing the data is collected in the correct fashion, i.e. with distinct increases in TIC 
against the background when a sample is analysed. This is necessary so that the software can 
detect sample mass spectra without the need for manual definition by a user. When a sample is 
analysed the TIC increases. If this passes through the set threshold the software detects the 
following mass spectra as from a sample and will attempt to classify them against an LDA model 
(a) (b) 
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previously trained with AMX. This makes for a streamlined screening process with real-time 
feedback if required.  
The compatibility with data generated by the AP-MALDI source is much the same as with the core 
AMX model builder. To demonstrate this an example screenshot of the AMX Recognition 
application window is shown in Figure 47. The classification of the sample being analysed is shown 
in the window as the sample is analysed, or as data is read by the software in a postprocessing 
mode. The classification is made by comparison to a model built with training data from samples of 
known classification. A record of the assignment of each mass spectrum, plus a probability score, 
allows data to be reviewed and stored for future reference. 
 
The 4-class PCA/LDA milk speciation model was used to classify a mixed test set of 15 HIP-
extracted samples, technical replicates of the milk stocks used to build the model. The 
classification model was selected, the data file for the test set was added to AMX Recognition in 
the post processing mode and the analysis initiated. As was to be expected from the cross-
validation results above, the 15 samples were classified correctly. The AMX Recognition settings 
are shown in Table 6. 
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Figure 47: The application window of AMX Recognition. The left pane shows the current sample classification, the right 
pane shows all analysed spectra with their identification probability and the bottom pane shows the chromatogram. 
 
Table 6: Parameters for the 4-class positive ion mode classification model in AMX Recognition. 
Parameter Value 
Apply Lockmass correction Yes 
Apply background subtraction Yes 
Threshold 10000 counts 
Lockmass m/z 758.5699 (soya) m/z 760.5851 (all others) 
Outlier type Standard deviation 
Standard deviation multiplier 5 
Intensity limit 4E5 counts 
Scans per spectrum 2 
Good spectrum timeout 1 s 
Probability threshold Global (0%) 
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3.2.4 Modelling with ions of charge >1+. 
The custom AP-MALDI ion source was designed for promoting the generation of multiply charged 
ions.108, 109 Recent publications have demonstrated the ability of this ion source for protein 
analysis in both ion modes, although generally negative ion mode signal is poorer in comparison 
to the positive ion mode.222, 223 The use of highly charged positive ions for classification models 
was investigated as a way of making more specific models from underlying organism biology. 
Enhanced understanding of the optimum ion source conditions, along with modifications to milk 
sample preparation, were required for the detection of ions of charge state greater than 1 in 
positive ion mode experiments. No cone gas was used when acquiring the spectra, as it was found 
to promote sodium and potassium adducts for protein ions (see Figure 48). This could be due to 
the increased residence time within the heated inlet while the gas flow is on, allowing more time 
for sodium and potassium ions from the inlet side walls to become attached to the protein ions. In 
addition, the charge state envelope appeared to shift to favour higher charge states without cone 
gas. 
 
Figure 48: Liquid AP-MALDI mass spectra of ubiquitin (10 pmol) produced with (top) and without (bottom) cone gas. 
Sodiation was promoted when cone gas is used, as evidenced by the zoomed 7+ ion region. 
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Positive ion mode mass spectra included ions of the abundant proteins in the animal milk 
samples, however negative ion mode spectra were absent of useable information from multiply 
charged ions (Figure 49).  
 
 
Figure 49: Ion mobility-filtered AP-MALDI-TOF mass spectra (5 min acquisition) show a distinct lack of multiply charged 
ions detected from milk samples in the negative ion mode for the two liquid matrices E and A. 
Figure 50 shows representative mass spectra for the six milk classes, analysed in the positive ion 
mode after extraction by the protein-favourable TCA-based extraction. 
Each sample was analysed for 60 s versus the 10 s used for the lipid-only samples to compensate 
for a relatively low TIC. Despite low analyte ion signal, the specificity of proteins to each species 
provided the opportunity to enhance the classification ability of the model. For example, bovine 
-s1-casein is 239 Da greater than caprine  -s1-casein meaning the two produce distinguishable 
ions at high charge states. This is due to some differences in the amino acid sequences, as 
displayed in Figure 51. 
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Figure 50: Positive ion mode mass spectra of the six milk types acquired over one minute. Ions of high-charge state for 
the abundant proteins in the animal milk (e.g. caseins) were detected above m/z 900. 
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Figure 51: the sequences of -s1-casein for cow and goat aligned to show the differences in the amino acid sequences. 
This results in a mass difference between the two proteins and thus their multiply charged ions exhibit different m/z 
values. 
A multivariate model featuring lipid, peptide and protein signals, for speciation of the six milk 
classes was built with 10 PCA components and 3 LDA components. The model used mass profiles 
from 30 technical replicates of each of bovine skimmed milk, caprine whole milk and ovine raw 
milk and 15 for each of bovine whole, ovine pasteurised and soya milk). This mass profiles were 
generated from AP-MALDI analyses lasting 1 minute per sample and included ions relating to the 
most abundant proteins in the milk typically with >m/z 1000 . The model parameters are shown in 
Table 7. 
Table 7: Properties for PCA/LDA model for milk speciation incorporating high charge state ions. 
Model Property Value 
PCA dimensions 10 
LDA dimensions 3 
Intensity limit 0 
m/z range 600 – 2000 
Binning (m/z) 1 
Binning mode Advanced 
Lockmass (m/z) 706.5381, 758.5699 (Soya only) 
Spectrum Interpretation One per burn 
Lockmass Yes 
Background subtraction Yes 
Normalisation Yes 
 
The projection of the LDA components is shown in Figure 52, where there is greater visual 
distinction between classes, compared to the equivalent lipid-only model (Figure 46a). Inspection 
of the score and loading plots in Figure 53 reveals highly charged ions that contribute to the 
classification power of the model. For example, the bins m/z 1515.5 and 1232.5 contributed to 
ovine milk classification and bins including m/z 1314.5 and 1445.5 contributed to bovine milk 
classification. The results of the ‘20% out’ cross validation are shown in Table 8. There was a 
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notable improvement in classification accuracy over the positive ion mode lipid-only model 
(77.44% increased to 92.59%).  
 
Table 8: ‘20% out’ cross validation results for 5 PCA/LDA models. 
Model Number of spectra Number correct Classification accuracy (%) 
Positive 4-class 266 266 100 
Negative 4-class 268 246 92.16 
Positive 6-class 266 206 77.44 
Negative 6-class 268 247 92.16 
Positive Proteins 135 125 92.59 
N.B. ‘4-class’ refers to models with the two bovine/ovine milk types (i.e. skimmed and whole, pasteurised and raw) 
combined. ‘6-class’ refers to models where the two bovine/ovine milk types were treated as individual classes. 
Table 9: Comparison of per-class classification accuracy for the positive ion mode models. 
 
The reason for this increase in overall accuracy was improved accuracy in classification of 
individual bovine and ovine milk types (Table 9). Bovine skimmed milk spectra were separated 
from bovine whole milk by highly charged ions corresponding to intact proteins such as -casein; 
the bovine whole milk was better characterised by lipids in the range m/z 600 – 760. The 
pasteurised ovine milk spectra featured greater abundance of highly charged ions in bins m/z 
1232.5, 1396.5 and 1513.5 than the raw milk.  
 
Class 
Accuracy for Lipids-
only model (%) 
Accuracy for Protein-
peptide-lipid model (%) 
Accuracy increase 
(%) 
Bovine skimmed 76 87 11 
Bovine whole 56 93 37 
Caprine 100 100 0 
Ovine pasteurised 64 80 16 
Ovine raw 71 93 22 
Soya 100 100 0 
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Figure 52: 3-dimensional LDA plot of six milk classes for the positive ion mode protein-peptide-lipid model; bovine whole 
(blue), bovine skimmed (red), caprine whole (orange), ovine raw (purple), ovine pasteurised (black) and soya (green). The 
shaded regions indicate the species. 
 
 
Figure 53: Score plot (left) and corresponding loading plot (right) from the six-class high-charge ion model. Some protein 
ions (underlined labels) strongly influenced the classifications. 
3.2.5 Lipid Identification 
Compound identification is not strictly necessary for classification models to be useful and, from a 
high-throughput perspective, adds complexity to experiments or data processing. However, 
knowledge of a model’s influential compounds can feedback into understanding the underlying 
biology. 
In this section, identification of compounds in TOF MS profiles is primarily based on accurate mass 
data. In addition, ion mobility data recorded in the N2 gas-filled Synapt G2-Si ion mobility cell 
enabled an orthogonal dimension of separation. Additional dimensions of data can be used to 
filter out background signal and provide greater confidence in compound identification. The 
combination of m/z ratio, collision cross section (CCS), and Kendrick mass defect (KMD) has been 
demonstrated in the literature for identifying molecules in complex mixtures.243, 244 The TWIMS 
cell was calibrated with polyalanine, allowing the CCS of the ions to be calculated. Practically, CCS 
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is a system-independent value, which means the values are comparable throughout the literature, 
whereas the raw TWIMS drift time measurements are not. In the positive ion mode, PC and PE 
[M+H]+ may be isobaric, along with similar m/z isotopic peak overlap with sphingomyelins (Figure 
54).  
 
Figure 54: Example of the peak overlap of two lipids, SM (38:1) and PC (34:1). At a resolution of 10,000 (blue) the second 
isotopic peak of SM (38:1) [M+H]+ is unresolved from the [M+H]+ peak of PC (34:1). At higher resolutions this issue is 
alleviated. 
However, each of these is discernible through IMS separation as they differ in structure, and thus 
CCS. In addition, matrix-related peaks and ubiquitous background ions like polyethylene glycol can 
be differentiated. Finally, the KMD was calculated to determine the degree of unsaturation. This 
provided a third value for identifying lipids as ions possessing differing degrees of unsaturation 
are separable by their KMD. This is a particularly useful feature for lipids, where there are many 
double bonds possible along the acyl chains. 
Three-dimensional plots for lipid ions detected in positive and negative ion mode from caprine 
milk are shown in Figure 55. CCS for different lipid classes are powerful in distinguishing ions of 
similar m/z, for example isotopic peaks of [SM(38:1)+H]+ (m/z 759.637, CCS 305 Å2) and 
[PC(34:2)+H]+ (m/z 758.569, CCS 293 Å2). Since these ions have one and two double bonds 
respectively, they are also separated on the KMD axis. Phospholipid accurate mass and collisional 
cross section data were searched against the LipidMAPS structural database and Waters 
Metabolic Profiling library through Progenesis QI.227 Additional CCS data were also sourced from 
the literature since this is a relatively new area of research and standardised data are only just 
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becoming widely available. A table containing identifications for phospholipids detected from 
goat milk by m/z and CCS can be found in Appendix 2 (Section 6.2). 
 
Figure 55: Three-dimensional plots of m/z, CCS and KMD for caprine milk lipid ions. Examples of ions are labelled for the 
positive ion mode (a) and negative ion mode (b). 
As an alternative to identifications that can be made with MS/CCS/KMD, MS/MS experiments can 
be used for structural analysis, as was demonstrated in Section 3.1. Fragmentation products of 
phospholipids are generally able to establish the lipid headgroup identity, but information about 
the side chain structure is lacking. This was a driving force behind the experiments described in 
Section 3.1. Additionally, a mass profile can include hundreds or thousands of individual 
compounds without chromatographic separation. This makes MS/MS of phospholipids challenging 
due to overlap and convoluted signals.  
Identification of higher charge state ions is discussed in detail in Section 3.3.2. 
 
3.2.6 Dual ion mode classification models 
Since the positive and negative ion mode lipid mass spectra featured exclusive classes of lipids, 
the possibility of models of greater classification power from the combination of this data was 
investigated. Multiple challenges arose with this; foremost, all commercial TOF analysers typically 
operate in only one polarity at a time, the Synapt G2-Si included, although there are some 
references to rapid polarity switching technology in the literature.245 Thus, data acquired from the 
positive ion and negative ion modes had to be combined in an offline process. The “Combine All 
Files” function of MassLynx was not capable of combining data from the two different ion modes 
to create summed spectra. At the time of writing, AMX does not feature tools for assigning 
multiple spectra to one sample, for combining multiple data files or support for importing an 
(a) (b) 
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externally-produced data matrix. This final point was crucial for the eventual test workflow; thus, 
two Progenesis QI projects were used to pre-process the lipid spectra from each ion mode with 
background subtraction, normalisation and peak picking and EZInfo was used for multivariate 
analysis. EZInfo allowed the export of data matrices for each polarity, which were combined in 
Microsoft Excel. The combined matrix was imported back into EZInfo. A similar classification 
method to LDA, PLS-DA, was available in EZInfo. PLS-DA is another supervised machine learning 
technique. Like LDA, the discriminating factors between sample groupings are assessed and 
subsequently used for classification of unknowns.246 PLS-DA models were then built with the lipid 
spectra for each individual ion mode, followed by the combined data matrix.  
A combined polarity model was constructed from lipid profiles of the 6 milk classes. Data were 
first acquired in the positive ion mode (TWIMS cell and TOF analyser calibrated with 10 g/mL 
polyalanine + LSM A) from sample droplets co-spotted with LSM A. These same samples were 
reanalysed without the need to re-spot after switching the TOF analyser to the negative ion 
mode. Polarity switching was performed immediately after positive ion mode analysis, followed 
by a period of approximately 30 minutes to allow the electronics to settle. Negative ion mode 
calibration of the TWIMS cell and TOF analyser was performed with polyalanine (10 g/mL) and 
LSM A after settling. Samples were analysed for ten seconds in each ion mode, with the laser 
pulse repetition rate of 30 Hz and approx. 20 J of laser energy per pulse. The PLS-DA model 
projection is shown in Figure 56. The results of the cross validation of this combined polarity 
model are shown in Table 10. This initial investigation suggests that there is the potential to 
increase classification power through the combination of positive and negative ion mode spectra. 
Total correct classifications for the positive and negative mode models were 94.4% and 84.6% 
respectively, whilst for combined data this was 98.4%. Whilst this is not suitable for online 
classification with current Synapt-generated data, offline classification could still benefit. Mass 
spectrometer types able to perform real-time polarity switching on the second timescale could 
also take advantage of this. Additionally, the technology for dual polarity TOF analysers has been 
demonstrated; it may be that commercial versions are available in the future.247, 248 Electronics 
that allow faster switching may yet be implemented on a future QTOF platform, although the cost 
is currently prohibitive.  
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Table 10: PLS-DA model cross-validation results for individual and combined ion mode analysis of milk species. 
Model MS Polarity Correct classification rate % 
PLS-DA 6-class 
+ 94.4 
– 84.6 
+ and – (offline combination of MS data from 
consecutive runs) 
98.4 
N.B. ‘6-class’ refers to both bovine milk types, both ovine milk types, caprine and soya milk. 
 
 
Figure 56: PLS-DA plot of lipid profiles for 6 milk classes with positive and negative ion mode data used for construction. 
 
3.2.7 Milk adulteration level estimation 
As an extension of the former sections, the potential for food product adulteration detection 
using a similar procedure as described above was assessed. Calvano et al. have previously 
described a MALDI-TOF MS method showing that the ratio of PC (30:0) [M+H]+ (m/z 706.6) and 
SM (16:0) [M+H]+ (m/z 703.6) can be used to determine whether milk is of bovine, caprine or 
ovine origin.178 Furthermore, they showed that from mixtures of two milk types the ratio of the 
two ions could be used as a predictive value for the %composition. The method was deemed to 
function as an adulteration screening test, to as low as a 10% adulteration level. 
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A MALDI-TOF MS method for detecting adulteration of edible oils used PCA to distinguish oil 
types.176 This method also used the ratio of two lipid ions to estimate olive oil adulteration levels. 
Both lipids were TAGS; the ratio of m/z 881.75, which contains palmitic acid, to m/z 907.76 
increased with greater olive oil content. The limit of detection was estimated to be approximately 
2% olive oil in canola oil. Both studies relied on comparing only two ions for adulteration 
estimates. This would make them easy to fool if they were standardised tests, since the 
adulteration could be masked by addition of the molecule in deficit to change the ratio. In the 
following section, use of the dimensions of a multivariate predictive model is demonstrated for 
adulteration level estimation. 
Positive ion mode spectra from HIP lipid extracts were acquired for 10 seconds per spectrum, at  
30 Hz laser pulse repetition rate, for caprine-bovine milk mixtures in 7 classes; 0%, 5%, 22%, 40%, 
60%, 77% and 100% bovine milk, 11 samples per group class. The percentage composition of the 
mixtures was determined by mass, rather than volume due to the potential for inconsistencies in 
pipetting because of the milk consistency. 
First, for comparison to the literature methods discussed above, the ratios of some abundant ion 
pairs in the same AP-MALDI-TOF MS profiles were evaluated. The regression plots are shown in 
Figure 57. Specifically, the R2 for the ion pair ratio 706.5/703.6 (Figure 57a) was 0.9891, 
comparable to the value reported by Calvano et al. (0.9954).  
To demonstrate the use of multivariate models for composition determination, an orthogonal 
(O)PLS-DA model was built in EZInfo. OPLS-DA allows for better visualisation than PLS-DA, and 
reduces model complexity by removing variation in descriptor variables that is orthogonal to the 
property variables.249 In this application, the descriptors are the sample classifications, and the 
property variable is peak intensity. This initial model contained only 100% bovine whole and 100% 
caprine whole milk spectra with the m/z range 600-1000. This made an orthogonal model with 
single-dimension ‘t[1]’ class discrimination based on the differences between bovine and caprine 
milk, and intraclass discrimination ‘to[1]’. Spectra from the caprine-bovine milk mixtures were 
processed and overlaid on these two dimensions, where separation on t[1] occurred per the 
mixture composition. Figure 58 shows the individual samples per class plotted in colour. Black 
points show the mean for each class with error bars indicating the 95% confidence interval. The 
trendline R2 of 0.9996 indicates a linear relationship between %mass bovine milk and mean 
interclass separation, t[1]. This type of plot would be suitable for use as a calibration curve for 
binary mixture content estimation. The model is likely to be more robust to individual molecule 
tampering since it is not dependent on only two ions. 
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The R2 value of the OPLS-DA model suggests it is beneficial to assess many spectral features for 
this application for best linearity. The R2 for the ion pair ratio 706.5/703.6 reported by Calvano et 
al. (0.9954) is slightly worse than the 0.9996 achieved with the OPLS-DA model. It is also true for 
all additional ion pair ratios investigated here (Figure 57). It is likely that the reason for this is that 
the variability in relative intensity when monitoring just two ions is greater than when all ions 
within a range are considered, thus leading to a less linear fit. With both the ion pair and OPLS-DA 
approaches, it is advantageous to produce the calibration plot based on the mean of multiple 
measurements since variation is evident on an individual sample basis.  
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Figure 57: Regression plots for ion pairs in the same bovine/caprine milk mixtures used for Figure 58. The coefficient of 
determination, R2, is displayed for each plot. The error bars show the 95% confidence interval. 
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Figure 58: OPLS-DA plot for mixtures of bovine and caprine milk (% mass bovine milk). Black points mark the mean of 
each class and error bars indicate the 95% confidence interval. The R2 value indicates a linear relationship between 
sample composition and t[1]. 
Composition prediction modelling with PCA/LDA is also possible using AMX. As of AMX version 
1.0.1563.0 the data matrix does not export the raw LDA dimension values, so plotting of a 
calibration curve is not possible. The model was built using the parameters shown in Table 11 and 
the LDA model is shown in Figure 59. 
Table 11: Parameters for constructing the bovine/caprine mixtures PCA/LDA model. 
Model Property Value 
PCA dimensions 10 
LDA dimensions 2 
Intensity limit (arb.unit) 0 
m/z range (ion mode) 600 – 1000 
Binning (m/z) 1 
Binning mode Advanced 
Lockmass (m/z) 760.5851 
Spectrum Interpretation One per burn 
Lockmass Yes 
Background subtraction Yes 
Normalisation Yes 
 
AMX ‘20% out’ cross validation resulted in a correct classification rate of 95.95%. The failed 
classifications were always classified as a member of an adjacent group (e.g. ‘bovine 5%’ 
identified as ‘caprine 100%), not unreasonable considering their closeness in the predictive space. 
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Figure 59: (a) Chromatogram as seen in AMX, where samples were automatically detected, and their classification 
defined (b) 2D LDA plot from mass profiles of mixtures of bovine and caprine milk (%mass). The colour of the sample 
indicates their classification as specified in (a). The samples are separated along the x-axis, which is the component that 
enabled discrimination between classes. 
 
AMX enabled the use of ‘AMX Recognition [Beta] version 1.0.1563.0’ for real-time and offline 
classification of samples. A disadvantage of this over the plotting of a calibration curve is that 
samples can only be classified into discrete groups. The classification scale is only as fine as the 
user decides by producing calibration samples for those discrete classes. Nevertheless, the speed 
of post-processing and the ability to run the software in real-time with sample acquisition makes 
for a rapid screening process. To demonstrate this concept, the PCA/LDA model described above 
was exported to AMX Recognition. The same data was loaded into the software for assessment, 
with the settings as shown in Table 12.  
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Table 12: Parameters for AMX Recognition demonstration with bovine/caprine milk binary mixtures. 
Parameter Value 
Apply Lockmass correction Yes 
Apply background subtraction Yes 
Threshold 10000 counts 
Lockmass m/z 760.5851 
Outlier type Standard deviation 
Standard deviation multiplier 5 
Intensity limit 6E5 counts 
Scans per spectrum 10 
Good spectrum timeout 1 s 
Probability threshold Global (0%) 
 
Figure 60 shows the processing window. The classification of MS scans is shown in the right pane, 
with the selected or current scans in the left pane. The bottom pane shows the chromatogram. 
Lockmass errors were reported when the laser was not sampling i.e. there was no m/z 760.5851 
peak to recalibrate to and indicates the inter-sample period. This does not apply where the ‘good 
spectrum’ timeout has been set optimally and ‘bad’ scans are ignored. The classification results of 
the model when assessed using AMX are shown in Figure 61. 
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Figure 60: Demonstration of AMX Recognition in 'Post-Processing' mode. The left pane shows the current or selected MS 
scan, the right pane shows the scan list and the bottom pane contains the chromatogram. Ten scans were combined per 
reported classification and the ‘intensity limit’ set to 6e5 counts to correctly select samples. 
 
It must be mentioned that AMX Recognition will require some usability upgrades to be fully 
compatible with the data produced by AP-MALDI. It is not easy to set the software to correctly 
detect samples and ignore background, particularly for samples with many scans of low signal 
intensity. This will be discussed later in relation to the contents of Section 3.3. In this case it was 
less of an issue because the signal intensity was high compared to the background. However, 
using too few scans would result in inaccuracies as shown in Figure 62. 
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Figure 61: Statistics for the reclassification of the samples used to build the model. 100% class accuracy is theoretically 
achieved at 14.29%.  
 
 
Figure 62: Example of classification inaccuracy in AMX, linked to sampling too few MS scans (2/spectrum); the correct 
classification for the sample in scans 1425-1439 was caprine 100%, but the high sampling rate did not allow a suitably 
intense spectrum to be produced. 
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3.3 Detection of mastitis in dairy cows by liquid AP-MALDI MS of sampled milk 
 
The development for this method began with an auspicious visit to the Centre for Dairy Research 
(CEDAR) at the University of Reading. A test set of milk samples was acquired from healthy and 
mastitis-affected cows. Additionally, some samples with a high somatic cell count, but not 
diagnosed as having mastitis, were included. In total, 10 healthy cows, 9 with mastitis and 10 with 
high SCC were included in the initial sampling. After HIP extraction, liquid AP-MALDI MS profiling 
and PCA in Progenesis QI, a loose clustering of samples according to the above groups was 
demonstrated (Figure 63). From this point, the method was developed using aqueous extractions 
to include more biologically specific molecules (proteins, peptides), as is explored in the following 
sections. 
 
Figure 63: The initial principal component analysis performed on HIP extracts using positive ion mode liquid AP-MALDI 
mass spectra. Blanks were the solvents used for lipid extraction (HIP). 
3.3.1 Classification 
The method was further developed for the Synapt’s AP-MALDI ion source, utilising the heated 
inlet to generate multiply charged peptide and protein ions, in addition to the lipids used in the 
original experiment. The samples were prepared by the method in Section 2.7. AP-MALDI-TOF MS 
profiles of 135 individual samples from two groups ‘Healthy’ and ‘Mastitis’ were compared 
(example spectra in Figure 64). For healthy samples, lipids and highly charged milk protein ions 
were detected. Mastitis samples featured additional ions, with charges between 2+ and 7+ 
indicative of peptides and larger protein fragments. In addition, the protein peaks detected in 
healthy samples were reduced in intensity or absent in the mastitis samples. The peaks at m/z 
868.86 and m/z 724.23 were obvious differentiating ions in the example spectra. However, using 
the multivariate statistical techniques discussed in Section 3.2 allowed multiple spectral features 
to be evaluated. An ion mobility-filtered spectrum that shows multiply charged ions from a 
mastitis sample is shown in Figure 65, revealing the richness of the information available from 
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peptide and protein ions.  
 
Figure 64: AP-MALDI-QTOF MS spectra representative of the two classes, (a)'Healthy' and (b)'Mastitis'. Ions of m/z less 
than 600 were not used for classification to avoid matrix-related ions. Underlined labelling indicates an ion charge >1. 
 
Figure 65: Ion mobility-filtered AP-MALDI-QTOF MS spectrum focused on the range m/z 500 -1000 for a mastitis sample 
featuring many multiply charged ions. The singly charged ion signals obscured many of the peaks without the filtering 
applied. Charge states were determined through a combination of isotopic pattern assessment and deconvolution. 
Cone gas was not used for the mastitis model data acquisition as it was detrimental to the ion 
signal intensity of higher charged ion species and led to increased sodiation (as demonstrated in 
Figure 48). The signal intensity per second was relatively low compared to the HIP extracts, so an 
acquisition time of one minute was required allowing for a more intense summed spectrum. This 
especially benefitted the protein ion signals. Further improvements to sample preparation and 
the ion source could reduce the acquisition time, increasing the throughput of the method. Initial 
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experiments with the 1 kHz Nd:YAG laser have suggested multiply charged ion signal intensity 
from these complex samples could not be enhanced just by increasing laser pulse rate, regardless 
of the cone gas setting. This was in contrast to results of liquid AP-MALDI experiments that have 
shown an approximately linear increase in signal intensity of multiply charged peptide ions at 
pulse rates up to 500-1000 Hz with a Nd:YLF laser ( = 349 nm; approx. 8 ns pulse duration).132 
Where that research showed the potential for a 100-fold increase in analysis speed (from 10 Hz to 
1 kHz), the same benefit was not found in a brief investigation with the 1 kHz laser in our set-up 
(=355 nm). While a benefit was seen with the doubly and triply protonated angiotensin I ions, it 
was not observed to the same degree with peptide ions in the crude milk extracts (Figure 66), 
which may be due to the effect of the biological matrix. It is likely that the high pulse repetition 
may effectively ‘drill’ through the liquid droplet if replacement of material by healing is not fast 
enough. This would lead to a lower than expected increase in absolute signal intensity. It may be 
necessary to use laser pulse energy nearer to the threshold energy when pulsing at higher 
frequency to avoid this.  
 
 
Figure 66: Fold increase in signal intensity at 10 Hz (all signals = 1), 30 Hz (=337 nm laser) to 650 Hz and 1 kHz (=355 
nm laser) pulse rates for ions of the peptide standard angiotensin I (A) and the 4340 Da peptide (P) found in mastitis 
samples. 
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Figure 67 shows mass spectra of a mastitis sample analysed at 1 kHz. Compared to Figure 64, the 
relative ion signal intensity for multiply charged ions is significantly reduced with respect to lipid 
signals. However, there are multiple factors to consider here. First, two different lasers were used 
each featuring a different UV wavelength and pulse width, likely influencing how much material 
was ablated from the droplet. The ion suppression effects of a complex biological matrix like milk 
is also likely to impact signal intensity. This could be investigated by spiking peptide standards into 
the milk and assessing signal intensity versus that of a standard of the same concentration in high-
purity solvents. As such, further investigation of different lasers and sample preparation 
modifications may provide advantages at a higher repetition rate.  
 
 
Figure 67: Liquid AP-MALDI mass spectra acquired with a 1 kHz Nd:YAG laser with a pulse energy of approximately 22 J 
(a) with cone gas and (b) without. Multiply charged peaks had a lower relative intensity compared with those acquired 
with a N2 laser at 30 Hz (Figure 64). The inset shows the example peak at m/z 868.68, which is prominent at 30 Hz with 
the N2 laser. 
For healthy and mastitis sample classification with data acquired using the 337 nm laser, a model 
featuring 10 PCA dimensions and 1 LDA dimension was constructed from a pool of 73 healthy 
mass profiles and 62 mastitis mass profiles acquired in automated sequences. Each mass profile 
represented a single sample from a cow on a given day. Some cows were sampled up to three 
times for this model but always with at least a week between sampling. The model properties are 
shown in Table 13, and an example of the AMX sample processing window is shown in Figure 68. 
AMX was used rather than Progenesis QI because of its better native handling of the ‘burn’ 
chromatograms, more streamlined process for classification and the cross-validation tools. The 
processing window enabled manual checking of sample detection and summed spectra. This was 
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necessary with the mastitis model, since the TIC was lower, and the automatic processing would 
sometimes select samples incorrectly. Variability in ion signal peak intensity between samples was 
minimised through preparation of extracts with fresh solvents, reagents and liquid matrices. 
Samples had all encountered two freeze-thaw cycles, once during collection and once for 
aliquoting. Samples were all stored and extracted in the same type of 1.5 mL centrifuge tube to 
reduce the risk of variability due to different polymer-related background ion signal. Likewise, the 
same type of pipette tips was also used. Three stainless steel MALDI sample plates were used 
exclusively and were cleaned with the same procedure. They were rinsed with HPLC grade water, 
followed by HPLC methanol then sonicated in 1:1 methanol/water for 5 minutes. Finally, the 
sample plates were blown dry with nitrogen, something which, anecdotally, reduced the 
frequency of liquid droplets escaping the sample plate wells. Droplets were observed prior to 
analysis to ensure homogenous appearance. Droplets that did not keep the ‘domed’ profile on the 
target were spotted again. Normalisation was applied to each mass profile based on the total ion 
count in order to account for ion production between sample droplets. This was essential to 
reduce variability introduced by the sample wells on the MALDI sample plate, the condition of the 
heated inlet and other sources of day to day variation. The lockmass peak for each class was also 
monitored. Samples where this peak was not detected were rejected since this indicated a 
problem at some point during sample preparation. 
 
Table 13: AMX Parameters for the mastitis detection PCA/LDA model. 
Model Property Value 
PCA dimensions 10 
LDA dimensions 1 
Intensity limit 0 
m/z range 600 – 2000 
Binning (m/z) 1 
Binning mode Advanced 
Lockmass (m/z) 760.5851 
Spectrum Interpretation One per burn 
Lockmass Yes 
Background subtraction Yes 
Normalisation Yes 
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Figure 68: Screenshot of the AMX sample list, automatic sample detection and mass spectrum display. 
 
Separation along PC2 showed the analysis detected differences between the sample groups, 
without additional classification information being supplied (Figure 69a). The PCA loading plot and 
LDA1 mass loading plot (Figure 69b and c respectively) show that the classification relies strongly 
on the abundant multiply charged ions detected, in addition to some phospholipids, as for the 
food analysis application.  
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Figure 69: (a) Projection of the first two PCA dimensions shows separation between two classes. (b) Loading plot for PC1 
and PC2. Underlined labels are for ions with z>1. (c) Mass loading plot for the LDA model. Peak intensity indicates ion 
influence on classification. 
 
The model classification performance was assessed by the built in ‘leave 20% out’ cross validation 
in AMX. Outliers were determined by a standard deviation of 5. Sensitivity of 0.90 (56/62 mastitis 
spectra) and specificity of 1 (73/73 healthy spectra) were obtained, with a total correct 
classification rate of 95.56%. Importantly, no false positives were reported possibly due to the 
‘closeness’ of the healthy samples in the classification space. The apparently greater level of 
variability for mastitis samples was tentatively attributed to the individual animal’s response to 
infection. Attempts to establish trends based on cow age, pathogen, and SCC did not reveal much 
information. With this level of classification accuracy, it is worth considering how this method can 
be adopted for a working dairy. The model was built without replicate samples and these could be 
included should further confidence in the classification be required. On the other hand, this would 
increase the workload throughout the method to the point where it may be impractical for a large 
herd. An alternative might be to accept the mastitis classification after two successive 
classifications as such. Milking may occur two or three times a day by a semi-automated process 
for large herds, so mastitis classification would still be obtainable within a day.  
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From the loading plots in Figure 69b, multiply charged ions in bins m/z 724.5, m/z 868.5, m/z 
869.5, m/z 1351.5, m/z 1350.5 and m/z 1182.5 were more abundant in mastitis samples than 
healthy, while for multiply charged ions in bins m/z 1091.5, m/z 1143.5 and m/z 1200.5 the 
opposite was true. Some singly charged ions corresponding to phospholipids also exhibited higher 
relative intensity in one class or another. The explanation of this trend in the multiply charged 
ions was found in the identification of these ions by spectrum deconvolution and MS/MS analysis 
(Section 3.3.2). 
 
As with previous sections, AMX Recognition was demonstrated for potential online, real-time 
classification. Using the healthy/mastitis PCA/LDA model (Figure 69) and AMX Recognition post-
processing mode, example datafiles were analysed by the software and are shown in Figure 70. 
Since the software is still in development, the settings for correct performance were tested to 
give correct sample selection. For this functionality demonstration the settings in Table 14 were 
used. 
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Figure 70: AMX Recognition windows showing the ability to classify healthy and mastitis samples in post-processing 
using the PCA/LDA model. This is transferable to online classification when samples are analysed in real time. 
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Table 14: Parameters for AMX Recognition demonstration with healthy and mastitis samples 
Parameter Value 
Apply Lockmass correction Yes 
Apply background subtraction Yes 
Threshold 10000 counts 
Lockmass m/z 760.5851 (All classes) 
Outlier type Standard deviation 
Standard deviation multiplier 5 
Intensity limit 1E6 counts 
Scans per spectrum 60 
Good spectrum timeout 60 s 
Probability threshold Global (0%) 
 
3.3.2 Mastitis model compound Identification 
Classification by multivariate analysis did not require the identity of compounds to be 
determined. However, ion identification was sought to better understand the underlying 
biological processes behind the classification. With this knowledge, the ability to build targeted 
methods and predicative models is possible enabling improvements to sample classification. 
Multiply charged ions detected by liquid AP-MALDI MS of milk extracts are displayed in Table 15. 
Some of these were of low intensity and only evident after ion mobility filtering for charge states 
greater than 1 (as seen in Figure 65). In the mastitis samples, peptide ions were more plentiful 
than in the healthy milk. This is arguably evidence of responses to infection, which result in the 
degradation or reduced synthesis of milk proteins.219 These ions were detected with charge states 
in the region of 2+ to 8+.  
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Table 15: High charge state liquid AP-MALDI ions from healthy and mastitis samples. 
Contributing ions (most abundant m/z) Deconvoluted mass (Da) Healthy Mastitis 
477.284+, 636.373+, 954.552+ 1905  x 
583.345+, 728.674+, 971.563+  2910  x 
664.876+, 797.455+ 3981 x x 
620.947+, 724.256+, 868.905+, 1085.884+, 
1447.823+ 
4340  x 
644.398+, 736.157+  5145  x 
1046.825+, 1307.754+  5226  x 
1224.307+, 1428.326+ 8561  x 
1051.019+, 1182.178+, 1351.027+, 
1576.376+ 
9450  x 
812.7813+, 880.5212+, 960.5511+  10551  x 
1183.1310+, 1314.819+, 1478.888+, 
1689.947+  
11820 x x 
1413.7413+, 1531.1212+, 1670.3111+ 18360 x x 
1046.8223+, 1092.9622+, 1145.2621+, 
1202.2420+, 1265.6719+ 
24020 x  
 
Using this information, a targeted PCA/LDA model was built from the same data as the original 
model, over a narrow m/z range (m/z 720 – m/z 740). This included three peptide ions (m/z 
728.8.67, 724.25 and 736.15) and multiple phospholipid ions. All other settings were as before. 
This narrow m/z range resulted in an increase in classification accuracy to 98.52% when assessed 
by ‘leave 20% out’ cross validation, while maintaining a specificity of 100%. Interestingly, the two 
samples that still failed classification were from two cows on the same date. This date (02 March 
2016) was the middle sample of three consecutive mastitis samples from the two cows. The cows 
had received treatment after the first sampling and required further treatment after the third 
sampling. This suggests that the mastitis symptoms (clots) had improved by the second sampling, 
in which case the markers for the multivariate model may also have been affected. This 
relationship will be assessed by the continuation of this project over the next few years. 
Deconvoluted zero-charge mass spectra also show the shift to lower mass analytes in the mastitis 
samples (Figure 71). The dramatic difference in the relative intensity of the 24,020 Da signal 
suggests degradation of caseins (including -casein and -s1-casein) was significant. The peak at 
28,420 Da was tentatively assigned to -lactalbumin (dimer), which also saw a reduction in 
intensity in mastitis samples. However, the signal at approx. 18300 Da was present in both sample 
classes, suggesting -lactoglobulin is less affected by mastitis infection. 
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Figure 71: Example of deconvoluted mass spectra calculated from multiply charged species detected from representative 
healthy and mastitis samples. ‘?’ indicates degradation products from abundant milk proteins. 
Some sufficiently intense multiply charged ions were subject to CID MS/MS. Shown in Figure 72a 
and b, two peptides were identified as N-terminal fragments of bovine α-s1-casein (accession 
number: P02662, without the signal peptide); (a) the 4340 Da peptide ([M+5H]5+ m/z 869) was 
amino acids R1-V37 and (b) the 2910 Da peptide ([M+4H]4+ m/z 729) was amino acids R1-F24. 
Cleavage of the protein occurred between V37/N38 and F24/V25 respectively. Neither of these 
peptides are the result of plasmin hydrolysis, which is an endogenous protease in milk that has 
specificity to the carboxyl side of Leucine (L) and Lysine (K).250, 251 Plasmin has been suggested for 
use in mastitis detection previously.252 The cleavage resulting in the 2910 Da peptide can be 
attributed to the action of Cathepsin B or D.253 The peptide of 4340 Da was reported previously, 
along with a peptide of approx. 3984 Da, which is the result of plasmin cleavage between residues 
K34 and E35, that potentially could be the identity of the peptide of 3981 Da. This peptide was not 
fragmented here but the mass difference could be due to low signal intensity and accuracy of the 
deconvolution. This peptide occurred in both healthy and mastitis samples here, detected by 
liquid AP-MALDI MS (see Table 15, Figure 65). Previously, it was hypothesised that the 4340 Da 
peptide is formed by another, unidentified enzyme.253, 254 Both peptides (4340 Da and 2910 Da) 
contain the sequence of a known antimicrobial peptide (isracidin, residues 1-23). Ions of the 4340 
Da peptide were especially powerful for the mastitis classification. 
-casein and α-s1-casein-derived peptides previously suggested as mastitis biomarkers from 
capillary electrophoresis (CE-) MS studies were not detected by liquid AP-MALDI MS, and 
conversely, peptides and protein fragments detected by AP-MALDI MS were not reported in the 
CE-MS work.255 This is perhaps because AP-MALDI detects the most abundant molecules since 
there is no chromatographic separation, whereas CE-MS features CE separation prior to MS, 
enabling greater sensitivity thanks to reduced competition between ions. 
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Figure 72: Liquid AP-MALDI-CID MS/MS spectrum of (a) [M+5H]5+ (m/z 869) and (b) [M+4H]4+ (m/z 729) annotated to 
highlight y, b and immonium ions. The proposed sequences are displayed above the mass spectrum and represent N-
terminal fragments (amino acids R1-V37 and R1-F24 respectively) derived from bovine α-s1-casein (P02662). 
CID MS/MS of the [M+7H]7+ precursor ion (m/z 1351, Figure 73) of the 9450 Da protein suggests 
identification as the C-terminal amino acids T126-V209 of -casein. In addition, CID MS/MS of the 
[M+8H]8+ precursor ion (m/z 1479, Figure 74) suggests the 11,820 Da protein is similar, consisting 
of -casein (P02666) C-terminal amino acids H106-V209. The first -casein fragment features an L 
residue at the cleavage site (L125/T126) and the second fragment includes a K residue (K105/H106), 
which may indicate plasmin-related activity is involved in their formation. With this information it 
can be suggested that the peptide of 8561 Da is the -casein C-terminal amino acids H134-V209, 
although MS/MS data were not obtained. The MS/MS peak lists for the CID-MS/MS spectra in 
Figure 72-Figure 74 are included in Appendix 3. That these protein fragments are largely exclusive 
to mastitis samples raises the potential for them to be used as markers for more targeted tests. 
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Figure 73: Liquid AP-MALDI-CID MS/MS spectrum of the [M+7H]7+ precursor ion at m/z 1351. The precursor ion can be 
attributed to a C-terminal fragment of -casein (P02666), amino acid residues T126-V209. 
 
Figure 74: Liquid AP-MALDI-CID MS/MS spectrum or the [M+8H]8+ precursor ion at m/z 1479. The precursor ion can be 
attributed to a C-terminal fragment of -casein, amino acid residues H106-V209. 
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3.3.3 Liquid AP-UV-MALDI profiling without a UV-chromophore 
As observed by Koch et al. with liquid samples, laser desorption/ionisation (LDI) at AP using a laser 
with a wavelength of 337 nm can also be performed without the addition of a traditional UV 
matrix chromophore.89 This simplifies the sample preparation through the omission of 
preparation of a matrix compound. Signals related to matrix chemical background are omitted, 
although there is still a contribution from other sources, for example the sample plate. Doubly 
charged metal-phospholipid ions of the type discussed in section 3.1 can be generated from liquid 
droplets without a chromophore. Figure 75 shows how the intensity of ions in BaCl2-doped (500 
pmol), PC (16:0/18:0) (1 pmol) liquid samples differs between chromophore and chromophore-
lacking droplets. No acid (TFA, FA, etc) was added to either sample. With a 2,5-DHB LSM (LSM A), 
the [L+H]+ ion peak was >100x as intense (4.55e6 counts versus 1.38e4 counts) than the peak for 
the [L+Ba]2+ ion. In the analysis with LSM G, the [L+H]+ peak intensity was only 2.26e3, three 
orders of magnitude lower than with LSM A. However, the [L+Ba]2+ peak intensity was similar to 
that recorded with LSM A. This suggests that the protonated ion formation may largely rely on 
processes involving the matrix e.g. proton transfer, whereas ionisation with the Ba2+ ion is 
independent of the matrix. This could indicate these ions are preformed in the droplet and are 
desolvated in the heated ion inlet upon ablation from the sample droplet.
 
Figure 75: BaCl2-doped liquid samples of PC (16:0/18:0) analysed by (a) AP-MALDI with LSM A and (b) AP-LDI with LSM G 
for 1 minute. The signal intensity (indicated above the ion label) for the protonated analyte ion is three orders of 
magnitude lower without a chromophore, suggesting protonated ion formation benefits from the inclusion of a MALDI 
matrix. The doubly charged barium adduct ion is very similar intensity in both samples. Known matrix-related ions are 
marked with ‘M’. 
Multiply charged ions are also generated for peptides and proteins, as with AP-MALDI LSMs and 
similarly to SAII, where multiply charged ions are also predominantly produced.256 Figure 76 
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demonstrates the potential for rapid profiling with a mastitis milk sample. The same number of 
laser shots (300) for matrices A (Figure 46a) and G (Figure 46c) produce drastically different 
spectra. However, a MALDI sample with LSM A (Figure 76b) analysed for the same time period (30 
seconds) but higher pulse repetition rate, and thus 900 laser shots, resulted in an improved 
spectrum compared to Figure 76c. However, analysis without a chromophore was more difficult 
to perform because of the requirement to focus on the droplet edge, and in general it appears the 
signal intensity per volume of sample consumed is higher. 
The protein fragment ion [M+7H]7+ at m/z 1531 is most resolved with the LSM G, allowing 
straightforward determination of its charge state. The ion is comparably intense in spectra (Figure 
76b) and (Figure 76c). Peptide (e.g. m/z 724.24) and phospholipid (e.g. m/z 703.57) ion intensities 
were also similar over the 30 second period. 
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Figure 76: Liquid AP-(MA)LDI mass spectra of mastitis sample 17M09 analysed with matrix A (a) 300 laser shots at 10 Hz 
(b) 900 laser shots at 30 Hz and (c) matrix G with 300 laser shots at 10 Hz. Underlined labels denote examples of multiply 
charged ions. The [M+7H]7+ peak at m/z 1531 is most resolved and intense without chromophore. 
 
An obstacle to analysis without a chromophore being adopted for automated analysis is that LSM 
G requires the laser to be focused on the edge of the droplet for ions to be detected, whereas 
LSMs containing chromophores e.g. LSM A do not. A computerised system which can identify the 
sample edge and position the laser accordingly would be necessary for this to be applicable to 
high throughput analysis with the current MALDI target. Optionally, a new target geometry could 
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be developed that simplified producing ions from these samples, for example by channelling the 
sample to a specific position on the sample plate surface. Some preliminary work related to this 
idea has been published by Koch et al..89 The chromophore-lacking samples were limited to 
analysis at lower laser pulse rates (< 20 Hz). This is possibly because the ‘healing’ ability of the 
droplet is compromised by being ablated at an edge, in part because the droplet is shallower. 
Finally, the sample consumption compared to chromophore-containing matrices appeared 
greater; droplets simply did not last for as long as with other LSMs at the same laser energy and 
pulse rate. This might explain the somewhat better signal intensity over a short period ,although 
signal per ablated volume is probably worse, but comes at the expense of not being able to return 
to a previously analysed sample after storage, for example. Material ejected from the 
chromophore-lacking samples was visually evident when the laser was focused on the droplet 
edge. It is probable that the shorter sample lifetime was observed partly due to this material 
being lost from the sample well. The long lifetime of a chromophore-containing LSM is still likely 
to yield best overall sensitivity given enough time to consume the whole droplet. 
 
 
Figure 77: Liquid material (red dashed ellipse) was ejected from chromophore-lacking samples when analysed by a laser 
focused (approx. red cross) at the droplet edge. This material was lost from the sample well and likely contributed to the 
sample’s relatively short lifetime.  
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3.4  Preliminary work for -lactam antibiotic resistance testing.  
Antibiotics are administered to dairy cattle in the event of bacterial infection, for example clinical 
mastitis, being diagnosed. Growth promoting antibiotics are also used to speed up animal growth 
and increase their economic value, despite evidence to the contrary.257 Some commonly used 
antibiotics are the -lactams, including the penicillin family of antibiotics. These antibiotics and 
their metabolites must fall below concentrations specified by a regional regulatory body (e.g. 
European Union) before the milk from treated animals can begin to be sold again.210 The levels of 
antibiotics in milk may be analysed by LC-MS/MS due to its sensitivity, specificity and the ability to 
perform absolute quantitation.258 These are usually multiple reaction monitoring (MRM) methods 
performed on highly sensitive triple quadrupole MS, which target the analytes and their 
fragments to produce highly specific data.  
Any ion source that does not benefit from chromatographically separating analytes prior to 
ionisation is unlikely to unseat LC-MS/MS from being the primary choice for quantitative analysis 
anytime soon. However, the speed with which an ion source such as MALDI can screen samples 
means there are other opportunities to explore. One such opportunity is the ability to determine 
the antimicrobial resistance of bacteria. Resistance is usually assessed after culturing the bacteria 
for a day or more. However, there is a drive to detect bacteria directly from samples by MALDI-
TOF MS without culturing because of the time savings possible.221  
In this section, the addition of -lactams to milk was explored to provide markers for detecting -
lactam resistant bacteria. It is intended as a demonstration of a methodology and requires further 
validation using samples of known bacteria. -lactam resistance is exhibited in bacteria that 
excrete the enzyme -lactamase, which acts to hydrolyse the four-membered ring of -lactams 
(Figure 78). The hypothesis was that, in the presence of the enzyme -lactamase, the 
concentration of hydrolysis products would increase, and thus their peak intensity in a mass 
spectrum. 
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Figure 78: The mechanism for hydrolysis of penicillin G catalysed by -lactamase. The product is 18 Da heavier. The 
opening of the four-membered ring removes the antibiotic property of the molecule. 
As detailed in Section 2.8, a mixture of -lactam antibiotics was added to aliquots of water and 
bovine whole milk and vortexed. To half of the samples from each matrix (water or milk), -
lactamase solution was added. All samples were subject to incubation at 30°C for two hours. They 
were then diluted with aqueous TCA solution to precipitate proteinaceous content and stop 
enzymatic processes, then centrifuged. The supernatant was analysed by liquid AP-MALDI MS 
with LSM A. Liquid AP-MALDI is tolerant to acids such as TFA and TCA, unlike ESI, so further clean-
up was not performed.259  
The resulting profile spectra were highly populated, including the protonated and sodiated adduct 
ions of the -lactams and hydrolysis products and matrix ions from the MALDI sample 
components. Thus, it was decided that an MS/MS method was required to confidently detect 
these small molecules against the high chemical background signal present in the relevant m/z 
ranges, an example of which is shown in Figure 79. Even with the high resolving power of the TOF 
analyser, it was not possible to confirm the signal at m/z 348.10 was exclusively due to cefalexin. 
Ion mobility separation was not possible as the antibiotic ions overlapped with the background 
signal in this dimension, too. 
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Figure 79: The peak for protonated cefalexin in (a) water and (b) milk extracts as an example of interfering peaks. The 
analyte peak is marked with * and is magnified 10x. The interfering peak (m/z 348.19) only differs by m/z 0.09. 
Parallel reaction monitoring (PRM) with CID was used to monitor multiple transitions from 
precursor to product ions; the product ion signal was used to confirm detection and provide 
precursor ion abundance. On the Synapt, a targeted method like PRM, which is essentially a QTOF 
application of MRM, allowing many fragments to be monitored in parallel due to the TOF’s non-
scanning ion recording) makes use of the transfer cell ion optics to improve sensitivity for the 
transitions monitored.  
First, standards of each antibiotic were subject to CID-MS/MS to determine which fragments to 
monitor. The antibiotic standards were also subject to hydrolysis by -lactamase after which the 
hydrolysis products were also analysed by CID-MS/MS. By choosing fragments from experimental 
data, rather than fragments reported in the literature, the method was tuned for the  specific 
instrumentation. The chosen monitored fragments are shown in Figure 80 for the non-hydrolysed 
antibiotics and Figure 81 for the antibiotic hydrolysis products. The structures of the fragment 
ions are suggested with respect to information in the literature and the METLIN in silico and 
experimental MS/MS spectral database.260, 261 
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Figure 80: Structures of the antibiotic ions studied. The bonds broken by CID to produce the fragments monitored by 
PRM are suggested by the dashed lines, with the nominal m/z value of the fragments indicated. 
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Figure 81: Structures of the antibiotic hydrolysis products studied. The bonds broken by CID to produce fragments 
monitored by PRM are suggested by the dashed lines, with the nominal m/z value of the fragments indicated. 
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In general, sodium adduct ions were favoured as the antibiotics were supplied as sodium salts. 
Example CID-MS/MS spectra from the PRM method for the antibiotics and their hydrolysis 
products from a control and test sample are shown in Figure 82 and Figure 83, respectively. The 
antibiotics and hydrolysed antibiotics product ions were monitored for all samples. This was 
because the enzymatic hydrolysis did not convert 100% of the available antibiotic so there was 
always some signal in the hydrolysed samples. Similarly, other hydrolysis reactions meant the 
hydrolysis products could be present in the enzyme-lacking samples.  
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Figure 82: Liquid AP-MALDI-CID-MS/MS spectra from the PRM data of antibiotic ions in a control sample and beta-
lactamase-containing test sample post-incubation at 30 °C for two hours. Precursors peaks are indicated by *. 
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Figure 83: Liquid AP-MALDI-CID-MS/MS spectra from the PRM data of the hydrolysed antibiotics in a control sample and 
beta-lactamase-containing test sample post-incubation at 30 °C for two hours. Precursors peaks are indicated by *. 
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The workflow for comparison of the test sample to the control is shown in Figure 84. The ratio of 
the summed intensity of each antibiotic’s CID product ions (AC or AB) was calculated versus the 
summed intensity of each hydrolysed antibiotic’s CID product ions (HC or HB) for a control (C) and 
a test (B) sample. Where the ratio of ‘AB/HB’ for the test sample was less than in the control, 
‘AC/HC’, this indicates that the signal for hydrolysed antibiotic product ions was greater.  
 
Figure 84: Workflow for comparison of a -lactamase-containing sample to a control sample. CID products ions of 
antibiotic and hydrolysed antibiotic precursor ions were monitored in both samples since the hydrolysed antibiotics may 
be formed by processes other than -lactamase activity. 
 
 
For every antibiotic in water, and for all but amoxicillin in milk, the ratio was weighted in favour of 
the hydrolysis product in β-lactamase-containing samples (see Figure 85).  The same change was 
not observed for the control samples, despite otherwise identical experimental conditions. This 
suggests that the enzyme was the main cause of hydrolysis of antibiotics in both water and milk. 
The relatively low signal intensity of the [M+H]+ ion is a possible cause of the amoxicillin result. 
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Figure 85: Bar charts showing the ratio of summed CID product ion intensity of antibiotics and their hydrolysis products 
for samples of (a) water and (b) bovine skimmed milk in a control sample and a test sample containing -lactamase. 
                                                                                                                                                                                                                                                                       
Generally, the method would benefit from improved sensitivity to provide confidence in detected 
ions and more rapid analysis. This could be achieved with a higher initial concentration of the 
antibiotic solution or multistep extraction methods such as dispersive SPE that are often used for 
small molecule extraction from biological matrices.262, 263 Modification of the PRM method to 
expand the m/z window transmitted by the quadrupole may also improve signal, although would 
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result in transmission of more of the chemical background. Additionally, coupling the AP-MALDI 
ion source to the most sensitive MS/MS instrumentation available i.e. a triple quadrupole MS 
would likely yield improvements. The current method does not require a high-resolution MS, 
although useful for method development, so this change would not be disadvantaged by this 
change. 
 
These initial results suggest that monitoring for -lactam hydrolysis products may be useful for 
detecting resistance to -lactam antibiotics, whilst avoiding the need to culture and classify the 
causative bacteria. Potentially, this is a reduction from days to hours for performing analysis. 
Liquid AP-MALDI coupled to an MS is potentially a sensitive, high throughput and semi-
quantitative method for these small molecules without the need for chromatography. An 
unknown for further development of this technique, which should be answered as a next step, is 
whether the natural abundance of -lactamase in milk from resistant bacteria would be high 
enough to produce a noticeable change in analyte ratio. The digestion period may require 
extension (thus giving greater time for enzymatic reactions) for changes to be noticeable, as the 
natural concentrations could be much lower than the 1.5 – 3.0 units added to the samples here. A 
milk sample set collected from cows with mastitis was bacteriologically characterised but did not 
provide enough resistant samples for a thorough analysis. As such, this remains an open question. 
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4 Conclusions 
 
4.1 Determination of structural information from metal-cationised phospholipids 
Structural information from PCs and SMs was obtained through liquid AP-MALDI MS generation of 
[L+M]2+ ions and subsequent CID or ETD-MS/MS. Barium was found to be the metal ion which 
produced the greatest intensity of [L+M]2+ signal. CID and ETD produced complementary fragment 
ions. The pseudo CID-MS3 method allowed detailed structural information of lipid acyl chains to 
be determined through charge-remote fragmentation product ions. The methodology was simple, 
involving the addition of small amounts of inexpensive BaCl2 (or other divalent metal salts) to 
liquid MALDI samples. This method complements other MS methods for lipid analysis but has 
been developed for compatibility with AP-MALDI as the focus rather than ESI. There is the 
potential to incorporate previously reported online and offline-coupled LC-MALDI for 
fractionation of complex samples.259, 264  
 
4.2 High-throughput milk speciation 
AP-MALDI-QTOF MS with liquid support matrices was demonstrated to be a flexible analytical 
technique for profiling complex biological samples. It was demonstrated that short analyte 
extractions were hugely beneficial for detecting lipids, peptides and proteins, rather than 
analysing directly from the crude sample. Specifically, phospholipids were readily detectable by 
AP-MALDI MS after a short hexane/isopropanol-based extraction. Multivariate models built from 
phospholipid MS profiles were suitable for classifying milk groups. The combination of data from 
both the positive and negative ion modes was confirmed to present the opportunity for higher 
classification accuracy, to as high as 98.4% with combined positive and negative ion mode data. 
The classification of binary milk mixtures with multivariate analysis was suggested to be more 
robust than classification based on the relative intensity of two 'marker' ions. 
Detecting additional biological molecule classes, such as peptides and proteins, as multiply 
charged ions was demonstrated to contribute to the classification specificity. Improvement was 
found in the positive ion mode, allowing better discrimination between very similar sample 
classes i.e. pasteurised and unpasteurised ovine milk, and skimmed and whole bovine milk. 
Similar highly-charged ions were not detected in the negative ion mode. Many ion sources used 
for rapid profiling do not ionise molecules this large, an advantage of liquid AP-MALDI that can be 
used for additional food profiling and exploited for new applications in the future.  
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4.3 Detection of mastitis in dairy cows by liquid AP-MALDI MS of sampled milk 
The combination of rapid AP-MALDI-QTOF MS analysis of liquid samples combined with 
multivariate analysis was demonstrated to provide the ability to classify samples from two milk 
sample groups, ‘Healthy’ and ‘Mastitis’. Only short sample preparation and analysis time (1 
minute) was necessary to achieve MS profiles suitable for multivariate analysis. The detection of 
multiply charged ions, including peptides and proteins was key to achieving a classification 
accuracy of 95.56% and sensitivity of 0.90, assessed by ‘leave 20% out’ cross validation. No false 
positives were reported. Furthermore, identification of some peptides and proteins in mastitis 
samples suggested that while plasmin proteolysis was partly responsible for casein proteins 
degradation, an unknown process (enzymatic or otherwise) produced some additional abundant 
peptides.  
With this understanding gained from clinical mastitis cases in this study, there is potential for 
these peptides to be used as markers for targeted subclinical mastitis diagnosis. A PCA/LDA model 
built with a targeted range m/z 720-740, which included three peptide ions, achieved an 
increased classification accuracy of 98.52% and retained 100% specificity when assessed by 'leave 
20% out' cross validation. 
4.3.1 Profiling without a chromophore 
The potential for analysis of milk samples without using a matrix chromophore was 
demonstrated. It was necessary to focus the laser at the edge of the droplet, like the sodium 
iodide ionisation described in Section 2. Peak intensity for highly charged ions appeared improved 
versus spectra acquired with a matrix chromophore on a short timescale. However, the 
chromophore-lacking samples were limited to analysis with approx. 10 Hz laser pulse frequency 
(=337 nm), possibly due to a greater ablated volume, which could require more time for droplet 
healing. In addition, their lifetime was much shorter than for chromophore-containing LSMs, 
partly owing to the ejection of droplet material across the sample plate. Chromophore-lacking 
samples are not yet suitable for AP-MALDI high-throughput experiments, but continued 
development of sample preparation and the ion source may make them viable in the future. 
 
4.4 Antibiotic resistance testing 
As an alternative approach to mastitis testing, indirect detection of the presence of -lactamase-
producing bacteria in milk could inform on the health of the cow. Samples spiked with an 
antibiotic mixture and -lactamase solution were analysed by AP-MALDI-PRM MS to determine 
monoisotopic peak intensity ratio differences between the antibiotics and their hydrolysis 
products. While this has yet to be demonstrated with real samples, the proof-of-principle is in 
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place; samples containing the enzyme generally resulted in a greater abundance of antibiotic 
hydrolysis products for experiments performed in water and milk. With further development, this 
experiment could be used as an indicator of bacterial resistance to -lactam antibiotics without 
the need for bacterial culture. 
 
4.5 Final conclusions 
Liquid AP-MALDI MS can play a significant role in the mass profiling field as the technology 
develops, and this thesis demonstrates some of the potential methods and applications. MALDI 
MS is already used for classifying bacteria in clinical environments, and its potential for food 
authentication has been demonstrated by research groups worldwide, as was shown in Table 1. 
The variety of other ambient ionisation sources within the field should mean rapid developments 
continue. The advantages of liquid AP-MALDI, such as dependable ion signal and multiply charged 
ion generation, have been demonstrated for high-throughput applications and biological molecule 
characterisation and alleviate some of the problems associated with traditional MALDI sample 
preparation. This makes it a compelling choice for tackling complex biological challenges, where 
other ion sources may be more limited, for example in their ability to ionise only a small selection 
of molecules. In addition, the option to add simple sample additives to modify the ions signals 
that are obtained from liquid samples provides AP-MALDI with a flexible toolset for molecular 
examination.  
 
The application of liquid AP-MALDI to the detection of bovine mastitis is particularly promising 
since the scale of the dairy industry requires millions of samples to be tested a year.265 Assays that 
maintain the high-throughput of current methods but with improved sensitivity and specificity are 
necessary to reduce economic losses and unnecessary antibiotic use. As such, ubiquitous, cheap 
but inaccurate tests, like the California mastitis test, are set to be replaced. Both the specificity 
and sensitivity of the liquid AP-MALDI MS test classification were higher compared to the existing 
testing methodologies. MALDI MS profiling for mastitis bacteria classification from animals is 
already established in a UK, which is an excellent indication of the potential to adopt more MS-
based techniques for routine testing. Targeted assays focusing on specific biomolecular markers 
for diseases are likely to be the future of many medical diagnoses, for humans too. The targeting 
of a narrow m/z range for mastitis detection here has demonstrated excellent sensitivity and 
specificity. Rapid mass spectrometry assays of human milk have already been initiated for 
REIMS.266 Routine testing of human breast milk with AP-MALDI within hospitals could improve 
detection of mastitis in new mothers, and the lessons learned from the cows’ milk study would 
provide valuable insight.  
122 
 
5 Future Work 
There are a wide range of developments that can be made to the instrumentation and 
methodologies employed in this research. This section discusses and suggests general 
modifications to the ion source and sample preparation methods, then focuses on each of the 
results sections for more specific improvements. 
 
5.1 General AP-MALDI development 
5.1.1 Sample preparation automation 
The sample preparation procedures discussed chapters were kept simple to limit the time 
between crude sample collection and analysis. Another benefit is that these methods are 
amenable to automation using existing proteomics and MALDI-focused robotics. This could 
include, but is not limited to, addition of extraction solutions to samples and spotting of MALDI 
samples onto the sample plate. The latter has been previously demonstrated with MALDI sample 
preparation robots.267 This will be especially important for future investigations involving larger 
cohorts of sampled organisms.  
5.1.2 Source and sample modifications 
Further development of the heated inlet may yield greater overall sensitivity and improved 
multiply charged ion production. There are many options here that could be investigated in a 
systematic study. For example, the inlet length could be varied; the inside of the inlet could be 
manufactured to provide increased surface area; multiple tubes could form the inlet, increasing 
the capacity. The gas could also be heated independently of the capillary. Gases other than 
nitrogen could be used as the counter-flow gas or modifiers, such as isopropanol, could be 
introduced as a vapour into the gas flow. This may affect, and possibly enhance ionisation as with 
the REIMS source.268 In this context, employing a heated impactor as in REIMS in addition to the 
heated inlet may have sensitivity benefits, however the temperature of the impactor may need to 
be tuned for best ionisation performance for peptides and proteins. 
Implementation of a communications setup between the mass spectrometer and MALDI laser 
would allow WREnS scripts to directly control the laser. The source’s current form requires the 
laser to be controlled by separate software. Incorporation with WREnS would allow further levels 
of automation. For example, it was beneficial to turn the laser off between samples on an 
automatic run, otherwise ions were still produced from ablation of the exposed stainless-steel 
target. This meant the difference in ion signal used to distinguish between samples in AMX was 
more obvious than for chromatograms produced with constant laser pulsing. In addition, it may 
be possible to synchronise the laser pulses and ion optics to further improve overall system 
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sensitivity by more efficiently transferring ions from source to detector. Splitting of the laser 
beam to form multiple foci, and thus ablation areas, on the droplet may be another way to 
improve sensitivity. 
The benefits of other lasers could be explored. A =2.94 µm IR laser would be interesting to 
incorporate since water and glycerol absorb this wavelength readily, and UV-MALDI matrices 
could be omitted from the workflow. IR lasers have already been demonstrated for remote 
sampling with a probe design like that of the iKnife.269, 270 Continuation of the work with high 
repetition rate lasers may enable more rapid analysis and greater sensitivity, but the conditions 
will need further optimisation. Other UV-MALDI matrix compounds may be more suitable than 
2,5-DHB for lasers with a wavelength other than =337 nm. The continuing work of group 
member Jeffrey Brown has focused on a solid-state laser (=349 nm). One interesting experiment 
would be to use a higher (>30 Hz) repetition rate =337 nm laser to see how signal intensity scales 
for this wavelength and beam profile. 
 
5.2 Determination of structural information from metal-cationised phospholipids 
This work could continue to be developed to include other species of phospholipids. For instance, 
it would be interesting to see how species such as phosphatidylserine and phosphatidylinositol 
behave since they are typically analysed in the negative ion mode. Confirmation of the lack of 
[PE+Ba]2+ formation is also important, since the current hypothesis is only based on a single 
compound. Finding a way to keep Ba2+ coordinated to the fatty acids would be beneficial for MS3 
sensitivity, since much of it is dissociated as Ba+• or BaOH+. The performance of this method on an 
ion trap instrument capable of ‘real’ MS3 (i.e. not ion mobility-enabled) would be interesting to 
assess. 
It may be interesting to attempt Paternò-Büchi reactions with a modified capillary and acetone 
vapour in the gas flow. Using a quartz capillary and UV lamp (=193 nm) this could be an 
alternative approach to characterisation with the Ba2+ adduct ions and be a demonstration of 
reactions in the ablated microdroplets. Alternatively, ozone could be used as the counter-flow 
gas, similarly to OzESI, to assess another potential gas phase reaction for phospholipid structure 
determination. 
 
5.3 High-throughput milk speciation 
The analysis and discrimination of multiple milk classes was demonstrated, but there is scope to 
expand this methodology to other dairy products and food groups in general. Liquid products are 
an obvious target since the source is natively compatible with this sample state. It may be 
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possible to use the information obtained from this research to learn how to analyse liquid food 
samples without sample preparation. However, a short extraction procedure has been shown to 
be very beneficial for easily detecting many analytes, so this should not be discounted. Other 
samples, such as fruit juices, could be investigated in this way. 
The throughput of this method reported here was approximately 10 s/sample, but it was 
demonstrated that suitable spectra could be obtained at a rate of 1 s/sample. This makes for a 
very high-throughput method on the standard 96-well MALDI sample plate. Since the source is 
limited by the XY-stage translation speed, an obvious and straightforward modification would be 
to use commercially available 386-well sample plates. The distance between each well is much 
smaller (approximately 2 mm), meaning shorter stage travel distance would be required. The 
small volume of wells on these plates (estimated to be approx. 0.25 L) would not be an issue, 
since, a liquid AP-MALDI analysis (performed on the order of seconds) consumes such a small 
volume of sample. Practically, the only required change to the method would be the coordinates 
in the WREnS script, to adapt for the higher density and different well locations on the 386-well 
sample plate. 
 
5.4 High-throughput mastitis detection 
Generally, the method is already successful. However, there are developments that should be 
targeted for further validation and increased rapidity. 
First, developments to the ion source described above could increase the sensitivity. This would 
improve peak intensity per scan and allow reduced sample analysis time, which ultimately would 
improve throughput. Improved sensitivity may also allow detection of lower abundance peptides, 
which in turn could improve classification accuracy. Sensitivity improvements may also be 
achieved from modifications to the sample preparation procedure. For example, replacement of 
sodium hydroxide with ammonium hydroxide may reduce ion suppression and adduct ion 
formation. Modifications should not impact the high-throughput focus of the method however, so 
time-consuming procedures like solid phase extraction should be avoided. 
The software used for building the classification models and online recognition (i.e. AMX and AMX 
Recognition) both require some usability improvements for this method. AMX would benefit from 
the ability to name individual samples on the chromatogram. At the time of writing, only the scan 
numbers are reported which makes relating spectra to samples cumbersome. This could be 
implemented in a standard sample list format, with support for importing .csv files for automatic 
spectrum assignment. This will be especially important for large datasets. 
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The first principal component of a model is often the result of a combination of experimental 
variables (for instance, sample age on target, sample position on target, etc.). It would be useful 
to be able to exclude specific components from the LDA calculation when they are not relevant to 
the classification of the sample groups. It would also be useful to be able to utilise the ion mobility 
data recorded during analysis. The mobility function is not currently used to allow filtering in 
AMX. The ability to import and apply drift time rules would enable subtraction of the signal for 
MALDI matrix ions, ubiquitous synthetic polymers etc. Currently this can be performed with 
DriftScope, but the exported data is often unreadable or appears corrupted when added to an 
AMX project.  
The AMX Recognition software requires the addition of a method more suitable for the liquid AP-
MALDI analyses. The software was developed primarily for use with the iKnife/REIMS ion source, 
where sampling is performed for an undefined amount of time. Thus, the sample is detected by 
the change in TIC. The inclusion of a mode where the sample is detected by the change in 
intensity of a certain ion (for example a MALDI matrix peak) could make for a more reliable 
detection system for liquid AP-MALDI. The matrix ion would not be detected outside of the 
sample wells and so ions produced from the MALDI sample plate would not interfere with the 
detection. This was an issue when the laser was not switched off between samples, where sample 
TIC was of similar intensity as the TIC from ablation of sample plate material. Alternatively, since 
each liquid AP-MALDI sample is analysed for a predetermined amount of time, the software could 
be told to expect samples during set scan ranges. These could be calculated by the software after 
the first sample scan is defined by the user. 
 
5.5 Chromophore-lacking liquid AP-LDI MS analysis 
An obstacle to this being adopted for automated analysis is that LSM G requires the laser to be 
focused on the edge of the droplet for ions to be detected, whereas LSMs containing a 
chromophore compound do not. A computerised system which can identify the sample edge and 
position the laser accordingly would be necessary for this to be applicable to high-throughput 
analysis with the current MALDI sample plate design. This could be done optically i.e. with a 
camera system. Alternatively, this could be achieved using a WREnS script to identify where signal 
intensity is greatest as the laser focus is scanned across the sample, although this would likely add 
a few seconds per sample to any analysis. Optionally, a new target geometry could be developed 
that simplified producing ions from these samples. Finally, the sample consumption compared to 
chromophore-containing matrices appeared greater; this might explain the higher signal intensity 
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but comes at the expense of sample longevity. Further optimisation of the analytical conditions 
may help to extend sample lifetime.  
As discussed in section 5.1.2, the use of a laser with a different wavelength might be a suitable 
solution. Water, glycerol and other diols would readily absorb IR radiation, and the recent 
development of picosecond pulse duration IR lasers could limit thermal effects. This modification 
has already been demonstrated to be a compelling soft ionisation technique with a similar 
ionisation inlet to the one used for this research project.271 
 
5.6 Antibiotic resistance testing 
A proof of concept has been demonstrated for using the conversion of -lactam antibiotics to 
their respective hydrolysis as an indicator for -lactamase activity in milk. This has yet to be 
demonstrated for samples containing -lactamase-producing bacteria. As future projects within 
the research group will continue with a more specific focus on microorganism profiling, there is 
opportunity for the applicability of this method to be assessed. 
  
As with all parts of this project, overall sensitivity improvements would benefit the method. 
Specific to this section, this could be achieved by performing a more efficient analyte extraction, 
for example by adding a dispersive SPE step. This would add time to the procedure but would still 
be faster than bacteria culturing. This should always be a consideration when modifying this 
method in the future. 
 
The MS method would be easy to adapt to highly sensitive triple-quadrupole mass spectrometers. 
It would be written as an MRM experiment in much the same way as the PRM experiment here. 
Tuning of transitions to the specific instrument used might be necessary. In theory, the ion source 
itself can be mounted to all Waters mass spectrometers manufactured within the last ten years 
with ease.  
The method could be expanded to assess additional -lactam antibiotics. Unfortunately, other 
classes of antibiotics, such as macrolides, are not modified to be less potent by resistant bacteria; 
rather the drug target is modified to be less susceptible to attack. For example, methylation of the 
bacterial ribosome is an erythromycin resistance pathway.272 This modification would be much 
more challenging to detect than the -lactam hydrolysis because the modified molecule is so 
much larger. A more specific analyte extraction procedure would likely be required for this to 
work. The proteinaceous content of bacteria in the samples could also be analysed, perhaps by 
adoption of the method described by Barreiro et al.221 
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6 Appendix  
 
6.1 WREnS Script – Arbitrary Wells Acquisition: 
Bold text would be replaced with values as required for the acquisition. 
 
using System; 
using System.IO; 
using System.Threading; 
using System.Collections.Generic; 
using MLReader; 
using MassSupport; 
using GenericInterface; 
using AcqWrensClient; 
using WrensDataProcessing; 
using RunCode; 
using DataConvertor; 
using Solid.Arduino; 
using Stage; 
using StageLogic; 
using SumClassLib; 
using Zaber.Serial.Core; 
 
namespace RunCodePartial 
{ 
public class RunCodeHeader : RunCodeScript 
{ 
public override void main() 
{ 
    connect("epc"); 
   //this will start the script when acquisition is started from MassLynx 
     //watch_file(@"C:\Masslynx\ProjectFolder\Data"); 
 
     //less specific as it watches a whole folder,  
//watch out for data processing taking place while you run as this will 
change the files and kick off the script 
 
  watch_folder(@"D:\data\AP MALDI\Month YEAR.PRO\Data"); 
   //watch_folder(@"D:\data\AP MALDI\name.PRO\Data"); 
   
} 
public override void MainMethod()  
{ 
   
    var port = new Zaber.Serial.Core.ZaberBinaryPort("COM4"); 
   port.Open(); 
   //StageLogic.Primitives.runPatternPlate(port, 
@"C:\wrens_data\88targetplatea.txt", 1000); 
   var dict = StageLogic.Helper.populateDictionary(X_coordinate,Y_cooridinate); 
   //sample well position dictionary. Requires A1 position, use A2 position 
coordinate 
  // knowing 1 mm equals 20997 steps and 4.5 mm distance between each well. I.e. A2 
X-coordinate - (4.5*20997) = A1 X-coordinate 
   dict = StageLogic.Helper.addLMDictionary(dict, X_coordinate,Y_cooridinate); 
   var SampleWell = new List<Tuple<string, int>> 
 { 
          Tuple.Create( "LMA1", time ms),  
          Tuple.Create( "A2", time ms),  
//etc for wells as required. 
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          // LM = lockmass well, time in milliseconds. Modify as required. Can 
analyse all wells except for Column 1. 
 
      }; 
   foreach (var well in SampleWell) { 
     StageLogic.Primitives.move_sample_well(port, dict, well.Item1); 
       wait(well.Item2); 
 } 
  
   port.Close(); 
} 
     
}//class 
}//namespace 
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6.2 Appendix 2: Identified milk lipids from liquid AP-MALDI MS and ion mobility 
data 
Table 16: Milk lipids identified by m/z and collision cross section. 
Descriptiona m/z Mass Error (ppm) Ion CCS (Å2)b ΔCCS (%)c Ref. CCS (Å2)d 
Cer(d40:1(2OH)) 638.605 -4.7 M+H 
 
  
PC(25:0(CHO)) 650.439 0.4 M+H 
 
  
PA(O-34:1) 661.520 4.5 M+H 
 
  
PA(P-34:0) 661.520 4.5 M+H 
 
  
PS(P-28:0) 664.456 2.4 M+H 
 
  
PA(34:5) 665.425 9.3 M-H 
 
  
SM(d32:1) 675.539 -6.7 M+H 
 
  
PE-Cer(d35:1) 675.539 -6.7 M+H 
 
  
PE-Cer(d34:1(2OH)) 677.523 0.3 M+H 
 
  
PS(28:0) 678.430 -7.6 M-H 
 
  
PA(35:5) 679.431 -5.5 M-H 
 
  
PG(O-30:1) 679.494 4.5 M+H 
 
  
PG(P-30:0) 679.494 4.5 M+H 
 
  
SM(d16:1/17:0) 689.555 -6.3 M+H 
 
  
PE-Cer(d36:1) 689.555 -6.3 M+H 
 
  
PS(P-30:1) 690.475 5.9 M+H 
 
  
PI(24:0) 697.391 -4.1 M-H 
 
  
PA(O-37:2) 699.533 -0.3 M-H 
 
  
PA(P-37:1) 699.533 -0.3 M-H 
 
  
PA(P-37:0) 701.546 -4.6 M-H 
 
  
SM(d34:1) 703.573 -2.5 M+H 293 0.8% 291 
PE-Cer(d37:1) 703.573 -2.5 M+H 
 
  
PG(31:1) 705.469 -2.6 M-H 
 
  
PA(O-37:0) 705.581 2.2 M+H 
 
  
PC(30:0) 706.538 -0.4 M+H 
 
  
PE-NMe(32:0) 706.538 -0.4 M+H 
 
  
PE(33:0) 706.538 -0.4 M+H 
 
  
PA(O-38:1) 717.586 9.2 M+H 
 
  
PA(P-38:0) 717.586 9.2 M+H 
 
  
SM(d35:1) 717.586 -6.5 M+H 
 
  
PE-Cer(d38:1) 717.586 -6.5 M+H 
 
  
PC(31:1) 718.545 9.5 M+H 
 
  
PE(34:1) 718.545 9.5 M+H 
 
  
PC(31:0) 720.553 -1.5 M+H 
 
  
PE-NMe2(32:0) 720.553 -1.5 M+H 
 
  
PE(34:0) 720.553 -1.5 M+H 
 
  
PI(26:0) 725.432 9.5 M-H 
 
  
PC(32:3) 728.518 -6.8 M+H 
 
  
PE(35:3) 728.518 -6.8 M+H 
 
  
SM(d36:1) 731.600 -8.8 M+H 299 0.7% 297 
PA(O-39:1) 731.600 6.6 M+H 
 
  
PA(P-39:0) 731.600 6.6 M+H 
 
  
PE-Cer(d39:1) 731.600 -8.8 M+H 
 
  
PC(32:1) 732.554 0.6 M+H 291 1.4% 287 
PE-NMe(34:1) 732.554 0.6 M+H 
 
  
PE(35:1) 732.554 0.6 M+H 
 
  
PC(32:0) 734.569 -1.2 M+H 295 1.2% 291 
PE(35:0) 734.569 -1.2 M+H 
 
  
PI(37:0) 739.438 -2.5 M-H 
 
  
PA(40:10)) 739.438 5.4 M-H 
 
  
PC(O-34:2) 742.571 -5.7 M-H 
 
  
PC(P-24:1) 742.571 -5.7 M-H 
 
  
PE(O-37:2) 742.571 -5.7 M-H 
 
  
PnC(34:1) 742.571 -5.7 M-H 
 
  
PG(34:3) 745.506 5.8 M+H 
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PC(33:1) 746.571 2.7 M+H 
 
  
PE(36:1) 746.571 2.7 M+H 
 
  
PE-NMe2(34:1) 746.571 2.7 M+H 
 
  
PA(39:0) 747.584 -7.8 M+H 
 
  
PC(33:0) 748.586 1.8 M+H 
 
  
PE(36:0) 748.586 1.8 M+H 
 
  
PI(28:1) 751.446 7.5 M-H 
 
  
PI(28:0) 753.454 -2.6 M-H 
 
  
PPA(34:1) 753.454 8.3 M-H 
 
  
PC(34:3) 756.549 -6.3 M+H 297 1.3% 293 
PE(37:3) 756.549 -6.3 M+H 
 
  
PC(34:2) 758.565 -5.3 M+H 294 0.5% 293 
PE-NMe(36:2) 758.565 -5.3 M+H 
 
  
PE(27:2) 758.565 -5.3 M+H 
 
  
SM(d38:1) 759.630 -9.4 M+H 306 0.2% 305 
PA(P-41:0) 759.630 5.4 M+H 
 
  
PC(34:1) 760.585 0.1 M+H 298 0.9% 295 
PE(37:1) 760.585 0.1 M+H 
 
  
PG(35:1) 761.539 6.7 M-H 
 
  
PC(34:0) 762.599 -2.4 M+H 300 1.1% 297 
PE(37:0) 762.599 -2.4 M+H 
 
  
PE-NMe(36:0) 762.599 -2.4 M+H 
 
  
SM(d39:1) 773.652 -1.8 M+H 
 
  
PA(O-42:0) 775.663 6.6 M+H 
 
  
PI(30:0) 781.493 6.9 M-H 
 
  
PC(36:4) 782.566 -5.0 M+H 299 0.4% 298 
PE(39:4) 782.566 -5.0 M+H 
 
  
PC(36:3) 784.577 -9.8 M+H 300 0.3% 299 
PS(O-37:2) 786.565 -1.2 M-H 
 
  
PS(P-37:1) 786.565 -1.2 M-H 
 
  
PC(36:2) 786.598 -3.1 M+H 301 0.0% 301 
PE(39:2) 786.598 -3.1 M+H 
 
  
SM(d40:1) 787.667 -2.3 M+H 311 0.1% 311 
PS(O-37:1) 788.579 -3.1 M-H 
 
  
PS(P-37:0) 788.579 -3.1 M-H 
 
  
PC(O-37:1) 788.659 8.1 M+H 
 
  
PC(P-37:0) 788.659 8.1 M+H 
 
  
PE(O-40:1) 788.659 8.1 M+H 
 
  
PE(P-40:0) 788.659 8.1 M+H 
 
  
PC(O-38:6) 790.581 6.2 M-H 
 
  
PC(P-38:5) 790.581 6.2 M-H 
 
  
PC(O-37:0) 790.670 2.4 M+H 
 
  
PE(O-40:0) 790.670 2.4 M+H 
 
  
MGDG(38:8) 799.542 8.5 M+H 
 
  
PG(38:4) 799.542 -7.7 M+H 
 
  
SM(d41:2) 799.661 -9.6 M+H 
 
  
PS(37:3) 800.546 3.4 M+H 
 
  
SM(d41:1(OH)) 801.683 -1.8 M+H 314 0.4% 313 
PI(O-33:1) 807.543 4.6 M-H 
 
  
PI(P-33:0) 807.543 4.6 M-H 
 
  
PI(O-33:0) 809.553 -2.3 M-H 
 
  
PA(44:3) 811.614 -9.4 M+H 
 
  
SM(d42:1) 815.698 -2.7 M+H 317 0.4% 316 
PG(39:1) 817.593 -4.3 M-H 
 
  
PI(O-34:0) 823.569 -1.4 M-H 
 
  
PS(O-40:4) 826.593 -3.6 M+H 
 
  
PI(O-35:2) 833.560 6.4 M-H 
 
  
PI(O-16:0/19:1(9Z)) 835.570 -1.1 M-H 
 
  
PI(P-35:0) 835.570 -1.1 M-H 
 
  
PI(O-35:0) 837.584 -2.6 M-H 
 
  
PG(41:1) 845.626 -1.9 M-H 
 
  
PG(42:6) 849.573 9.1 M-H 
 
  
PI(O-36:0) 851.595 -8.0 M-H 
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aLipid nomenclature adapted from the LIPID MAPS Classification System (E. Fahy, S. Subramaniam, R. 
Murphy, M. Nishijima, C. Raetz, T. Shimizu, F. Spener, G. van Meer, M. Wakelam, and E. Dennis, Journal of 
Lipid Research, 2009, 50, S9-S14).  bExperimental collisional cross section (CCS) as measured by ion mobility.  
cPercentage difference of experimental CCS compared to the reference literature CCS.  dReference literature 
value of CCS obtained from Waters Metabolic Profiling CCS Library (Waters Corporation) or K. M. Hines, J. C. 
May, J. A. McLean, L. B. Xu, Anal. Chem. 2016, 88, 7329.  Negative ions are highlighted in grey. 
  
PI(P-37:2) 859.569 -1.4 M-H 
 
  
PI (36:2) 861.556 7.6 M-H 300 0.2% 300 
PI(O-37:2) 861.587 1.3 M-H 
 
  
PI(P-37:1) 861.587 1.3 M-H 
 
  
PI (36:1) 863.570 5.5 M-H 306 0.6% 304 
PI(O-37:1) 863.602 0.5 M-H 
 
  
PI(P-37:0) 863.602 0.5 M-H 
 
  
PS (40:3) 864.577 1.3 M-H 302 -1.1% 305 
PG(44:7) 875.575 -7.0 M-H 
 
  
PG(44:6) 877.591 -6.7 M-H 
 
  
PI(P-39:1) 889.625 8.7 M-H 
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6.3 Appendix 3: MS/MS peak tables for Figure 72, Figure 73 and Figure 74 
 
Table 17: Main sequence ions for CID MS/MS [M+5H]5+ m/z 869 
Ion Experimental m/z (mono) Theoretical m/z (mono) m/z Accuracy (ppm) 
y2+ 246.1968 246.1812 63 
b62+ 365.2418 365.2296 33 
y62+ 354.2092 354.2080 3 
y3+ 375.2379 375.2238 38 
y72+ 403.7391 403.7422 -8 
b133+ 506.6420 506.6319 20 
y92+ 516.7934 516.7898 7 
b143+ 549.6494 549.6461 6 
y5+ 560.3416 560.3402 2 
b92+ 561.8424 561.8358 12 
b153+ 582.6757 582.6689 12 
b102+ 590.3508 590.3465 7 
y112+ 638.8580 638.8504 12 
b112+ 646.8944 646.8886 9 
b224+ 650.3874 650.3739 21 
b173+ 658.3884 658.3779 16 
y122+ 674.3672 674.3690 -3 
y6+ 707.4135 707.4087 7 
y132+ 723.9108 723.9032 11 
b203+ 777.1219 777.1011 27 
y7+ 806.4832 806.4771 8 
b142+ 823.9641 823.9655 -2 
y152+ 870.9816 870.9716 12 
b233+ 915.8631 915.8523 12 
b162+ 930.0436 930.0418 2 
y8+ 935.5259 935.5197 7 
b243+ 964.8926 964.8751 18 
b253+ 997.9117 997.8979 14 
b263+ 1021.5961 1021.5769 19 
y9+ 1032.5814 1032.5724 9 
b364+ 1056.0659 1056.0864 -19 
b283+ 1102.9733 1102.9507 21 
y10+ 1179.6567 1179.6408 14 
b10+ 1179.6592 1179.6858 -23 
y212+ 1240.6566 1240.6705 -11 
y11+ 1276.7162 1276.6936 18 
b11+ 1292.7584 1292.7698 -9 
y222+ 1297.2396 1297.2125 21 
y12+ 1347.7568 1347.7307 19 
b252+ 1496.3866 1496.3432 29 
b262+ 1531.9108 1531.8618 32 
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Table 18: Main sequence ions for CID MS/MS [M+4H]4+ m/z 729 
Ion Experimental m/z (mono) Theoretical m/z (mono) m/z Accuracy (ppm) 
y1+ 166.0893 166.0863 18 
y2+ 313.1601 313.1547 17 
b62+ 365.2325 365.2296 8 
b3+ 382.2412 382.2561 -39 
b113+ 431.6056 431.5948 25 
y3+ 469.2502 469.2558 -12 
b82+ 497.8162 497.8065 20 
b4+ 519.3247 519.3150 19 
b143+ 549.6517 549.6461 10 
b92+ 561.8514 561.8358 28 
y4+ 582.3381 582.3398 -3 
b102+ 590.3516 590.3465 9 
y102+ 632.8926 632.8561 58‡ 
b112+ 646.8951 646.8886 10 
y5+ 695.4228 695.4239 -2 
b122+ 695.4228 695.4149 11 
b6+ 729.4448 729.4519 10 
b132+ 759.4464 759.4442 3 
y6+ 809.4839 809.4668 21 
b142+ 823.9678 823.9655 3 
b7+ 857.5694 857.5468 26 
b152+ 873.5227 873.4997 26 
b162+ 930.0602 930.0418 20 
y7+ 938.5136 938.5094 5 
y8+ 1052.5731 1052.5524 20 
y9+ 1165.6617 1165.6364 22 
y10+ 1264.7825 1264.7048 61‡ 
b11+ 1292.7837 1292.7698 11 
y11+ 1393.8014 1393.7474 39 
y13+ 1618.9507 1618.8588 57‡ 
‡likely overlap with a-ions 
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Table 19: Main sequence ions for CID MS/MS [M+7H]7+ m/z 1351 
Ion Experimental m/z (mono) Theoretical m/z (mono) m/z Accuracy (ppm) 
y2+ 231.1705 231.1703 1 
y4+ 441.2980 441.3071 -21 
y102+ 547.8270 547.8397 -23 
y122+ 632.8947 632.8924 4 
y6+ 685.4058 685.4283 -33 
y142+ 730.9427 730.9530 -14 
y7+ 742.4437 742.4498 -8 
y152+ 795.4787 795.4743 6 
b8+ 886.4579 886.4516 7 
y8+ 898.5356 898.5509 -17 
y172+ 941.0295 941.0353 -6 
b243+ 943.8433 943.8217 23 
b263+ 1013.8719 1013.8673 5 
b9+ 1023.5091 1023.5106 -1 
b10+ 1136.5979 1136.5946 3 
b273+ 1046.2239 1046.2182 5 
y10+ 1094.6735 1094.6721 1 
y11+ 1151.7012 1151.6935 7 
b535+ 1179.8472 1179.8429 4 
b313+ 1188.9603 1188.9547 5 
b323+ 1237.9468 1237.9775 -25 
y12+ 1264.7770 1264.7776 0 
b696+ 1310.2096 1310.2015 6 
b595+ § 1331.1140 n/a 
b706+ 1331.6980 1331.7086 -8 
b736+ § 1383.2428 n/a 
b746+ § 1392.7464 n/a 
b242+ 1415.2584 1415.2289 21 
b766+ § 1425.4332 n/a 
b776+ 1451.4886 1451.4501 27 
y14+ 1460.8993 1460.8988 0 
b806+ § 1501.6405 n/a 
b262+ 1520.3162 1520.2973 12 
y413+ 1537.4891 1537.5411 -34 
y15+ 1589.9457 1589.9414 3 
yo584+ 1597.8291 1597.8665 -23 
y584+ 1602.4028 1602.3871 10 
b*443+ § 1649.5294 n/a 
y16+ 1717.9913 1718.0000 -5 
y312+ 1775.9213 1775.9678 -26 
b312+ 1782.9479 1782.9283 11 
b322+ 1856.4905 1856.4626 15 
y17+ 1881.0402 1881.0633 -12 
y18+ 1994.1421 1994.1473 -3 
§: identification suggested by isotopic pattern and approx. m/z from low intensity signal 
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Table 20: Main sequence ions for CID MS/MS [M+8H]8+ m/z 1478 
Ion Experimental m/z (mono) Theoretical m/z (mono) m/z Accuracy (ppm) 
y2+ 231.1701 231.1703 -1 
b3+ 395.2552 395.2037 130 
y4+ 441.2979 441.3071 -21 
y122+ 632.8943 632.8924 3 
y142+ 730.9381 730.9530 -20 
y7+ 742.4234 742.4498 -36 
y152+ 795.4708 795.4743 -4 
y8+ 898.5626 898.5509 13 
b162+ 979.4773 979.4795 2 
y10+ 1094.6942 1094.6721 20 
y11+ 1151.6827 1151.6935 -9 
y12+ 1264.8586 1264.7776 64‡ 
b11+ 1354.7030 1354.6976 4 
y14+ 1460.9055 1460.8988 5 
y302+ 1727.4359 1727.4414 -3 
b14+ 1727.8645 1727.8614 2 
‡likely overlap with a-ions 
 
 
 
 
